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ABSTRACT 
 
Taking into consideration the complex biology of bone tissue it is quite clear that the 
understanding of the cellular interactions that regulate the homeostasis and 
regeneration of this remarkable tissue is essential for a successful Tissue Engineering 
strategy. The in vitro study of these cellular interactions relies on co-culture systems, a 
tremendously useful methodology where two or more cell types are cultured at the 
same time. Such strategy increases the complexity of typical monoculture systems, 
allowing the in vitro settings to closely mimic the in vivo environment. Moreover, 2D co-
culture systems have been extensively used by cell biologists to study cell interactions 
as an attempt to understand specific cellular mechanisms and signalling pathways. The 
interaction between osteoblasts/ osteoprogenitor cells and different cell types relevant 
within the bone Tissue Engineering context, namely mononuclear cells from peripheral 
blood and umbilical cord blood and fibroblasts, has been addressed in the first part of 
this thesis. The different co-cultures showed that mononuclear cells from peripheral 
blood were capable of accelerating the osteogenic differentiation of human bone 
marrow stromal cells by producing BMP-2. On the other hand, osteoblasts cultured on 
carrageenan membranes were capable of supporting the culture of endothelial 
progenitors cells present in the mononuclear fraction of umbilical cord blood that 
contributed to the in vivo angiogenesis after implantation in an inflammatory setting. 
Furthermore, fibroblasts, which are key players in the formation of fibrotic tissue after a 
biomaterial implantation, were shown to decrease the osteogenic activity of osteoblasts 
through gap junctional communication. 
A serious limitation of the paradigmatic use of scaffolds for bone Tissue Engineering is 
the lack of oxygen and nutrient supply to the cells in the core of the engineered 
construct leading to cell necrosis at the bulk of the constructs. Furthermore, foreign 
body response to the implanted biomaterial is a frequent reaction of the host and has 
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as a consequence the formation of fibrotic tissue surrounding the implant.  The use of 
cell sheet engineering for bone Tissue Engineering can potentially avoid those 
shortcomings. One of the explored strategies comprised the production of osteogenic 
cell sheets using this technology. Its potential for in vivo bone formation was analyzed 
and the formation of vascularized bone tissue with a marrow was originally 
demonstrated by implanting a single osteogenic cell sheet in a nude mice model. 
Furthermore, in order to promote vascularization, co-cultured osteogenic cell sheets 
with endothelial cells were also created. Endothelial cells, stacked in between 
osteogenic cell sheets, were proven to contribute to new vessel formation and 
increased bone formation in vivo 
This thesis demonstrates that monocytes/macrophages from peripheral blood can 
accelerate the osteogenic differentiation of osteoprogenitor cells while fibroblasts, have 
a deleterious effect on the osteogenic phenotype of osteoblasts. In addition, within an 
inflammatory host reaction, cells from the mononuclear fraction of umbilical cord blood 
were capable of contributing to new blood vessel formation after co-culture with 
osteoblasts. Moreover, when using the cell sheet technology to fabricate a bone tissue 
engineering construct, endothelial cells were also shown to improve in vivo bone 
formation. 
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RESUMO 
 
Considerando a complexa biologia do tecido ósseo torna-se claro que compreender as 
interacções celulares que regulam a homeostasia e regeneração deste tecido notável, 
é de extrema importância numa estratégia de Engenharia de Tecidos. O estudo in vitro 
destas interacções celulares baseia-se em sistemas de co-cultura, uma metodologia 
de grande utilidade onde dois ou mais tipos de células diferentes são cultivados 
simultaneamente e no mesmo espaço. Estes sistemas representam um aumento de 
complexidade, em relação aos sistemas de monocultura, que permite que as 
condições in vitro mimetizem melhor o ambiente in vivo. Além disso, sistemas de 
cultura 2D têm sido muito utilizados por biólogos no estudo de interacções celulares 
numa tentativa de compreender os mecanismos e vias de sinalização envolvidas. A 
interacção entre osteoblastos ou células osteoprogenitoras com células 
mononucleares do sangue periférico e do cordão umbilical, e com fibroblastos para 
aplicações em Engenharia de Tecido Ósseo foi estudada na primeira parte desta tese. 
As diferentes co-culturas permitiram mostrar que as células mononucleares do sangue 
periférico são capazes de acelerar a diferenciação osteogénica de células do estroma 
de medula óssea humana através da produção de proteína morfogenética do osso 2 
(BMP-2). Por outro lado, foi também demonstrado que osteoblastos cultivados em 
membranas de carragenano suportam a cultura de células progenitoras endoteliais 
presentes na fracção mononuclear de sangue do cordão umbilical humano e que 
estas, por sua vez, contribuem para a angiogénese in vivo e em condições 
inflamatórias. Além disso, foi mostrado que fibroblastos, células-chave na deposição 
de tecido fibrótico após a implantação de um biomaterial, inibem a actividade 
osteogénica de osteoblastos através da comunicação por Gap Junctions. 
A utilização paradigmática de matrizes de suporte para a Engenharia de Tecido Óssea 
tem como limitação grave a falha de fornecimento de oxigénio e nutrientes às células 
no interior da matriz construída levando à necrose dessas mesmas células. Além 
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disso, a resposta do hospedeiro à implantação de corpos estranhos, como matrizes tri-
dimensionais, tem como consequência frequente a formação de tecido fibrótico à volta 
do implante. A aplicação da Engenharia de cell sheets na Engenharia de Tecido ósseo 
tem a expectativa de ultrapassar estas limitações. Uma das estratégias exploradas 
teve como base a produção de cell sheets osteogénicas utilizando esta tecnologia. O 
potencial destas cell sheets para induzir a formação de osso foi analisada in vivo tendo 
sido demonstrada a formação de osso vascularizado com uma estrutura medular 
organizada após a implantação de uma única cell sheet num modelo de ratinho nude. 
Além disso, numa tentativa de promover a vascularização, foram criadas cell sheets 
osteogénicas co-cultivadas com células endoteliais. Estas, quando cultivadas entre cell 
sheets osteogénicas sobrepostas, contribuíram para a formação de novos vasos in 
vivo bem como para o aumento da formação de novo osso. 
Esta tese demonstra que monócitos/macrófagos do sangue periférico podem acelerar 
a diferenciação osteogénica de progenitores osteogénicos enquanto os fibroblastos 
exercem um efeito negativo no fenótipo osteogénico de osteoblastos. Mais ainda, no 
contexto de uma reacção inflamatória do hospedeiro, ficou comprovado que células da 
fracção mononuclear do sangue do cordão umbilical participam na formação de novos 
vasos após co-cultura com osteoblastos. Além disso, as células endoteliais adultas, 
quando combinadas com cell sheets osteogénicas, promovem a formação de osso in 
vivo. 
xi 
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INTRODUCTION TO THE STRUCTURE OF THE THESIS 
The whole strategy of this PhD was based on the assumption that the use and 
development of co-culturing systems could provide a superior way to understand and 
to modulate mechanisms related with bone biology. This understanding and the ability 
to manipulate cell behavior would then have as a result models or tools that could be 
applied in Bone Tissue Engineering in order to overcome some of the current 
shortcomings of this field. Since the ultimate aim is related with bone therapies, the 
connecting thread of the works described in this thesis is osteogenic or osteoprogenitor 
cells(Ost/OstP). In fact, the interactions of Ost/OstP with different types of cells were 
addressed in order to be able to take advantage of those interactions to increase the 
osteogenic potential of Ost/OstP or Ost/OstP-based constructs. 
  
Figure I - Scheme depicting the interactions of osteoblasts or osteoblast progenitors with other cells 
addressed in the works described in the thesis. PB: peripheral blood; mon/mac: monocytes/macrophages; 
BMP-2: bone morphogenetic protein 2; hBMSC: human bone marrow stromal cells; CBMNCs: cord blood 
mononuclear cells; HUVECs: human umbilical vein endothelial cells; CS: cell sheets; VEGF: vascular 
endothelial growth factor. 
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All together, the defined lines of work, based on four co-culture models and one 
homotypic model (figure I), were able to provide new insights over different cellular 
mechanisms that influence the osteogenic process and consequently bone 
regeneration. Under this context, and aiming at framing the explored approaches, an 
introduction is provided in Chapter 1.  
A detailed description of the materials and methods used along the experimental work 
is provided in Chapter 2. This chapter intends to present a clear, although detailed and 
practical presentation of all the techniques used to achieve the reported results. 
Although Chapter 2 contains some information repeated in the subsequent chapters, it 
allows for a better comprehension of the overall methodology followed and provides the 
justification for those options. 
The following 5 chapters of the thesis are based on either already published or 
submitted manuscripts, in the respective formats of the Journals. Each one of them 
comprises the specific background of the study, a brief description of the 
methodologies used, and the presentation and discussion of the results.  
The first work, described in chapter 3, studied how BMP-2-producing mononuclear 
cells isolated from human peripheral blood, more exactly monocytes/macrophages, 
could affect the osteogenic differentiation of human bone marrow stromal cells in a 
direct co-culture system. The eventual supportive effect of osteoblasts over the survival 
of endothelial progenitors of the mononuclear fraction from cord blood was verified in 
chapter 4. 
In chapter 5, a direct co-culture model of osteoblasts and fibroblasts was established to 
characterize the potential interactions between osteoblasts and fibroblasts after the 
implantation of a tissue-engineered construct. Gap junctional communication between 
those two types of cells was verified and its effects over osteoblasts behavior were 
assessed.  
xxxix 
 
Cell sheet engineering is established as a very promising approach for bone 
regeneration being described in chapter 6, while the final work, presented in chapter 7 
takes advantage of the higher complexity provided by co-cultures and combines it with 
cell sheet engineering to demonstrate how addressing the vascularization issue can 
further promote the osteogenic potential of cell sheets. 
The implications and final remarks of the described works are summarized in the last 
chapter, Chapter 8. 
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Chapter 1 
BACKGROUND 
 
  
  
Chapter 1 - Background 
 
3 
 
Chapter 1 
BACKGROUND 
 
Chapter based on Pirraco RP, Marques AP, Reis RL Cell interactions in bone tissue 
engineering. J Cell Mol Med.14:93-102. 2009. 
 
1.1 Introduction 
Taking in account the functional importance of bone tissue, one may infer that any 
bone injury poses a high impact on the quality of life of an individual.  In the US alone, 
there are about 8 million bone fractures/year of which 5-10% represent cases of 
healing delay or non-union fractures (1-2) that require the enhancement of the bone 
tissue innate regenerative capacity. In order to tackle these issues, Tissue Engineering 
(TE) presents itself as a phenomenal tool. TE has been defined(3) as an 
interdisciplinary area that combines the knowledge of the Engineering and Life 
Sciences fields for the creation of functional constructs that improve, maintain or 
restore the function of a given tissue.  The current TE paradigm encompasses the 
application of three basic elements: appropriate cells, a 3D polymeric matrix that 
supports cell growth, and growth factors that provide cells an adequate chemical 
environment (4-5).  Nonetheless, in order to apply these principles to such a special 
tissue like bone it is imperative to be sensitive to bone biology aiming at understanding 
how its correct function is achieved. Clearly, fundamental in this process is to recognize 
the complex biochemical environment that surrounds cells in bone tissue and within 
which cellular interactions play a pivotal role.  The importance of cell-to-cell interactions 
in the context of bone tissue engineering is addressed by looking at what has been 
done to study those interactions and by analyzing several co-culture models in the 
frame of the different strategies used in Bone TE. Finally, the possibility of the 
application of the state-of-the-art technology of cell sheet engineering to bone 
regeneration is also discussed. This technology has been successfully applied to treat 
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several tissue disorders and there is currently a strong focus in attempting to use cell 
sheet engineering to engineer thick tissues. 
Therefore, this chapter intends not only to establish the theoretical background of this 
PhD thesis but also to frame the described strategies inside the current problems of 
bone tissue engineering and regenerative medicine. 
 
1.2 Bone Biology 
In the adult skeleton, bone tissue presents two different architectural forms: the 
trabecular bone (6-9), with 50-90% porosity, represents approximately 20 % of the 
skeleton and can be found in the metaphysys of long bones and in vertebral bodies; 
and the cortical bone (6-9), an almost solid form of bone with a low porosity that 
represents 80% of the skeleton.  
Osteoblasts, osteocytes and osteoclasts are the three main cell types that can be 
found in bone tissue, having each one of these defined functions crucial for bone 
homeostasis (10-14). Osteoblasts, anchorage dependent cells, are highly responsive to 
mechanical and chemical stimulus that are relayed through multiple cell-to-matrix and 
cell-to-cell interactions(15-16).  These interactions are mediated through specific 
receptors and transmembranous proteins such as integrins, cadherins and connexins 
leading to bone’s extracellular matrix production and mineralization (15-19). As matrix 
is deposited and calcified, some osteoblasts become entrapped in it and achieve their 
fully differentiated state, becoming osteocytes. These are the most abundant cells in 
bone. They are smaller and rounder than osteoblasts and present a high number of 
filopodia that permit homotypic connections as well as interactions with bone-lining 
osteoblastic cells. These connections form a 3D network which is believed (13, 20-21) 
to function as a mechanical stimuli transduction system and as a general regulator of 
bone homeostasis. Nonetheless, osteoclasts are also seen as critical players in this 
regulatory process. They are multinucleated and  highly specialized cells, derived from 
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the hematopoietic lineage, that have the function of resorbing bone by creating a tight 
seal resorption pit at the bone surface(22-24). In these pits, osteoclasts create an 
acidic environment and secrete lytic enzymes that become activated at low pH.  
The exact mechanisms involved in bone homeostasis are still far from being well 
understood; however, two routes are currently accepted to be responsible for skeletal 
formation and maintenance: bone modeling and bone remodeling(25-27). The 
modulation of skeleton geometry during growth, in order to reach the optimal geometry 
to fulfill the requirements of bone function, is referred to as bone modeling(25-27). This 
process progresses by selective bone resorption or formation at specific sites. 
Osteoclastic activity is regulated independently of osteoblastic activity, i.e., bone 
formation never occurs where bone is being resorbed (25-27).  In opposition, in bone 
remodeling(25-27), osteoclastic activity is strictly coupled with osteoblastic activity.  
Bone forming and bone resorbing activities occur in a coordinated manner, so that the 
amount of produced bone balances the amount of resorbed bone (27). This coupling of 
bone formation and bone resorption is spatially enclosed within specialized anatomic 
structures called basic multicellular units (BMUs) (27-30). These temporary structures, 
mainly formed by osteoblasts and osteoclasts, exert their action in three sequential 
phases that, overall, constitute a bone remodeling cycle: activation (of remodeling 
activity in the target area), resorption and formation (27-30). It is currently accepted 
(27, 29-30) that BMUs progress through the bone in a three dimensional way, forming 
tunnels in the cortical bone or trenches in the trabecular bone. Spatial control of the 
BMUs, in terms of target area selection and movement, is thought to be controlled by 
the osteocytes(27, 29-30) since the sensitivity of these cells to mechanical stimulus in 
bone tissue, as well as their organization in a network represent significant properties 
for the perfect conduction of the bone remodeling process (27, 29-30). Bone 
vasculature is also decisive in the remodeling process. In addition to the demonstration 
of an intimate relation between new blood vessels and osteogenesis(31-33), it was 
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already proved that every BMU is located in the vicinity of a blood vessel(34) which 
grows at the same rate the BMU advances(34-35). These facts indicate the crucial role 
of vasculature in bone remodeling and consequently the importance of vascular cells 
such as endothelial cells and pericytes. The most likely role of blood vessels as a 
source of biochemical signals and cells, and as major players in the coupling of bone 
resorption and formation during bone remodeling is explored elsewhere(36). 
 
1.3 Cellular interactions in Bone Tissue Engineering 
1.3.1 The relevance of cell–cell interactions in bone tissue engineering 
Taking in consideration the biology of bone tissue it is quite clear that the 
understanding of the cellular interactions that regulate the homeostasis and 
regeneration of this remarkable tissue is essential to a successful Tissue Engineering 
strategy. The study of these cellular interactions in vitro relays on co-culture systems, a 
tremendously useful methodology where two or more cell types are cultured at the 
same time. It increases the complexity of typical cell culture systems, allowing the in 
vitro settings to closely mimic the in vivo environment. 2D co-culture systems have 
been extensively used by cell biologists to study cell interactions as an attempt to 
understand specific cellular mechanisms and pathways.  
The self-renewal and multilineage differentiation abilities of stem cells (SCs) render 
these cells as the potential ultimate source of cells to create tissue-like constructs for 
TE, including bone TE. Subsequently, several studies (37-43) regarding cellular 
interactions relevant for bone TE have been focusing, in addition to osteoblasts, to 
different populations of SCs obtained from various origins and species. However, these 
studies have been performed mainly to assess the differentiation potential of SCs 
towards the osteogenic lineage by establishing several co-culture systems. Mature 
cells like chondrocytes (37-39), macrophages (40), endothelial cells(42) or myeloma 
cells(41) have all been proven to promote the osteogenic differentiation of 
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mesenchymal SCs (MSCs), either by direct or indirect interactions. Co-culture with 
osteoblasts was also reported as a method to direct the differentiation of Embryonic 
Stem Cells (ESCs), either from mouse or human origin, into the osteogenic lineage 
(44-45).  However, a major issue that many tissue engineers fail to address is the 
atypical osteoblastic function of osteoblastic cells in culture when compared with 
osteoblasts in vivo. This is reflected on the quality of bone formed by osteoblasts in 
vitro (46-48), either in a 3D or a 2D environment, which is undoubtedly a major 
drawback when envisaging a possible clinical application.  
Another very important issue that greatly affects the performance of a TE construct is 
the vascularisation since an insufficient blood supply in implanted engineered tissues 
will determine their failure (49-52). Vascularisation is regarded as essential in TE in 
general, and in bone TE in particular(53-54).  In the usual bone TE strategy, where 
bone cells are seeded and cultured in scaffolds before implantation, a recurrent finding 
points out to cell death at the bulk of the scaffold by hypoxia (49-50, 55).  It became 
clear that the production of a vascular network that could perfuse the engineered 
constructs is essential. So far the proposed solution relies on the creation of a blood 
vessel network within an engineered tissue prior to transplantation by incorporating 
cells that will lead to blood vessel formation within the scaffold matrix (56-59) and 
subsequent engraftment with the host tissue. Moreover, the extent of knowledge 
regarding the interactions between endothelial cells and bone forming or 
osteoprogenitor cells indicates the existence of reciprocal interactions between both 
types of cells that are essential to their normal function (60-69). It is therefore logic that 
the interaction of endothelial cells and osteogenic or osteoprogenitor cells is a critical 
issue to be explored by bone tissue engineers.     
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Figure 1.1 - Positive (+) and negative (–) effects of cell-to-cell interactions between osteoblasts or osteoprogenitor cells 
and stem cells(44-45, 70), chondrocytes (71-74)(37-39), osteoclasts(75-77) and endothelial cells(56, 61-63, 65-68, 78-
90). Cell differentiation, function and proliferation were the reviewed parameters 
As described in the previous section, bone modelling and remodelling processes rely in 
the specific crosstalk between osteoblasts and osteoclasts. It is for example well 
established that osteoblasts are deeply involved in the formation of osteoclasts as well 
as in their correct functioning(47, 91-95) but the effects of osteoclasts over osteoblastic 
function are still poorly understood. Studies done with osteoclast deficient mice models 
have shown not only a lack of bone resorption activity but also deficient osteoblastic 
activity, which is reflected in the quality of the formed bone(96-97). Dai et al (96) 
showed that implanting bone buds from osteoclast deficient mice into wild type mice 
resulted in the recovery of the buds’ normal development. This work presents a major 
indication that engineering bone tissue for clinical use may require the use of 
osteoclasts along with osteoblasts. Therefore, compelling evidence suggests that  
osteoclasts have functions, namely regulatory functions, other than just bone 
resorption, which are reviewed elsewhere (75). Additionally, the vital importance of cell 
to cell interactions for bone homeostasis has been also reinforced by other works. 
Indications regarding the production of pro-osteogenic factors by osteoclasts were 
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given in a study that proved that osteoclast conditioned medium induced bone nodule 
formation by murine MC-3T3-E1 pre-osteoblasts(98). Increasing attention has also 
been given to the signalling action between ephrinB2 cell surface protein, present in 
osteoclasts,  and its receptor EphB4, present in osteoblasts(76). It was shown that 
ephrinB2-EphB4 signalling is bidirectional and links two key molecular mechanisms of 
differentiation, one osteogenic and the other osteoclastogenic(76). This is of major 
importance since it describes a mechanism where both cells influence the 
differentiation of one another, possibly in simultaneous, by cell-cell contact.  
Additional cues to create a successful bone TE construct might be provided by the 
endochondral ossification process in which chondrocytes produce a cartilaginous 
anlage that is mineralized by osteoblasts and osteocytes later in the process. A logic 
analysis would consider the high probability of chemical factors being produced by 
chondrocytes that enhance osteogenic activity and mineralization.  Nonetheless, a 
study by Jiang et al (71) showed that in spite of an increase in alkaline phosphatase 
(ALP) activity in osteoblasts co-cultured with chondrocytes, their mineralization ability 
was diminished when compared to controls. This negative effect seemed however 
restricted to fully differentiated osteoblasts, which is in accordance with other works in 
the literature that describe chondrocytes as having a positive effect on the osteogenic 
differentiation of MSCs (37-39).  Thus, in a Bone Tissue Engineering strategy based in 
the use of chondrocytes, it may be beneficial the use of MSCs or others osteoblastic 
precursors instead of fully differentiated osteoblasts(99). Hence, creative ways to 
ensure the clinical success of engineered constructs are needed. The study of the 
interactions between cells types relevant for bone TE is a powerful tool in the design of 
tissue engineered bone constructs. But how is this knowledge applied by bone tissue 
engineers? 
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1.3.2 Co-culture models in bone tissue engineering 
Angiogenesis 
As mentioned before, vascularization is a critical issue for TE constructs aiming at 
regenerating vascularized tissues. It has been demonstrated that the in vivo 
implantation of a cellularized construct without the production of an adequate vascular 
network leads to cell necrosis in the bulk of the construct (49-52). 3D co-cultures 
established in scaffolds have been proposed by tissue engineers as a powerful tool to 
overcome this question (56, 79-90).  Two works reported that co-culturing endothelial 
cells with human bone marrow stromal cells (hBMSCs) in poly-lactic-glycolic acid 
(PLGA) scaffolds increased bone formation after implantation in a critical size rat 
calvaria defect compared to implanted scaffolds only seeded with hBMSC (85-86).  
These studies emerged as a proof-of-concept that co-culturing endothelial cells with 
osteogenic or osteogenic progenitor cells in a 3D scaffold can be an adequate strategy 
for targeting the vascularization of tissue engineered bone. Several other works (56, 
79-90) have been reporting the co-cultivation of endothelial cells with osteogenic or 
osteoprogenitor cells for bone TE purposes. Rouwkema et al (82) showed that co-
culturing human umbilical vein endothelial cells (HUVECs) with hMSCs in a spheroid 
aggregate model upregulated ALP expression of the hMSCs in comparison with 
monocultured spheroids. On the other hand, Kyriakidou et al (87) found that co-
culturing  HUVECs with a human osteoblast-like cell line, MG-63, in porous poly(ε-
caprolactone) (PCL) scaffolds under dynamic conditions favored the proliferation of 
both types of cells but not their function. ALP activity and extracellular matrix (ECM) 
production of the osteoblast-like cells did not show a significant enhancement in 
comparison to the controls. More interestingly, Yu et al (89-90) reinforced the potential 
of osteoblast/endothelial cell 3D co-cultures for bone tissue engineering purposes.  
ECs and osteoblasts differentiated from the bone marrow of BALB/c mice were co-
cultured in hydroxyapatite-PCL (HA-PCL) scaffolds and implanted in a critical size bone 
defect in the femur of mice of the same strain (89). The authors observed a dramatic 
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increase in vascularization and bone formation in the co-culture groups in comparison 
with scaffolds only seeded with osteoblasts. In addition, necrosis was found to occur in 
the osteoblasts groups but not in the co-culture groups. Similar results were found by 
the same group in a work that was carried out under the same conditions but in 
rats(90). Besides the enhanced bone formation and vascularization without signs of 
necrosis, the co-culture grafts presented better mechanical properties than those only 
seeded with osteoblasts. 
A significant effort has also been applied to understand the effect of osteogenic or 
osteoprogenitor cells on the angiogenic potential of endothelial cells. Wenger et al (88) 
established a 3D collagen-based co-culture system of HUVECs and human osteoblasts 
(hOB). In this model, cells were grown in spheroid aggregates (the result of cell’s self-
aggregation in non-adhering conditions), either homotypic, only with HUVECs, or 
heterotypic, HUVECs plus hOB, and then embedded in collagen gels. It was verified 
that the presence of osteoblasts within the heterogeneous aggregates, diminished the 
formation of sprouts under angiogenic stimulus as compared with homogeneous 
spheroids suggesting an inhibitory effect of osteoblasts over endothelial cells activity. In 
contrast, Rowekema et al (82) developed a spheroid model where HUVECs were 
cultured with hMSCs. In this case, HUVECs were capable of forming a pre-vascular 
network which was further developed after in vivo subcutaneous implantation in nude 
mice. Using polyurethane (PU) cylindrical scaffolds, Hofmann et al (81) performed in 
vitro co-cultures of  HUVEC and hOB, having platelet released growth factors (PRGF) 
as the only supplementation of the culture medium. Osteoblasts-seeded scaffolds were 
found to support cell proliferation and vessel formation by HUVECs in contrast with 
scaffolds loaded only with HUVECs.  The contradictory results of some of these works 
suggests that this strategy is highly dependent on culture conditions such as cell 
seeding density, 2D or 3D culture and differentiation state of osteogenic cells.   
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The origin of endothelial cells appears also as an important issue.  Stahl et al (83) 
established a co-culture model similar to Wenger et al (88) but of HUVECs and human 
umbilical cord blood endothelial progenitor cells (EPCs) and primary osteoblasts. The 
authors verified that osteoblasts inhibited the sprouting of HUVECs but not of EPCs. 
Similar results were reported in works that established co-cultures of human primary 
osteoblasts and HUVECs, Human Outgrowth Endothelial Cells (hOECs) and Human 
Dermal Microvascular Endothelial cells (hDMECs)  in 2D conditions, 3D aggregates 
and 3D scaffolds (80, 84). hDMECs were cultured in the presence and absence of hOB 
on porous discs of three different materials, beta-tricalcium phosphate (beta-TCP), HA, 
nickel-titanium (NiTi) and, additionally, on silk fibroin nets (84). For all the materials, 
hDMECs only formed microcapillary-like structures in the presence of osteoblasts, 
independently of the angiogenic supplementation. When hOECs and HUVECs were 
cultured with and without osteoblasts either in 2D conditions or in a 3D spheroid 
aggregate co-culture model, a pre-vascular network was only formed by hOECs and in 
the presence of osteoblasts(80). In accordance, Santos et al (56)  co-cultured hDMECs 
with primary human osteoblasts in starch-poly(3-caprolactone) (SPCL)  fiber mesh 
scaffolds. Results showed that hDMECs self-assembled in a microcapilary-like 
structure, with a lumen where cells where positive for collagen IV, a marker of 
endothelial basement membrane. No such results were encountered in the control 
groups where hDMECs were cultured alone. Moreover, osteoblasts were found to 
produce more vascular endothelial growth factor (VEGF) and their collagen I mRNA 
levels were significantly higher when in co-culture. This is a proof of osteoblast-
endothelial cell bi-directional communication. Reinforcing this, similar results were 
reported (79) when hOB were co-cultured with hOECs in SPCL scaffolds and then 
subcutaneously implanted in SCID mice. The constructs with both types of cells 
revealed improved vascularization in comparison with constructs only seeded with 
hOECs. Thus, these works have proven that osteoblasts provide endothelial cells 
sufficient stimuli for them to form a network of micro-vessel like structures.  More 
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importantly, in some cases, the formation of that network was achieved without the 
addition of angiogenic factors to the culture medium (84).  This is probably the best 
demonstration on how co-cultures provide a higher complexity culture system, with 
self-regulation, that can be of much use in Tissue Engineering approaches   
Overall these approaches represent the growing awareness of bone tissue engineers 
to the significance of working on the vascularization issue prior to bone tissue formation 
which, is a natural evolution taking in account the (lack of) results delivered by typical 
TE approaches so far. 
 
Osteochondral strategies 
There are clinical conditions where cartilage defects progress to the underlying sub-
chondral bone, affecting, at the same time, bone and cartilage tissues (100). In these 
cases, the application of osteochondral TE constructs is seen as a valid solution to 
regenerate both bone and cartilage tissues(101-102). To date, the proposed 
osteochondral TE constructs consist on co-culturing osteogenic and chondrogenic cells 
in 3D supports (72-74).  However, there are few works in the literature using 
osteochondral constructs that address bone formation, most of them focusing, instead, 
on the cartilage part.   
Spalazzi et al (72) studied the interactions between bovine osteoblasts and 
chondrocytes in Polylactide-co-glycolide and bioactive glass (PLGA-BG)  composite 
scaffolds and films. The authors observed that in comparison with control groups, only 
seeded with osteoblasts or chondrocytes, co-culture constructs enhanced the ability of 
chondrocytes to maintain their normal morphology for a longer time period. The 
presence of osteoblasts and respective layered matrix also increased chondrocyte 
proliferation and matrix production. Similar results were observed by Mahmoudifar et al 
(74) after co-culturing, under dynamic conditions, human foetal chondrocytes and 
osteoblasts in PLGA scaffolds. The presence of osteoblasts was found to improve 
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cartilage formation in terms of glycosaminoglycans (GAG) content and total collagen 
deposition in comparison with no osteoblasts-containing controls. In contrast, the 
authors did not find significant benefit, in terms of cartilage formation, in co-culturing 
the chondrocytes with either bone chips or cartilage chips as possible sources of 
growth factors. Although the authors acknowledge that mineralization occurred in the 
osteoblast seeded part of the scaffold, no further analysis, like for  the work by Spalazzi 
et al (72), were performed concerning the osteogenic performance of the construct.  
The effect of chondrocytes over osteogenic cells in an osteochondral construct was 
explored in a work by Cao et al (73). Human osteogenic cells, previously differentiated 
from stromal cells of the iliac crest, were co-cultured with human chondrocytes, 
obtained from the rib cartilage, in PCL scaffolds. The presence of chondrogenic cells 
had a positive effect on the production of the early osteogenic marker ALP but a 
negative effect on the expression of the later marker, osteocalcin. Nevertheless, the 
mineralization of the osteochondral construct was supported by the osteogenic cells. In 
contrast, Jiang et al (71) reported that culturing bovine chondrocytes and osteoblasts in 
micromass culture had a negative effect both on the chondrocyte and osteoblastic 
phenotype. Moreover, mineralization in the co-cultures was significantly diminished in 
comparison with monoculture controls.  
These results demonstrated that chondrocytes and osteoblasts can modulate both cell 
types’ phenotype in tissue engineered constructs. However, how will tissue engineers 
manipulate these interactions, either by controlling the culture conditions or the 3D 
scaffold, in order to obtain suitable osteochondral constructs is still to be seen. 
 
Macrophages, Monocytes and osteoclasts 
Macrophages, which are key players in an inflammatory process within the 
periprosthetic milieu, produce several cytokines and other soluble factors that affect all 
the other neighboring cells (103-105) and have been often associated with implant 
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failure. In this sense, co-cultures of monocytes and macrophages, with osteoblasts 
have been used in the biomaterial field as a way to elucidate the macrophages 
biological response to orthopedic biomaterials particulates in a more complex system 
that includes bone-forming cells, osteoblasts (106-108). The translation of the results 
from these works into the TE field is scarce; however, co-culturing 
monocytes/macrophages or monocyte/macrophages-derived osteoclasts and bone 
cells in 3D biodegradable matrices might be an interesting approach towards 
engineering high quality bone(47). Bone tissue engineers have not explored much this 
approach, existing therefore few works(77, 109) that co-cultured monocytes and 
stromal cells in 3D scaffolds. Domaschke et al (77) studied the in vitro remodeling of 
mineralized collagen I scaffolds using co-cultures of ST-2, a mouse bone marrow 
stromal cell line, and human monocytes. In this work, it was demonstrated that the co-
cultures induced both osteoclastogenesis and osteoblastogenesis from progenitor cells 
of both lineages in a process, according to the authors, comparable to bone remodeling 
that involved the resorbing of the scaffold by the osteoclasts and matrix mineralization 
by the osteoblasts. 
It seems obvious that exploring this model that focuses on the balance between the 
degradative osteoclastic and the constructive osteoblastic activities, as well as co-
culturing monocytes/macrophages and bone cells to highlight the initial bone healing 
mechanisms, may be of extreme use for developing successful bone tissue 
engineering strategies. 
 
Stem Cells 
Nowadays, stem cells, which are capable of differentiate into the most varied lineages 
of cells, are seen as an exceptionally promising tool in TE. In bone TE there has been 
the tendency to differentiate those cells into the osteogenic lineage using exogenous 
factors, before scaffold seeding, probably due to time and cost efficiency. Nonetheless, 
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stem cells differentiation can be also directed towards the osteogenic lineage in situ 
using co-culture systems in a 3D environment. Kim et al (70) showed that human ESCs 
committed to the osteogenic lineage by co-culture with primary cells from bone 
explants and seeded in poly(D,L-lactic-co-glycolic acid)/hydroxyapatite composite 
scaffolds were able to support new bone formation in an immunodeficient mouse 
model. Although not presenting the controls with hESCs not subjected to co-culture 
with the bone primary cells, this work demonstrates the potential of the use of co-
cultures to direct the fate of stem cells.  There is no doubt that using 3D co-cultures to 
induce the differentiation of stem cells towards the osteogenic lineage will be a 
potentially successful path for future bone tissue engineers. 
The study of cellular interactions can provide not only the understanding of the major 
drawbacks that tamper bone TE evolution but also the solution to overcome those 
obstacles. The jump from 2D cultures to 3D cultures in the TE field was an 
acknowledgement that culture systems needed to emulate more closely in vivo 
systems. In fact, it was suggested that many of the lessons brought by 3D research in 
TE could be adopted to other field such as cancer research(110).  
 
1.4 Cell Sheet Engineering 
Professor Teruo Okano’s laboratory first proposed the use of temperature-responsive 
surfaces for cell culture in 1990 (111).  These dishes allow to culture cells and, after 
confluency, to recover them and their ECM as a sheet simply by lowering the 
temperature. These surface were obtained by uniformly spread isopropylacrylamide 
(IPAAm) monomers dissolved in 2-propanol over tissue culture polystyrene (TCPS) 
dishes(111-112). As IPAAm monomers polymerize, they are irradiated with an electron 
beam (EB) for covalent grafting to TCPS. EB methodology, although requiring the use 
of complex apparatus, offers many advantages over other techniques of graft 
polymerization. It allows a uniform covalent polymer grafting over TCPS using few 
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steps and it is suitable for large-scale production. It has been reported, for instance, the 
use of plasma polymerization to produce poly(N-isopropylacrylamide) (PIPAAm)-
grafted surfaces. Although the grafting was successful for surfaces such as glass(113), 
silicon(114) or TCPS(115-116) using only one step, this method is not suitable for large 
scale application due to issues related to the continuous treatment required and size of 
the apparatus.  Furthermore, it was shown by XPS analysis(117) that following cell 
sheet recovery, there was a greater quantity of residual ECM proteins left on PIPAAm-
TCPS dishes polymerized with plasma than on dishes polymerized with EB irradiation.  
Using EB methodology, the thickness of the grafted PIPAAm is controlled by the 
concentration of the monomers and radiation energy.  In fact, the thickness of the 
grafted polymer is critical for the adhesion behavior of cells.  It was determined that for 
optimal cell adhesion and detachment by temperature decrease, the PIPAAm layer on 
a TCPS surface should have a thickness of 20 nm and a density range of 0.8-2.2 
μg/cm 2(118-119).  It was also shown that increasing thickness and density of the 
grafted PIPAAm the surfaces did not present the hydrophobic/hydrophilic property 
alterations above and below the low critical solution temperature (LCST) (118), i.e., 
surfaces became more hydrophobic.  This is related with the mobility of PIPAAm 
chains. For thicker layers of grafted PIPAAm, there is a greater mobility of PIPAAm 
chains and even above LCST the hydrophobic environment in the vicinity of 
polystyrene surface is not enough to promote dehydration and aggregation of the 
outermost chains. However, for thin or ultra-thin PIPAAm layers the mobility of the 
PIPAAm chains is more restricted and the chains at the interface with substrate, which 
have decreased hydration due to the hydrophobicity of the polystyrene, manage to 
drive dehydration of the outermost chains(118). This results in a slightly hydrophobic 
surface for cells to adhere.  It is then clear that controlling the thickness of grafted 
PIPAAm is a critical issue for obtaining the desired temperature-dependent switchable 
attach/detach behavior of cultured cells.  
Chapter 1 - Background 
 
18 
 
PIPAAm-TCPS dishes are hydrophilic below PIPAAm LCST, 32ºC, and therefore cell 
repellent.  When the temperature rises above 32ºC, PIPAAm chains dehydrate, 
collapse and cells are allowed to adhere and proliferate(118-119). Furthermore, after 
culturing cells in the dishes, when temperature falls below the LCST, attached cells 
detach spontaneously without the use of proteolytic enzymes. This spontaneous 
detachment is in fact an active detachment since it involves ATP spending as was 
demonstrated in works using inhibitors of ATP synthesis and tyrosine kinases (119). 
Other works focused on detachment mechanisms at cytoskeletal and intracellular 
signaling levels (120-122). From all of these works we can conclude that intracellular 
signal transduction is necessary for cells to detach from temperature responsive TCPS 
dishes. Moreover, cell detachment behavior from temperature responsive TCPS dishes 
is profoundly cell type-dependent. The nature and amount of ECM produced by cells is 
a critical factor for cell detachment from temperature responsive dishes. Since different 
cell types produce different types of ECM, the time required for detachment will vary or 
might not take place at all (123).  
 
1.4.1 Applications in Regenerative Medicine 
Many hopes have been put in the tissue engineering and regenerative medicine 
(TERM) field to solve many of the problems in organ regeneration. Several obstacles, 
however, still subsist due to current techniques limitations. Promising results have been 
achieved by injection of cell suspensions in the damaged site (124-131) or by 
transplantation of TE substitutes composed by biodegradable scaffolds and cells (132-
133).  Nevertheless, each of these techniques has their own important drawbacks. 
Migration of injected cells and consequent low efficiency in delivering the cells to the 
desired anatomic site, is a recurrent problem (134-135). Biodegradable scaffolds with 
cultured cells, on their hand, have the limitation of oxygen and nutrient supply to the 
cells in the core of the construct. This results in cell necrosis at the bulk of the construct 
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(50-52). Furthermore, foreign body response to the implanted biomaterial is a frequent 
reaction of the host and has as a consequence the formation of fibrotic tissue 
surrounding the implant (136).   
The use of cell sheets in the TERM field, circumvent most of the problems described 
above. Cells are recovered from temperature sensitive dishes as a cohesive sheet 
where all cell-cell and cell-ECM connections are maintained (137-138). The ECM in the 
cell sheets acts as a natural glue that enables cell sheets to be applied in virtually all 
anatomic sites. Also, cells sheets comprise only cells and their matrix, so, besides the 
absence of a biomaterial, using autologous cells avoids an immune rejection of 
implanted cell sheets. Following all these advantages, Professor Okano’s group has 
applied cell sheet engineering to the regeneration of various tissues as discussed 
below.  
In the ophthalmology field, clinical trials to treat unilateral or bilateral total corneal stem 
cell deﬁciencies due to alkali burns or Stevens-Johnson syndrome were carried out. 
Using autologous limbal stem cells (for the unilateral cases) (139) or autologous oral 
mucosa epithelial cells (for the bilateral case) (140) and cell sheet engineering, patients 
with such conditions were successfully treated.  
For the treatment of oesophageal ulcerations a method was developed where 
endoscopic submucosal dissection was combined with endoscopic transplantation of 
autologous oral mucosal epithelial cell sheets (141-142). These type of ulcerations are 
a major postoperative burden for many patients that can result in stenosis (141). Using 
the developed method patients who underwent oesophageal endoscopic mucosal 
resection due to oesophageal carcinoma were treated by endoscopic transplantation of 
autologous oral mucosal epithelial cell sheets(142). This was the first reported case of 
regenerative medicine applied to endoscopic treatment. 
Cell sheet engineering application in periodontology has also been tested using animal 
models (143-146). In a recent work using beagle dogs as animal model, autologous 
periodontal ligament cell sheets were layered and, using a woven polyglycolic acid 
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support, transplanted to dental root surfaces having three-wall periodontal defects. 
Bone defects were filled with porous β-tricalcium phosphate. (146) Both new bone and 
cementum connecting with well-oriented collagen fibers was found only after cell sheet 
transplantation, confirming the usefulness of cell sheet engineering for periodontal 
regeneration in clinical settings. 
Recently, Okano’s group proposed cell sheet engineering as a potential supply therapy 
for diabetes type I (147). In this work, rat pancreatic islet cells were cultured on laminin 
5-coated temperature-responsive culture dishes. Cells sheets were recovered and 
implanted subcutaneously in rats. Pancreatic cell sheets remained biofunctional, 
producing insulin and glucagon after 7 days of transplantation. This opens a new 
perspective for the treatment of type I diabetes and other islet-dependent diseases. 
Myocardial tissue regeneration was also vastly studied by Okano’s group using cell 
sheet engineering(148-158). The reconstruction of cardiac tissues has been tackled by 
producing cell sheets of mesenchymal stem cells(154), cardiac myocytes (148-152)  
and skeletal myoblasts(155-156, 158). In addition, the spontaneous beating of 
cardiomyocyte cell sheets synchronizes after CS layering (151, 157) thus rendering a 
cardiac patch that might be transplanted to a defective heart.  
The diffusion limitations associated with increasing thickness of engineered tissues 
were possible to be circumvented by polytransplantation of cell sheets(150).  
Furthermore, Sasagawa et al(159) successfully pre-vascularized in vitro a myoblast cell 
sheet construct, by culturing HUVECS between myoblasts cell sheets, leading to the  
formation of microvessels containing red blood cells after implantation in the 
subcutaneous tissue of nude rats.  
All the work developed by Okano’s group in engineering thick tissues, and in particular 
cardiac tissue reconstruction, strongly suggests that cell sheet engineering is an 
extremely promising, ever evolving technology for that purpose. Although bone is a 
support tissue with very specific mechanical properties i.e., different from cardiac 
tissue, the achievements of these works comprise a significant starting point for 
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overcoming the main obstacle to engineer thick tissues, the lack of vascularization. 
Thus, the way for bone TE using cell sheet engineering is open. 
 
1.4.2 Cell Sheet Engineering and Bone Tissue Engineering 
The use of cell sheets for bone tissue engineering purposes has been addressed in 
several works. Zhou and colleagues (160) combined osteogenic cell sheets, made form 
porcine BMSCs, wrapped around PCL–calcium phosphate scaffolds. Post-
subcutaneous implantation analysis of the construct showed some degree of new bone 
formation but mainly at the periphery of the scaffolds. The same pattern of new 
calcified tissue, around the scaffold, was achieved by Gao et al (161), using a coral 
scaffold, and Akahane et al. (162), using a hydroxyapatite ceramic scaffold. In the latter 
case, the cell sheets were also ectopically implanted without any scaffold (162) and 
new bone formation, albeit disorganized, was verified. In the three approaches, new 
bone tissue was fairly disorganized, poorly vascularised and limited to the surface of 
the scaffolds around which the cell sheets were wrapped. Ma et al (163) rolled cell 
sheets composed of BMSCs in a cylinder shape and implanted subcutaneously in nude 
mice.  Once again, new bone formation was evident; however, the size and 
morphology of the construct inhibited the vascularisation of the construct.  Akahane et 
al (164) proposed the injection of osteogenic cell sheets as a non-invasive method for 
hard tissue reconstruction. From the same group, Nakamura et al (165) wrapped an 
osteogenic cell sheet around a rat femur defect and found that, compared with the 
controls without cell sheet, the cell sheet groups showed improved regeneration and 
bone union.  
The works described above showed the high potential of using cell sheets for bone 
tissue engineering. However, for all the studies, cell sheets were detached using a cell 
scraper. Cell sheets obtained using thermo-responsive dishes have unique features as 
they are harvested as confluent cells as sheets together with their ECM. The ECM 
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contains adhesive proteins that will act as a natural glue that, besides facilitating cell 
sheet adhesion to anatomic sites, also allows the union between the cell sheets after 
stacking. Using this principle, the production of three dimensional bone tissue, by the 
sequential layering of cell sheets without the use of scaffolds, constitutes an extremely 
promising approach for bone TE purposes.  
 
1.5 Final Remarks 
To manipulate cellular function through the use of co-cultures is nothing less than trying 
to mimic what happens in vivo. As this is one of the precepts of TE it should be largely 
embraced by tissue engineers. Combining co-cultures with 3D culture is the way to 
achieve higher complexity models of superior quality. 
Nonetheless, the major hurdle in bone TE, is and will continue to be, the 
vascularization issue. The question “OSTEOGENESIS AND THE VASCULATURE: 
SHOULD THE SCAFFOLD COME FIRST?” as presented by Mikos et al [57] makes 
more sense than ever. The tendency in the next few years will be to make endothelial 
cells an indispensable component of any bone TE strategy though osteoblasts or 
osteoprogenitor cells will continue to be essential. Perhaps the default strategy in the 
future will be to co-culture, in 3D, endothelial and osteogenic cells.  
Moreover, other shortcomings brought by the use of scaffolds limit the number 
successful clinical applications in the field of bone TE. The application of cell sheets 
avoids those shortcomings while presenting encouraging prospects for the creation of 
thick tissues and for dealing with the vascularization issue of TE constructs. It is then 
clear that cell sheet engineering presents an enormous potential as a strategy for bone 
tissue engineering. 
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Chapter 2 
MATERIALS AND METHODS 
The works presented in this thesis are focused on the study of the interactions between 
different cell types for possible applications in Bone Tissue Engineering. An indirect co-
culture system was established in order to assess the effect of soluble factors 
produced by human peripheral blood monocytes/macrophages over the osteogenic 
differentiation of human bone marrow stromal cells. In a step forward, mononuclear 
cells from umbilical cord blood were co-cultured with osteoblasts differentiated from 
human adipose derived stem cells in carrageenan membranes as a way to enhance 
post-implantation neovascularization. The effect of human dermal fibroblasts (hDFb) 
over human mesenchymal stem cell-derived osteoblasts with the involvement of Gap 
junctional communication was also assessed in a direct co-culture. In addition to the 
addressed heterotypic cellular interactions, the enormous advantage of the cell sheet 
engineering technology of being able to preserve cell-cell and cell-extracellular matrix 
interactions was also explored in the context of bone tissue engineering.  
A detailed description of i) the materials used in the experimental work and of ii) the 
methodologies that led to the results displayed in the following chapters are provided in 
this chapter. As the approaches followed to attain specific results to support the 
proposed hypotheses of this PhD work required a strong application of both in vitro and 
in vivo methodologies, this description was sub-divided within these two main items. A 
characterization section encloses all the techniques used, some of them common for 
the in vitro and in vivo assays. 
 
2.1. Materials 
 
2.1.1 Carrageenan 
 
Natural-based polymers have been increasingly proposed for biomedical 
applications due to their ability to elicit favorable biological responses and their high 
degree of processing flexibility(1). Carrageenan (CRG) in particular is a polyssacharide 
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isolated from red seaweed that has been used mainly in the food industry as a 
thickener(2). Recently, carrageenans of the kappa type have been proposed for 
regenerative medicine purposes (3-5) due to their favorable mechanical properties and 
an anticoagulant effect (6). Therefore we considered this polymer as a suitable material 
to produce the membranes to support the co-cultures of osteoblasts and mononuclear 
cells from cord blood in chapter 4. 
The standard name carrageenan is used to name a class of galactan 
polysaccharides that behave as intercellular matrix materials, like agars, in specific 
species of red seaweeds, including the genus Gigartina, Chondrus, and Eucheuma a 
marine algae included in the class Rhodophyta (7-9). The CRGs are grouped into 
several sub-types according to their sulphation patterns and distribution of 3,6-anhydro-
D-galactose (AG) residues (8-9). Kappa, iota and lambda CRGs are obtained by 
treatment in alkaline conditions(10), and are the molecular types with high relevance in 
industry. The commercial forms of these CRG types are rarely pure and usually contain 
varying amounts of the other CRG types, whose exact amount depends on the weed 
source and/or on the extraction procedure(9, 11).  
   CRGs are also classified as hydrocolloids, due to their structure comprising 
highly sulphated, alternating α(1→3) and β(1→4)-linked galactose residues, 
disaccharides repeating units. In addition, the galactose units linked β-(1→4) in this 
general structure often occur as 3,6-AG. The numbers and positions of the sulphate 
ester groups have an impressive effect on the tertiary structure and the subsequent 
interactions that occur for the different CRG types. Kappa is sulphated only at C4 in the 
1,3-linked galactose ring, while iota has an additional sulphate at C2 in the 1,4-linked-
3,6-anhydro-d-galactose ring. Due to these structural properties, the formation of 
double-helical segments is allowed leading to a proper arrangement as gel structures 
at appropriate conditions of salt concentration and temperature(9). Lambda-CRG has a 
higher average level of sulphation per disaccharide residue than iota- and kappa-CRG. 
The β-(1→4)-D galactose ring is not conformationally locked in the -3, 6-anhydro form, 
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and carries sulphate groups at C2 and C6. In addition, sulphation in the α(1→3)-D-
galactose-1 residue occurs at C2. The removal of the anhydrous bridge confers a 
linking effect that inhibits double-helix formation, thus lambda-CRG does not undergo 
conformational ordering, and consequently does not form gels.  
The gelling CRG viscoelasticity is sensitive to both the nature and concentration of 
cations, being lambda the least and kappa the most one salt sensitive. Through CRGs 
blending, the viscoelasticity of the gel phase can be varied, in order to suit a wide 
range of applications. Commercially available CRGs are essentially ground, 
dehydrated gels containing approximately 7% water. Generally, the higher the 3,6-AG 
content and the lower the ester sulphate level, the less readily will the CRG hydrate. 
Hydration and solubility of kappa and iota CRG can be optimized by ion exchanging the 
CRG leading to a material predominantly in the sodium form (8).  
  
2.1.2 CRG Membranes preparation 
 
The type iota-kappa (hybrid) CRG extracted from the red algae Chondrus crispus by 
CEAMSA (Porrino, Spain) was used to produce the membranes. This hybrid CRG 
presents several processing advantages like a higher degree of flexibility, when 
compared to kappa CRG, and a higher robustness when compared to pure iota CRG. 
Other advantage is related with the fact that is naturally a hybrid polymer, meaning that 
it is not a blend, and thus behaves as a monocomponent system, concentrating in a 
single molecule, properties of both kappa and iota CRGs. The ionic environment 
chosen for processing this hybrid also conferred specific features to the developed 
systems. The potassium chloride (KCl) solutions allowed preserving the structures 
processed by solvent casting and potassium hydroxide (KOH) provided the alkaline 
environment needed for the crosslinking reaction while its dissociation gave the 
potassium necessary for the stability of the membranes (12-13). The cations affect the 
balance of attractive and repulsive forces between the molecules, so that optimum gel 
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strength will occur at certain levels of each cation.  In the case of kappa-CRG, alkaline 
ions bind to the helix of the hydrocolloid, causing the partially neutralization of sulphate 
groups, leading to the aggregation of the double helixes and thus increasing gel rigidity.   
The hybrid iota-kappa CRG was dissolved in distilled water to a final concentration of 
2% w/v. While hot, 25-35 mL of the solutions were placed in square petri plates and left 
to dry at room temperature for 48 hours. In order to preserve its structural features 
while cutting was taking place, the formed membranes were placed into a low-
hydrating solution of 20% (v/v) ethanol plus 3% (w/v) KCl (Sigma, USA) and cut into 
small round samples of 1.1 cm diameter. The average thickness was of 1mm (wet). 
The CRG membranes were crosslinked in a water solution of 50% (v/v) 2-propanol 
(Fluka, Czech Republic), and 0.32M potassium hydroxide (KOH, Fluka, Czech 
Republic) and 4.63 mM of epichlorohydrin (ECH) (Aldrich, USA) for 24h, at 37ºC under 
100 rpm agitation. The samples were then washed twice with a 17% ethanol (v/v) and 
0.1M sodium hydroxide (NaOH, Panreac, Spain) solution, aiming at blocking the 
partially reacted ECH and twice with water at 50Cº for 1h (while monitoring and 
neutralizing the pH).  
Generally it is well accepted that the crosslinking of natural polymer alone or with 
other components induces higher resistance to degradation(14) as well as new 
physico-chemical properties that can be modulated by the degree and type of 
crosslinking agent and by modification of reaction parameters (15-16). The crosslinking 
approach chosen was based on the works published by Guner and co-workers(17) for 
dextran using different agents, and by Keppeler and co-workers (18)  with several 
modifications dependent on the structures to be produced and the raw material used. 
The CRG crosslinking reaction was preceded in the presence of KOH, which is the 
acceptor for hydrogen chloride (HCl) - product of the dehydrochlorination of 
chlorihydrine. Some consider that adding ECH to CRG macromolecules, in the base-
aqueous medium, a molecular reaction occurs via the side-chain alkoholate formation 
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stage  (18). The chlohydrine fragments formed can be easily transformed to epoxy 
groups by dehydrochlorination in the presence of KOH.  
CRG membranes were then sterilized overnight with 70% ethanol. Before cellular 
assays, the membranes were maintained in sterile phosphate buffered saline (PBS, 
Sigma, USA) with 3% (w/v) KCl and washed twice in sterile PBS immediately before 
cell seeding. 
 
2.1.3 Temperature-responsive dishes 
 
Temperature-responsive dishes for cell culture allow cells to be cultured and then, after 
reaching confluency, to harvest all the cells and their extracellular matrix deposited 
during culture as a single contiguous cell sheet by lowering temperature.  For the 
original fabrication of these dishes, isopropylacrylamide (IPAAm)  monomers are 
dissolved in 2-propanol at a concentration of 55% w/w and then 70 µL of the solution is 
uniformly spread over tissue culture polystyrene (TCPS) dishes(19-20).  For 
polymerizing and covalent grafting onto TCPS dishes, these are irradiated with a 0.25 
MGy electron beam (EB). PIPAAm-grafted dishes were rinsed with cold-distilled water 
to remove ungrafted monomer, and dried in nitrogen gas. Dishes were finally sterilized 
with ethylene oxide gas prior to experimental use.  
 
 
2.2. IN VITRO Methodologies 
2.2.1 Tissue samples procurement  
All the human samples were obtained after written protocols were established between 
the 3B’s Research Group and the involved institutions. The protocols also required in 
all cases approval from the respective ethical committees. This resulted in strict rules 
for assuring the patient’s compliance for the collection of samples as well as patient’s 
anonymity. 
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In what concerns the rat bone marrow collection, the procedure was carried out after 
approval of the laboratory ethical committee and according to international animal 
welfare regulations. 
Given that osteoprogenitors and osteogenic cells have the central role in the works 
described in this thesis, mesenchymal progenitor cells were the cells of choice to 
undergo osteogenic differentiation. Bone marrow stromal cells (BMSCs) have been 
proposed as the gold standard for bone Tissue Engineering due to their immuno-
privileged phenotype and their high osteogenic differentiation potential (21), true for 
cells both from human and rat origin. Human adipose derived stem cells (hASCs) share 
those molecular and functional characteristics of BMSCs (22), though adipose tissue is 
increasingly seen as more accessible and easier to harvest than bone marrow, 
rendering it a better source for tissue engineering purposes.  
Human monocytes/macrophages were isolated from human peripheral blood, a readily 
available and abundant source of these cells (23). The use of primary 
monocytes/macrophages, obtained from different donors, instead of using a cell line 
intends to provide a more realistic approach that is more relevant for the extrapolation 
of the results to the clinical setting. This is also true for the selection of human skin for 
the isolation of dermal fibroblasts. 
Under a different context, umbilical cord blood (UCB) was used as a source of 
endothelial progenitors aiming at eventually composing a bone tissue engineering 
construct. Despite the potential lower accessibility, UCB contains more progenitors 
than peripheral blood (24) and therefore the higher larger available amount of 
peripheral blood is easily fight by this knowledge. As the role of transplanted 
endothelial progenitors in a bone tissue engineering approach is still far from being 
revealed, mature human umbilical cord vein endothelial cells (HUVECs) were also 
used to pre-vascularize engineered constructs. These cells have a widespread use in 
research since they are functional endothelial cells that are relatively easy to isolate 
and culture (25). 
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Human BMSCs Isolation 
Human bone marrow samples were obtained from bone marrow aspirates provided 
after routine surgical procedures in Hospital da Prelada, Porto, Portugal. All the 
sampled were collected before cut of the femoral head in hip prosthesis placement in 
order to avoid potential contamination of with osteoblasts. Bone marrow aspiration 
needles (Angiotech, USA) were used to collect 5 mL of marrow. These were 
transferred to a 50 mL falcon tube containing 10mL sterile Dulbecco’s Modified Eagle’s 
Medium (DMEM, Sigma, USA) supplemented with 10% fetal bovine serum (FBS, 
Invitrogen, USA), 5% of antibiotics (A/b, Invitrogen, USA) and 400 units of heparin 
(Sigma, USA) per mL. Transport was carried out under controlled temperature 
conditions and samples were processed within 2 hours after collection. Samples were 
centrifuged in PBS and ressuspended again in PBS for mononuclear cell isolation 
(section 2.2.2). 
 
Peripheral Blood Mononuclear Cells (PBMNCs) Isolation 
Buffy coats from human peripheral blood were obtained from the Portuguese Institute 
of Blood (IPS) after voluntary donations. The samples provided were from healthy 
donors and were discarded by the institute due to insufficient volume for further use of 
the institution. Total blood was collected in citrate phosphate dextrose adenine (CPDA) 
I and processed into buffy coats in the day before use. Transport was carried out under 
controlled temperature conditions and samples were processed right after arrival. Prior 
to differential centrifugation to isolate the mononuclear cell fraction described in section 
2.2.2, buffy coats were diluted 1:2 in PBS (Sigma, USA) in order to avoid gradient 
overload.  
 
 
 
Chapter 2 - Materials and Methods 
 
52 
 
hASCs Isolation 
Discarded subcutaneous adipose tissue from lipoaspiration procedures in Hospital da 
Prelada, Porto, Portugal, was collected to sterile containers with 100 mL of PBS 
(Sigma, USA) with 10% antibiotics (Invitrogen, USA). Lipoaspirates were washed with 
PBS, in order to discard the majority of blood, and then digested with 0.05% 
collagenase II (Sigma, USA) at 37ºC for 45 minutes. Following that, the digested tissue 
was passed through a strainer and centrifuged at 1000g for 10minutes, at 4ºC. The 
obtained pellet was ressuspended in PBS and centrifuged again at 800g for another 
10minutes, at 4ºC. The resulting pellet was then ressuspended in Minimum Essential 
Medium alpha-modification (alpha-MEM, Invitrogen, USA), supplemented with 
10%FBS and 1% Antibiotic-antimycotic, filtered with 100 µm cell strainer (BD 
Biosciences, USA) and plated in tissue culture polystyrene flasks, using the referred 
culture medium. After 24 hours, colonies of spindle-shaped adhered cells started to 
appear. 
 
Cord Blood Mononuclear Cells (CBMNCs) Isolation 
Cord blood was collected during programmed caesareans in Hospital de São Marcos, 
Braga. Cord was clamped in the proximity of the abdomen of the newborn and cut. 
Cord blood was collected from the vein, before placenta removal, directly to the 
collection bag containing CPDA I (Fenway Europe sprl, Belgium) as anticoagulant. 
Transport was carried out under controlled temperature conditions and samples were 
processed within 2 hours after collection. The blood was then diluted 2:1 in PBS 
(Sigma, USA) for posterior mononuclear cell isolation as described in section 2.2.2. 
 
hDFb Isolation 
hDFb were isolated from discarded skin tissue specimens obtained from healthy 
patients undergoing abdominoplasties at Hospital da Prelada, Porto. Transport was 
carried out under controlled temperature conditions and samples processed less than 
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24 hours after collection. Skin samples were washed with sterile phophate-buffered 
saline (Sigma, USA) and cut into small pieces (2mm2), and digested with a 2.4 U/mL 
Dispase II (Sigma, USA) solution at 4ºC, overnight. After the incubation the epidermis 
was removed, and the remaining dermal components were further incubated with a 
0.1% collagenase type IA (Sigma, USA) solution for 3 hours at 37ºC, under gently 
agitation. The digested dermis was then passed through a 100µm cell strainer (BD 
Biosciences, USA), centrifuged at 400 G for 10 minutes and the pellet ressuspended in 
low-glucose DMEM medium (Sigma, USA) supplemented with 10% FBS ((Invitrogen, 
USA) and 1% Antibiotic/Antimycotic (Invitrogen, USA). Spindle-shaped cells were 
adhered after 24 hours of culture. 
 
Rat BMSCs Isolation 
Male Wistar rats with 4 weeks of age (Charles River, Yokohama, Japan) were 
euthanized with CO2 following animal safety regulations. Subsequently, rats were 
cleaned with 70% ethanol, placed in a flow chamber and femurs were surgically 
removed. The femoral condyles were removed with the joints to expose the marrow. 
The epiphysis were cut and a needle, coupled to a syringe containing DMEM medium 
supplemented with 10% FBS and 1% antibiotics, was inserted in the marrow cavity 
which was flushed several times, with the culture medium, into a falcon tube. The 
recovered marrow was then repeatedly pipetted to disaggregate any cell clumps before 
mononuclear cell isolation as described in section 2.2.2. 
 
2.2.2 Mononuclear Cell Isolation  
Cell populations present in blood, both peripheral and from umbilical cord, encompass 
mononuclear cells, erythrocytes and platelets. The populations of interest for the works 
in question are present in the mononuclear fraction so in order to avoid interference 
from the remaining cellular components, Histopaque, a density gradient, was used to 
separate that fraction. 
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The cell suspensions isolated as described above, with the exceptions of hDFb and 
hASCs, were placed over Histopaque 1077 (Sigma, USA) or Histopaque 1083 (Sigma-
Aldrich Japan, Japan), respectively for human and rat cells. For this, 5 mL of 
Histopaque at room temperature were placed in 15 mL conical falcon tubes and 3 mL 
of the cell suspensions were carefully layered over it. The tubes were then centrifuged 
at 400 G for 30 minutes, at room temperature. Cells in the interface between plasma 
and Histopaque were recovered using a pasteur pipette, washed three times in PBS 
and counted using a Neubauer chamber. Mononuclear cells were then ready for 
downstream characterization and culture. 
 
2.2.3 Cell Culture 
Osteogenic Differentiation  
The differentiation of BMSCs and ASCs towards the osteogenic lineage is extensively 
described in the literature(26-27) and has been demonstrated to be induced by 
supplementing specific culture medium with ascorbic acid, beta-glycerophosphate and 
dexamethasone (28). As ascorbic acid, proven to increase matrix production (29), has 
a very short half-life in the medium (30), a salt of ascorbic acid, ascorbate-2-phosphate, 
is used.  Beta-glycerophosphate is involved in matrix mineralization by providing 
phosphate ions (31) while dexamethasone is a corticoid that commits osteoprogenitor 
cells to the osteogenic lineage (32-33)  
Therefore, mesenchymal progenitors from either human bone marrow, rat bone 
marrow or human adipose tissue cells were cultured in DMEM (Sigma, USA) medium 
supplemented with10 mM beta-glycerophosphate (Sigma, USA), 50 µg/mL of ascorbic 
acid (Sigma, USA or Wako, Japan) and 10-8M of dexamethasone (Sigma, USA or 
DEXART, Fuji pharma, Japan) (osteogenic medium). 
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Cell Sheets Fabrication 
Cell sheet engineering, as vastly stated in the background introduction to this thesis, 
allows recovering cultured cells as sheets with intact cell-cell junctions and intact ECM 
through the use of thermoresponsive dishes(20). The intact ECM can then act as a 
natural glue that easily adheres to tissues, new culture surfaces or other cell sheets. 
Besides this, the existing volume of work regarding the vascularization of 3D 
multilayered cell sheet constructs, demonstrate the significant potential of this 
technique for bone tissue engineering applications. 
 
Osteogenic Cell sheets  
Isolated rBMSCs were seeded in 100 mm diameter tissue culture polystyrene (TCPS) 
dishes and cultured in basal medium DMEM (low glucose; Wako Pure Chemical 
Industries, Tokyo, Japan), supplemented with 10% FBS (Japan Bioserum Co.Ltd, 
Hiroshima, Japan) and 100 units/ mL of penicillin–streptomycin (Sigma Japan, Japan) 
at 37 ºC and in a 5% of CO2 humidified atmosphere. After 24 hours of culture, non-
adherent cells were removed and the adherent cells were then cultured until semi-
confluence was achieved. Cells were detached using a 0.25% trypsin-EDTA solution 
(Gibco BRL LifeTechnologies, Carlsbad, USA) and seeded in 35 mm of diameter 
thermo-responsive dishes (CellSeed, Japan) at a concentration of 2.5 x 105 cells per 
dish. Cultures were maintained for 21 days in osteogenic medium to commit cells into 
the osteogenic lineage. 
 
Osteogenic Cell Sheets with Endothelial Cells 
The use of endothelial cells in bone tissue engineered constructs has been proven to 
be promising in promoting in vivo vascularization and construct survival (34-38).  
Mature and functional endothelial cells can be isolated in significant numbers from the 
vein of umbilical cords in a relatively simple procedure. Therefore, these cells widely 
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used in research models involving angiogenesis/vascularization were chosen as 
initiators of the pre-vascularization of cell sheet-based constructs. 
HUVECs were purchased from Lonza Japan (Tokyo, Japan), seeded in 75 cm2 
Primaria culture flasks (BD Biosciences, USA) and cultured in Endothelial Cell Growth 
Medium MV2 (ECGM, Promocell, Heidelberg, Germany), 3 days before the rBMSC 
seeded in thermoresponsive-dishes completed 21 days of culture. HUVECs at passage 
3 were seeded in half of the dishes at a density of 1 x 105 cells per dish and co-cultures 
were maintained in ECGM supplemented with 10-8 M dexamethasone (FujiPharma, 
Japan), 50 µg/mL ascorbic acid (Sigma, Japan) and 10 mM beta-glycerophosphate 
(Sigma, Japan) for 3 additional days until transplantation. 
 
Cell Sheets Recovery from thermo-responsive dishes 
In order to recover the cells from the thermoresponsive dishes, culture medium was 
removed and replaced by 1 mL of PBS (Sigma, Japan).  A poly(vinylidene difluoride) 
(PVDF, Immobilon-P, Millipore Corporation, USA) membrane with a diameter of 2 cm 
was placed over the cells in the thermoresponsive dishes and incubated at 20 ºC for 10 
minutes. After this time, cell sheets spontaneously detached from thermoresponsive 
dishes attached to the PVDF membranes. 
 
Cell Sheets Stacking 
Osteogenic cell sheets were stacked immediately before transplantation. The first cell 
sheet was recovered from thermo-responsive dish using a PVDF membrane after 
temperature reduction. The cell sheet and membrane were then stacked on top of a 
second cell sheet, homotypic (control) or co-cultured with HUVECs, the temperature 
was reduced and the stacked cell sheets were recovered from the dish and 
transplanted as described in section 2.3.2. 
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Co-cultures 
Heterotypic cell interactions involve direct cell contact or the production of soluble 
factors that will have a paracrine action on target cells, or frequently both(39). To study 
in vitro the direct cell interactions, direct co-culture models where more than one type 
of cells are cultured together can be used (39). The disadvantage of these models is 
that paracrine signalling is difficult to block which makes it complex to isolate the effect 
of direct contact communication. To study the indirect paracrine signalling between two 
different types of cells there are two different ways that avoid their physical contact, the 
use of conditioned medium or the use of co-culture inserts. The first one involves to 
culture one cell type in medium previously conditioned by the other cell type while the 
second involves culturing both cell types in the same medium at the same time but in 
different surfaces (39). The use of culture inserts is more accurate since it allows bi-
directional communication between the cell types. 
 
hBMSCs and monocytes/macrophages co-cultures 
hBMSCs in passage 1 (Section 2.2.1) were plated in 24-well culture plates, 30 000 per 
well, and cultured in 600 uL of osteogenic medium for 24 hours before establishing the 
co-culture with monocytes/macrophages. Monocytes/macrophages were obtained by 
cell adhesion selection (40) from the hPBMNCs isolated after differential centrifugation 
of the buffy coats (Sections 2.2.1). In detail, 50 000 hPBMNCs were plated in 6.5mm 
Transwells® inserts(Corning, USA), with 0.4µm pore polycarbonate membrane, and 
left to adhere for 24 hours to select the monocytes/macrophage sub-population. After 
that time, non adherent cells were discarded and the indirect contact co-cultures were 
set by placing the inserts on the 24-well culture plates wells with the hBMSCs seeded 
24 hours before. Both cell types were cultured in osteogenic medium, for 2, 5 and 7 
days.  
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  Bone Morphogenetic Protein-2 Role 
The study of the role of specific molecules in a defined pathway, either in vitro or in 
vivo, has been successfully addressed by using respective antagonists capable of 
blocking their action. The use of an anti-Bone Morphogenetic Protein (BMP)-2 antibody 
is described in the literature as a way to block the action of soluble BMP-2 (41-42). The 
concentration of blocker with maximum effect was optimized by testing the effect of 
four dilutions (1:50, 1:100, 1:200 and 1:400) over hBMSC proliferation in the presence 
of monocytes/macrophages. As the blocking effect was maximum, and similar, for the 
1:50 and 1:100 dilutions, anti-BMP-2 antibody was added to the medium of half of the 
hBMSCs in co-culture at a concentration of 1:100. Monocultures of hBMSCs in 
osteogenic medium were set as controls of the assay. 
 
hASCs-derived osteoblasts and CBMNCs co-cultures 
Isolated hASCs in passage 3 were cultured for 21 days in osteogenic medium in order 
to obtain osteoblasts. The osteoblasts derived from hASCs were seeded on the CRG 
membranes in a concentration of 82x103 cells/cm2 and cultured for 5 days in complete 
M199 medium plus 10% FBS and 1% A/b supplemented with osteogenic factors (as 
described in section 2.3.1), 50 µg/mL of endothelial cell growth supplement (ECGS, BD 
Biosciences, USA) and 50 µg/mL of heparin (Sigma, USA). After this time, the isolated 
CBMNCs were seeded over the hASCs-derived osteoblasts adhered onto the CRG 
membranes at a concentration of 82x104 cells/cm2 and maintained in culture for further 
7 and 21 days. Monocultures of hASCs-derived osteoblasts and of 
monocytes/macrophages in the membranes were set as controls.  
 
Human Bone Marrow MSCs-derived osteoblasts and hDFb co-cultures 
Human bone marrow-derived mesenchymal stem cells (hMSCs) were purchased from 
Lonza (Lonza, Switzerland). Cells in passage 1 were cultured in DMEM (Sigma, USA) 
osteogenic medium for three weeks until osteogenic cells were obtained. A hMSC-
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derived osteoblast cell suspension, with a cell density of 5 x 103 cells/mL, was 
prepared, transferred to 24-well culture plates (1mL per well) and incubated for 24 
hours. After this time of culture, hDFb were prepared and added to the wells previously 
seeded with osteoblasts at a cell density of 2.5 x 103 cells/mL (1 ml per well) thus 
establishing the direct contact co-culture model. As the isolated fibroblasts had a higher 
proliferation rate than hMSCs-derived osteoblasts the cell number ration in the co-
cultures was defined having that in consideration. Monocultures of osteoblasts were 
kept as controls in parallel with the co-culture for 2, 7 and 12 days. All cells were used 
in passage 3. 
 
 Involvement of Gap Junctional Communication 
Gap junctional communication (GjC) is known to be involved in bone cellular 
differentiation (43-44), in cellular communication between endothelial cells and 
osteoblasts (45), in mechanical signal transduction between bone cells (44) and in 
immune response and tissue inflammation and repair (46). The most important gap 
junctional protein present in osteoblasts (47) is connexin 43 (Cx43) and GjC through 
this protein modulates osteoblast gene expression (48). Cx43 is also widely expressed 
in fibroblasts (49) and is involved, for instance, in skin wound healing increasing tissue 
repair rate (50-51).  
The assessment of the involvement of GjC between the osteoblasts and fibroblasts in 
co-culture was targeted by using a chemical inhibitor of Gj communication, 18-alpha-
Glycyrrhetinic acid (AGA) (Sigma, USA). This chemical has been described to 
effectively inhibit gap junctional communication between osteoblasts and other cell 
types and is therefore suitable to study this cell-cell communication mechanism (52-
54). 
AGA was dissolved in fresh dimethylsulfoxide (DMSO, Sigma, USA) and diluted to a 
working solution of 25 mM with PBS (Sigma, USA). The co-cultures were prepared as 
described above but AGA was added to the medium attaining a final concentration of 
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100 µM. This concentration was defined after previous toxicity testing. Osteoblasts 
were cultured in the presence of 0, 10, 50, 100 and 500 µM of AGA and viability and 
calcein-AM transfer between cells were evaluated. The concentration of 100 µM of 
AGA that presented maximum inhibition of calcein-AM transfer while having no effect 
over cell viability. Therefore, AGA was added to the cultures 24 hours before the 
establishment of the co-cultures and of the parachute assay. In the case of the co-
cultures, AGA was added to the culture medium every renewal, ie, every other day. 
Controls were made by adding either DMSO or AGA to the hMSC-derived osteoblasts 
monocultures in the same concentrations.  
 
 Parachute Technique 
The visualization of GjC was achieved using the parachute technique where one type 
of cell is labelled with a Gj-permeable fluorescent dye and seeded (parachuted) over a 
second cell type. The assumption of occurring GjC between the cells is confirmed if the 
dye staining the parachuted cells permeate to the other cell type (55).  
hDFb and hMSCs-derived osteoblasts were prepared separately by seeding 7 x104 
cells per 24 well coverslip, 24 hours before the assay. At the time of the assay, hMSCs-
derived osteoblasts or hDFb were labelled with 2 µM of calcein-AM (Invitrogen, USA) 
for 15 minutes at 37ºC. Cells were then thoroughly washed with PBS (Sigma, USA), 
seeded over the previous culture of the other cell type (7 x103 cells/well) and cultured 
for 15 minutes at 37ºC. Cultures were observed with the Axioplan Imager Z1 
fluorescence microscope (Zeiss, Germany) to assess if the Gj-permeable calcein was 
transferred from the “parachuted” cells to the cells in the monolayer.   
 
2.3. IN VIVO Assays 
2.3.1 Sub-cutaneous implantation of CRG membranes with co-cultures 
Twenty-four 4-week-old female Balb/C nude mice with an average weight of 20 g 
(Charles River Laboratories Inc. USA) were anaesthetized with a mixture of ketamine 
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(1.2 mg/mouse s.c., Imalgene® 1000, Merial, Lyon, France) and medetomidine (20 
µg/mouse s.c., Domitor®, Orion Corp., Finland) prepared in physiological serum. After 
the confirmation of analgesia/anaesthesia one incision was performed (reaching a 
maximum of 1.5 cm each) in the intrascapular region. Two craniolateral oriented 
pockets were created by blunt dissection and the implants (2 per animal except for the 
controls) were subcutaneously inserted. The incision was sutured and the mice 
transferred to heated recovery compartments and, when the recovery from 
analgesia/anaesthesia was confirmed, returned to their respective cages and kept 
under food and drink ad libitum. The number of animals per conditions, as well the 
times of implantation are summarized in table 2.1. After each implantation time, 
animals were euthanized with and intracardiac overdose of anaesthesia for implant 
retrieval and subsequent characterization.  
Table 2.1 - Number of animals used per condition in the in vivo assays of the different works 
Constructs Conditions Number of Animals 
Implantation 
Time 
CRG 
Membranes 
7 days of in vitro co-culture 
3 
3 
7 Days 
21 Days 
21 days of in vitro co-culture 
3 
3 
7 Days 
21 Days 
Osteoblasts Monoculture for 7 days 
(Control)  
3 
3 
7 Days 
21 Days 
Osteoblasts Monoculture for 21 days 
(Control)  
3 
3 
7 Days 
21 Days 
 Cell Sheets 
Osteogenic Cell Sheets 
3 
3 
3 
7 Days 
3 Weeks 
6 Weeks 
Silicone Membranes (Control) 
3 
3 
3 
7 Days 
3 Weeks 
6 Weeks 
Stacked Osteogenic Cell Sheets with 
HUVECs 5 
7 Days 
Stacked Osteogenic Cell Sheets (Control) 3 
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2.3.2 Cell Sheets Transplantation 
The cells sheets were transplanted into a mouse subcutaneous dorsal flap model. Male 
or female 6 weeks old nude mice (Charles River Japan, Yokohama, Japan) were 
respectively used for the transplantation of osteogenic cell sheets and osteogenic cell 
sheets with HUVECs. Animals were anesthetized with a constant flux of 4% of 
isofluorane.  Dorsal skin was cut opened using 3x3cm cutting sides and recovered cell 
sheets were placed on mouse subcutaneous dorsal flap and left to adhere to the 
connective tissue of dorsal skin for 5 minutes. After that time, the PVDF membranes 
were peeled off from the adhered CSs and silicone membranes were placed over the 
cell sheets to prevent the contact between the cell sheets and the muscular tissue. 
Control mice were also defined by implanting only silicone membranes, as controls of 
the osteogenic cell sheets, or double osteogenic cell sheet constructs, as controls of 
the osteogenic cell sheets with HUVECs. Skin incisions were closed using 5-0 nylon 
sutures. Animals were kept with food and water ad libitum. The number of animals per 
conditions, as well the times of implantation are summarized in table 2.1. After each 
implantation time animals were euthanized with CO2 and implants were recovered for 
characterization. 
 
2.4 Characterization Techniques and Methodologies 
2.4.1 Flow Cytometry Analysis  
The phenotype of the isolated hPBMNCs, hCBMNCs and hBMSC was screened by 
flow cytometry using the markers depicted in table 2.2, known to be expressed or not 
by the targeted cells. Flow cytometry allows a fast and accurate screening, within a 
population, of the number of cells simultaneously positive for a defined panel of 
markers. Panels encompassing CD14, CD45 and CD34 markers were used to 
characterize the mononuclear population of cells from the peripheral and cord blood 
(56). The expression of CD73, CD90 and CD105 markers in more than 95% of the 
Chapter 2 - Materials and Methods 
 
63 
 
population permits to confirm them as mesenchymal stem cells (57) while CD31 
marker identify cells both from the monocytic and endothelial lineages (58). 
 
Table 2.2 - Panels of antibodies used to characterize, by flow cytometry, the different isolated 
cell populations 
Cells Antibodies Panel 
hPBMNCs 
CD14-PE (BD Pharmingen, USA) 
CD45-FITC (BD Pharmingen, USA) 
CD34-PE (BD Pharmingen, USA) 
CD105-FITC (eBiosciences, USA) 
CD90-APC (eBiosciences, USA) 
 
hCBMNCs 
CD14-PE (BD Pharmingen, USA) 
CD45-FITC (BD Pharmingen, USA) 
CD34-PE (BD Pharmingen, USA) 
CD105-FITC (eBiosciences, USA) 
CD90-APC (eBiosciences, USA) 
CD73-PE (BD Pharmingen, USA) 
 
hBMSCs 
CD45-FITC (BD Pharmingen, USA) 
CD73-PE (BD Pharmingen, USA) 
CD34-PE (BD Pharmingen, USA) 
CD31-APC (R&D Systems, USA) 
CD105-FITC (eBiosciences, USA) 
CD90-APC (eBiosciences, USA) 
 
 
PE: Phycoerythrin; FITC: fluorescein isothiocyanate; APC: allophycocyanin 
 
 
The cells to be analyzed were ressuspended in cold PBS with 2% (w/v) bovine serum 
albumin (BSA, Sigma, USA) solution in PBS (BSA/PBS). Each cell suspension (100 
µL), containing 2x105 cells, was incubated with the antibodies at the concentration 
advised by the manufacturer (table 2.2). After incubation for 20 minutes at room 
temperature, in the dark, cells were washed with PBS/BSA and ressuspended in PBS 
with 1% of formaldehyde. Cells were analyzed in a BD FACScalibur flow cytometer (BD 
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Biosciences, USA). Cells of interest were gated in a forward versus side scatter dot plot 
with a linear scale. Isotype controls were made to discern non-specific from specific 
staining. A minimum of 10 000 gated events were acquired and displayed in dot plots 
created using the Cyflogic software (version 1.2.1, CyFlo Ltd, Finland). 
 
2.4.2 Proliferation Assessment 
Cell proliferation can be reliably assessed by dsDNA quantification. However, it is a 
non-specific assay which means that, in the case of direct co-cultures, the dsDNA from 
the two cell types was not distinguishable. Therefore, in the case of co-cultures of 
hMSCs-derived osteoblasts with hDFb and in monoculture, cell number along the time 
of the cultures was additionally followed using a cell tracking fluorescent marker, which 
permitted to quantify independently the cell number of the different cell types in the 
direct co-culture. 
 
PicoGreen Quantification Assay 
Proliferation of cells in the co-cultures of hMSCs-derived osteoblasts with hDFb and in 
monoculture was assessed after total dsDNA quantification along the culture time. For 
this, the PicoGreen Quantification Kit (Invitrogen, USA) was used. Picogreen is a 
fluorescent staining that binds to dsDNA and therefore permit to measure the 
proportional fluorescence enhancement (59).  A protocol was defined according to 
manufacturer instructions and applied after obtaining a lysate, by consecutive osmotic 
and thermal shocks, of the cells of interest. Standard samples were prepared from a 
2ug/mL standard solution of dsDNA by serial dilutions. The samples and standards 
were mixed with the PicoGreen reagent, previously diluted 200-fold in Tris-EDTA 
buffer, on a 1:1 ratio in a 96-well white opaque plate (Corning, USA) and incubated for 
five minutes protected from light. Fluorescence was then read at 480 nm of excitation 
and 520 nm of emission in a Synergy HT microplate reader (Bio-Tek, USA). A standard 
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curve was made with the standards readings for extrapolation of the samples dsDNA 
concentration. 
 
Image Analysis 
In the beginning of each experiment a hMSCs-derived osteoblasts cell suspension was 
prepared and incubated with a 2 µM solution of 1,1′-Dioctadecyl-3,3,3′,3′-
tetramethylindocarbocyanine perchlorate (DiI) (Sigma, USA) in culture medium for 15 
minutes at 37 ºC. After, cells were washed 3 times in warm medium and seeded for the 
experiments as described above. After each time point, three samples of each 
condition were fixed with formalin and stained with nuclear stain 4',6-diamidino-2-
phenylindole (DAPI, Sigma, USA). Fluorescent micrographs of three independent fields 
of each one of the analyzed samples were taken using the Axioplan Imager Z1 
fluorescence microscope (Zeiss, Germany) and the Axiovision software (Zeiss, 
Germany). The micrographs were analysed using the image-processing software 
ImageJ (Wayne Rasband, NIH, USA). The fraction of hMSCs-derived osteoblasts in 
the co-cultures was determined by dividing the number DiI positive cells by the total 
number of cells given by DAPI staining. The direct correlation between the dsDNA 
values and the cell number (60) allowed to extrapolate the dsDNA values 
corresponding to the fraction of hMSCs-derived osteoblasts in culture.  
 
2.4.3 Alkaline Phosphatase Activity Quantification 
Alkaline phosphatase (ALP) is a common hydrolase thought to be involved int he 
mineralization process by osteogenic cells(28). This enzyme activity quantification has 
been extensively used to confirm the osteogenic differentiation or osteogenic activity 
(28). The analysis was performed in the same cell lysates used for the DNA 
quantification and obtained by osmotic and thermal shocks, and following an adapted 
p-nitrophenol assay (28, 61). In this assay, p-nitrophenil phosphate was used as an 
ALP substrate. ALP, if present, hydrolysed p-nitrophenil, colourless, into p-nitrophenol 
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(yellow). In each assay 20 µL of lysate were incubated with 80 µL of p-nitrophenil 
phosphate solution (0.2% w/w, in diethanolamine, Sigma, USA) in a transparent 96 well 
microplate, at 37ºC, for 45 minutes. The reaction was stopped using 80 µL of a 2M 
NaOH (Sigma, USA) and 0.4 mM EDTA (Sigma, USA) solution.  The optical density of 
the samples was read at 405 nm. A calibration curve was previously prepared using 
the p-nitrophenol (Sigma, USA) standards of 0, 0.05, 0.10, 0.15 and 0.20 µmol/mL and 
used to extrapolate the ALP activity values. These values were then normalized 
against dsDNA results obtained within the same experiments. 
 
2.4.4 Alizarin Red Staining 
Alizarin Red S, an anthraquinone derivative, is used to identify calcium deposits in in 
vitro cultures and tissue mineralization(62). Calcium forms an Alizarin Red S-calcium 
complex in a chelation process, and the end product is birefringent (62). Despite the 
non specific character of the reaction, the elements such as magnesium, manganese, 
barium, strontium, and iron that might interfere are usually present in sufficient 
concentrations. The identification of mineralized tissue was carried out both in in vitro 
and in vivo samples. In the case of in vitro cultured cells, these were fixed in 3.7% (v/v) 
buffered formalin (Sigma, USA) for 20 minutes at room temperature, washed in PBS to 
remove the formalin and washed with ddH2O. For tissue sections, these were 
depparafinized and washed with ddH2O.  
A solution of 0.1 % w/v of alizarin red S (Sigma, USA) was prepared in ddH20 and the 
pH was adjusted to 4.6 by using a 10% ammonium hydroxide (Sigma, USA) solution. 
The samples, both in vitro and in vivo, were incubated in this solution until a red 
colour/purple colour developed indicating the calcified tissue. After this, sections were 
quickly dipped in hematoxylin, washed in running tap water, dehydrated, mounted and 
visualized with a visible light microscope. In vitro samples in tissue culture well plates 
were further washed in ddH2O and visualized with a visible light microscope. 
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2.4.5 Acetylated Low Density Lipoprotein Uptake 
Monocytes/macrophages and endothelial cells possess scavenger receptors at their 
surface specific for acetylated low density lipoprotein (AcLDL) (63). When taken up by 
those cells, AcLDL accumulates intracellularly, which allows to target and to identify 
specifically endothelial and macrophagic cells. This technique was used to identify cells 
of these lineages adhered on the CRG membranes.  
After the different time points the CRG membranes with the cells were incubated with 
10 µg/mL of the fluorescent complex DiI-AcLDL (Invitrogen, USA) for 15 minutes, at 
37ºC. Cells were then washed with warm medium and fixed with 3.7% (v/v) buffered 
formalin (Sigma, USA) for 20 minutes at room temperature. Cells were then 
counterstained with DAPI and visualized using a Axioplan Imager Z1 fluorescence 
microscope (Zeiss, Germany). 
 
2.4.6 Immunostaining 
The principle of immunostaining techniques that use antibodies to target specific 
markers is the same as for flow cytometry. Both can be used to identify specific cell 
types or the particular expression of that marker, although immunostaining of cultured 
cells, immunocytochemistry, or of fixed tissues, immunohistochemistry, is only 
quantitative if coupled to image analysis methods. 
 
Immunocytochemistry 
After each culture time point, the samples were fixed in a 3.7% (v/v) buffered formalin 
solution for 30 minutes at room temperature. After fixation, cells were washed three 
times in PBS and either kept at 4ºC or directly used for immunocytochemistry. Non-
specific binding was blocked by incubation with a 3% (w/v) BSA/PBS solution for 30 
minutes. Cells were then incubated with the primary antibody diluted in 1% (w/v) 
BSA/PBS for 1 hour at room temperature at a pre-determined concentration (Table 
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2.3). Cells were then washed three times with PBS and incubated for 1 hour at room 
temperature with an appropriate AlexaFluor (Invitrogen, USA) secondary antibody at 
1:500 dilution. Cells were again washed in PBS and counterstained with DAPI 
(Invitrogen, USA) or Hoechst 33342 (Wako, Japan). Cells were analyzed in an 
Axioplan Imager Z1 fluorescence microscope (Zeiss, Germany) or in an Eclipse 
TE2000-U (Nikon, Japan).  
 
Table 2.3 - Antibodies used to perform immunocytochemistry to characterize different cultured 
cells 
Antibody Antibody Dilution Screened Cells 
Mouse anti-human CD14-
FITC (BD Pharmingen, USA) 1:15 hPBMNCs 
Mouse anti-human STRO-
1(Invitrogen, USA) 1:100 hBMSCs 
Mouse anti-human CD31 
(Dako Cytomation, Denmark) 1:30 hASCs-derived osteoblasts 
and CBMNCs in co-culture Rabbit anti-human vWF 
(Dako Cytomation, Denmark) 1:100 
Mouse anti-human FSP 
(Sigma, USA) 1:500 hDFb 
Rabbit anti-human Connexin 
43 (ABM, Canada) 1:100 
hBMSCs-derived osteoblasts 
and hDFb in co-culture 
Mouse anti-human CD31 
(Dako Cytomation, Denmark) Ready to use HUVECs 
FITC: fluorescein isothiocyanate; STRO-1: Stromal Cell Precursor Surface Antigen-1; vWF: von Willebrand 
Factor, FSP: Fibroblast surface protein 
 
 
 
Immunohistochemistry 
Sections were depparafinized, immersed in an antigen retrieval solution (table 4) and 
heated in the microwave for 2 minutes at maximum power. After cooling, sections were 
incubated with a peroxidase inhibitor solution (table 2.4) for 10 minutes, washed with 
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PBS and incubated with a blocking solution (table 2.4) for 20 minutes to impede non-
specific protein interactions. Sections were then washed in PBS-tween 20 (PBS-T) and 
incubated with the primary antibody, at a pre-determined concentration (table 2.5) 
overnight at 4ºC. Sections were washed in PBS-T and incubated for 45 minutes at 
room temperature with a byotinilated universal secondary antibody for 30 minutes 
(Table 4). After washing, cells were incubated first with a streptavidin- horseradish 
peroxidase (HRP) conjugate (Table 2.4) and then with enzyme substrate 3,3’-
diaminobenzidine (DAB) chromogenic substrate (Table 2.4).  
Stained sections were mounted and analysed with an Axioplan Imager Z1 fluorescence 
microscope (Zeiss, Germany), or with an Eclipse E800 microscope (Nikon, Tokyo, 
Japan). 
Table 2.4 - Reagents used along the immunohistochemistry procedure for different sets of 
experiments 
Reagent CRG-Based Implants Cell Sheets-Based Implants 
Antigen Retrieval Solution 
10mM Sodium Citrate, 0.05% 
Tween 20, pH 6.0 
Target Retrieval Solution, pH 
6 (Dako) 
Peroxidase Inhibitor 3% H2O2 in H2O Peroxidase Blocking (Dako) 
Blocking Solution 3% BSA Serum (Dako) 
Secondary Antibody Universal (Vector Labs) Universal (Dako) 
Streptavidin- HRP conjugate Vector ABC system (Vector 
Labs) Dako LSAB2 kit (Dako) 
Enzyme chromogen-
substrate 
DAB (Vector Labs) DAB (Dako) 
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Table 2.5 - Antibodies used to perform immunohistochemistry to characterize different samples. 
Antibody Dilution Screened Implants 
Mouse anti-human CD31 
(Dako Cytomation, Danmark) 1:30 Carragenan-based 
Mouse anti-human 
osteocalcin (AbD Serotec, 
UK) 
1:100 Carragenan-based  
Rabbit anti–mouse/rat 
osteocalcin (Millipore 
Corporation, Billerica, USA) 
1:200 Cell Sheets/Single Osteogenic Cell Sheet  
Goat anti-mouse/rat SRY 
(Santa Cruz Biotechnology, 
USA) 
1:100 
Cell Sheets/ Stacked 
Osteogenic Cell Sheets with 
and without HUVECs  
Mouse anti-human CD31 
(Dako Cytomation, Danmark) RTU 
Cell Sheets/ Stacked 
Osteogenic Cell Sheets with 
and without HUVECs  
Rabbit anti-human/mouse/rat 
collagen I (Abcam, USA) 1:200 
Cell Sheets/ Stacked 
Osteogenic Cell Sheets with 
and without HUVECs  
Rabbit anti-human/rat/mouse 
osteopontin (Abcam, USA) 1:100 
Cell Sheets/ Stacked 
Osteogenic Cell Sheets with 
and without HUVECs  
Rabbit anti-human/mouse/rat 
osterix (Santa Cruz 
Biotechnology, USA) 
1:100 
Cell Sheets/ Stacked 
Osteogenic Cell Sheets with 
and without HUVECs  
RTU: ready to use 
 
2.4.7 Hematoxylin and Eosin Staining 
Retrieved tissues after implantation were fixed in 4% paraformaldehyde at 4ºC, for 12 
hours, and then embedded in paraffin (Microm, Germany) and sectioned. The 
thickness of the sections varied between 3 µm for the implanted CRG membranes and 
10 µm for the cell sheets. 
Standard hematoxylin and eosin stainings were used to make a general morphological 
assessment of the sectioned tissues. Sections were deparaffinized in xylene (Thermo 
Scientific, USA) and hydrated by incubation with increasingly diluted ethanol solutions 
(75%, 90% and 95%). Sections were then washed in water and incubated with 
hematoxylin for 5 minutes. After this, sections were washed under running tap water for 
10 minutes and finally ddH2O. After the incubation with eosin for 1 minute, sections 
were dehydrated with ethanol, washed with xylene and mounted. 
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2.4.8 Gene Expression Analysis 
Quantitative Real Time Polymerase Chain Reaction was used to evaluate the 
expression of several osteogenic related genes. The whole procedure consists on: 
extraction of RNA, cDNA production from the extracted RNA and real-time 
quantification of the amplification of specific sequences using specific primers. 
 
RNA extraction and cDNA production 
Messenger RNA (mRNA) of cells (section 2.2.3) and tissues (section 2.3) was 
extracted, after each time-point, using Tri-reagent (Sigma, USA) according to 
manufacturer instructions. 800 µl of the reagent were added per 1X106 cells or 50 mg 
of tissue, and samples were homogenized by vigorous pipetting.  Following 5 minutes 
incubation, 160 µl of chloroform (Sigma, USA) were added to each sample; samples 
were then incubated for 15 min at 4°C and centrifuged at 13000rpm and 4°C for 15min. 
After the centrifugation, the aqueous part of each sample was collected and an equal 
volume of isopropanol (Sigma, USA) was added. Following an overnight incubation at -
20°C, samples were centrifuged at 9000 rpm and 4 ºC for 10 minutes. Supernatants 
were discarded and pellets were washed in ethanol, centrifuged at 9000rpm and 4°C 
for 5 minutes and re-suspended in 12 µl of RNase/DNase free water (Gibco, UK). RNA 
quantity and purity were assessed with a NanoDrop ND-1000 Spectrophotometer 
(NanoDrop Technologies, USA). Samples with a 260/280 ratio between 1.6 and 2.0 
were used for cDNA synthesis. The cDNA synthesis was performed using iScript cDNA 
synthesis Kit (BioRad, USA) and the thermoblock of the MiniOpticon Real-Time PCR 
Detection System (BioRad, USA). An initial amount of 2 µg of mRNA was used in a 
total volume of 20 µl of RNase/DNase free water.  
 
Quantitative Real Time PCR 
Osteocalcin and osteopontin transcripts were quantified in the cDNA samples using a 
quantitative Real Time PCR reaction. For each sample GAPDH was used as the 
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housekeeping gene. The primers were designed using the Primer 3 software (v 0.4.0) 
and synthesized by MWG Biotech (Germany) (Table 2.6). 
Table 2.6 - List of the primers and respective sequences used to perform qRT-PCR analysis of 
the expression of different genes.  
Gene Primers Forward (F) and Reverse (R) Sequences (5’-3’) Controls 
hGAPDH 
 
hOsteocalcin 
 
hOsteopontin 
F: ACA GTC AGC CGC ATC TTC TT 
R: GAC AAG CTT CCC GTT CTC AG 
F: GTG CAG AGT CCA GCA AAG GT 
R: TCC CAG CCA TTG ATA CAG GT 
F: CCC ACA GAC CCT TCC AAG TA 
R: GGG GAC AAC TGG AGT GAA AA 
Monocultures 
of hBMSCs 
with and 
without 
inhibitor; 
monocultures 
of hMSC-
derived 
osteoblasts 
hGAPDH 
 
hOsteocalcin 
 
hOsteopontin 
 
Collagen I 
F: ACA GTC AGC CGC ATC TTC TT 
R: GAC AAG CTT CCC GTT CTC AG 
F: GTG CAG AGT CCA GCA AAG GT 
R: TCC CAG CCA TTG ATA CAG GT 
F: CCC ACA GAC CCT TCC AAG TA 
R: GGG GAC AAC TGG AGT GAA AA 
F: AGC CAG CAG ATC GAG AAC AT 
R: ACA CAG GTC TCA CCG GTT TC 
Monocultures 
of hASCs-
derived 
osteoblasts 
VE-Cadherin 
 
CD31 
 
vWF  
F: CAC AGT GCT GGC CAT GGA 
R: GTC CTG CGG ATG GAG TAT CC 
F:AAG GCC AGA TGC ACA TCC 
R:TTC TAC CCA ACA TTA ACT TAG CAG G 
F: CCC TGG GTT ACA AGG AAG AAA AT 
R: AGT GTC ATG ATC TGT CCT CCT CTT AG 
Monocultures 
of CBMNCs 
mOsteocalcin 
 
mCollagen I 
 
mOsterix 
 
mGAPDH 
 
hGAPDH 
 
hVE-Cadherin 
F:CTGAGTCTGACAAAGCCTTC 
R:GCTGTGACATCCATACTTGC 
F:GAGCGGAGAGTACTGGATCG 
R:GCTTCTTTTCCTTGGGGTTC 
F:GCTCCTCGGTTCTCTCCATCTG 
R:TGTGTTGCCTGGACCTGGTG 
F:ACGGCCGCATCTTCTTGTGCA 
R:AATGGCAGCCCTGGTGACCA 
F:TGCACCACCAACTGCTTAGC 
R:GGCATGGACTGTGGTCATGAG 
F:CACAGTGCTGGCCATGGA 
R:GTCCTGCGGATGGAGTATCC 
Stacked 
osteogenic 
cell sheets 
implanted 
without 
HUVECs 
Chapter 2 - Materials and Methods 
 
73 
 
 
A concentration of 200 nM of primer was used in a final volume of 25 µl of sample. The 
Real Time PCR reaction was done using the iQ Syber Green SuperMix (BioRad, USA), 
in a MiniOpticon Real-Time PCR Detection System (BioRad, USA). 
The relative quantification of gene expression was performed using the 2-∆∆CT method 
(Perkin Elmer User Bulletin No.2). All values were first normalized against GAPDH 
values and then against a chosen control (Table 2.6) 
 
2.4.9 Calcium Quantification 
The retrieved cell-sheet implants (Sections 2.3.2) were used for calcium quantification. 
Halves of the recovered implants were weighted and incubated in 0.5M HCl (Sigma, 
USA) to remove and dissolve the calcium. Calcium quantification in the obtained 
solutions was performed using the o-cresolphtalein-complexon method with the Roche 
Cobas kit (Roche Diagnostics, Germany). In a 96 well plate, 175 µL of reagent 1 
(ethanolamine, 1M, pH10.6) were mixed with 10 µL of each sample and incubated for 5 
minutes at room temperature. 70 µL of reagent 2 (o-cresolphtalein-com plexon 0,3 mM, 
hydroxy-8-quinoleine 13,8 mM, HCl 122 mM) were added at each well and incubated at 
37ºC for 2 minutes. The absorbance of the samples was read at 570 nm in a 
microplate reader Synergy-HT (Bio-Tek, Germany). The calcium concentrations were 
extrapolated from the calibration curve obtained using serial dilutions of a 200 mg/L 
calcium chloride solution and then normalized using the initial tissue mass. 
 
2.4.10 Micro-computed Tomography 
In order to investigate the 3D structure of the mineralized tissue formed after 
transplantation, non-destructive techniques, X-Ray and Micro-Computed Tomography 
(SkyScan, Kontich, Belgium), were used. Recovered implants, after paraffin 
embedding, were cut in half and scanned in a high-resolution mode of 11.32 µm x/y/z 
and an exposure time of 1900ms. The energy of the scanner used was 50 keV with a 
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171 mA current. The µCT scans were followed by a 3D reconstruction of serial images 
and quantification of the mineralized tissue using a minimum threshold value of 70. 
 
2.5. Statistical Analysis 
Data was obtained from the minimum of 3 separate experiments with 3 replicates for 
each condition and averaged. Standard deviation is reported as a measure of sample 
deviation. Statistical analysis was performed using either student t-test for n=4 or one 
way ANOVA test. The first was applied to test the difference between the means of two 
independent groups subjected to different treatments. When more than two groups 
and/or treatments were compared at the same time, one-way ANOVA test was applied 
using Tukey-Kramer method as a post-hoc pairwise comparison test. For both tests, 
values were considered statistically significant for p≤0.05.  
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Chapter 3 
EFFECT OF MONOCYTES/MACROPHAGES ON THE EARLY OSTEOGENIC 
DIFFERENTIATION OF HBMSC 
Abstract 
Heterotypic cell interactions are essential for the homeostasis of bone tissue, in 
particular the widely studied interaction between osteoblasts and osteoclasts. Closely 
related with osteoclasts are monocytes/macrophages. These have been proven before 
to produce osteogenic factors, namely bone morphogenetic protein (BMP-2), and to 
play a key role in bone metabolism. The mechanisms through which 
monocytes/macrophages interact with osteoblasts are however still not well 
understood. 
The aim of this work was to assess the influence of human peripheral blood 
monocytes/macrophages over the early osteogenic differentiation of human bone 
marrow stromal cells (hBMSCs), in the presence of dexamethasone-supplemented 
osteogenic medium. The co-cultures were performed using porous transwells that 
allowed the interaction between both cell types through the production of paracrine 
factors. The potential effect of BMP-2 produced by monocytes/macrophages was 
addressed by adding to the co-cultures an anti-BMP-2 antibody. 
It was found that hBMSCs cultured in the presence of monocytes/macrophages had a 
higher proliferation rate than hBMSCs cultured alone. The quantification of the early 
osteogenic marker alkaline phosphatase (ALP) revealed higher activity of this enzyme 
in cells in the co-culture throughout the time of culture. Both of these effects were 
inhibited when an anti-BMP-2 antibody was added to the cultures. Moreover, qRT-PCR 
for osteocalcin and osteopontin transcripts showed overexpression of both markers, 
although more evident for osteocalcin. Once again, the effect of 
monocytes/macrophages over hBMSC osteogenic differentiation was completely 
inhibited in the co-cultures by blocking BMP-2. 
The present work confirmed that monocytes/macrophages produce BMP-2 that 
promotes osteogenic differentiation and proliferation of hBMSC cumulatively to 
dexamethasone-supplemented medium. This potentially implies that 
monocyte/macrophages have a stronger role in bone homeostasis than supposed so 
far. 
Chapter based on Pirraco RP, Reis RL, Marques AP, Effect of 
Monocytes/Macrophages on the early osteogenic differentiation of hBMSC, (2010) 
submitted. 
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3.1 Introduction 
It is well established that heterotypic cellular interactions in bone microenvironment are 
essential for bone homeostasis. The demonstration that  cells of the osteoblastic 
lineage control the formation and activity of bone resorbing cells, the osteoclasts (1) is 
even more relevant for biologists that intend to understand bone biology and in 
particular bone remodeling and regeneration(2-4). Bone formation and bone resorption, 
essential for a normal bone turnover, are coupled processes (5-6) that co-exist within a 
delicate balance, controlled by factors such as hormones(7) and other growth factors 
(8). Osteoclasts, being multinucleated and highly specialized cells derived from the 
hematopoietic lineage that have the function of resorbing bone, are seen as critical 
players in this well balanced regulatory process (2-3, 9). Also from the hematopoietic 
lineage, and closely related to osteoclasts, are circulating peripheral blood monocytes 
which can easily reach almost any tissue in the human body(10). While in physiological 
conditions monocytes differentiate into resident macrophages after tissue infiltration 
(10), upon injury or infection, monocytes are recruited to the injury site and differentiate 
into activated macrophages (10) participating in the tissue response. In the particular 
case of bone tissue, after acquiring an inflammatory phenotype, for instance at a 
fracture site, macrophages can differentiate into osteoclasts (11-12).  
The role of monocytes/macrophages in bone remodeling and regeneration certainly 
does not simply rely on this phagocytic lineage interplay. Monocytes/macrophages are 
linked to the production of several cytokines and growth factors like tumor necrosis 
factor (TNF)-alpha, transforming growth factor (TGF)-beta, platelet derived growth 
factor (PDGF), fibroblast growth factor (FGF) and others (13-14). Additionally, it has 
been proven that macrophages produce several osteogenic factors such as for 
instance 1,25-dihydroxyvitamin D3 (15) and BMP-2 (16). All these molecules have a 
potential effect on other cells present at the fracture healing site, namely mesenchymal 
stem cells (MSCs) and osteoblastic progenitors (13). Furthermore it is well known that 
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activated monocytes/macrophages contribute to in vitro vascular calcification by means 
of affecting the osteoblastic differentiation of calcifying vascular cells (CVCs), a 
subpopulation of osteoblast-like cells derived from the artery wall (17). Recently, some 
works focusing on bone resident macrophages proposed a complex bone regulatory 
role for those cells (18-19). These works suggested that macrophages can be key 
players in bone homeostasis, acting both in bone resorption by regulating osteoclasts 
activity, and in osteoblast mineralization ability through cytokine production. However, 
the precise effect of monocytes/macrophages over mesenchymal progenitor cells has 
been subject of very few studies, which either focus on the immunomodulatory effect of 
the MSCs (20-22) or on the osteoclastic differentiation potential of macrophages (12, 
23-24).   
BMP-2 is part of the super family of TGF-β and is proven to induce bone formation in 
vitro and in vivo (25-28). Its potential for bone regeneration is attested by several 
clinical studies involving this protein (26). Champagne et al (16) demonstrated, in vitro, 
that  macrophage cell lines influence the differentiation behavior of human MSCs by 
producing BMP-2, which in turn triggered its osteogenic differentiation. This was an 
important finding since it eventually implicates macrophages in the process of bone 
healing.  
The objective of the present study was therefore to assess the effect of human 
peripheral blood monocytes/macrophages over the osteogenic differentiation of human 
bone marrow stromal cells (hBMSCs) in order to understand this cross-talk and to 
complement what was previously reported with murine and human macrophage cell 
lines. For that, an indirect co-culture system, using culture inserts, was set with 
hBMSCs and human peripheral blood-derived monocytes/macrophages under 
standard osteogenic conditions in the presence of an anti-BMP-2 antibody. The use of 
osteogenic culture conditions intended to further explore the effect of the culture 
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medium, and in particular of the dexamethasone supplement, over the role of 
monocytes/macrophages in the osteogenic differentiation of hMSCs. 
3.2 Materials and Methods 
3.2.1 Cells Isolation and Culture 
Human bone marrow aspirates (n=4) were obtained from routine hip revision surgeries 
in Hospital da Prelada, Porto, Portugal, after informed consent. Buffy coats (n=4) were 
obtained from the Portuguese Blood Institute (IPS, Porto, Portugal). All samples were 
acquired under cooperation agreements with the 3B’s Research Group, University of 
Minho, Portugal. 
Mononuclear cells from Human bone marrow samples were obtained after 
homogenization of the samples and differential centrifugation using Histopaque 1077 
(Sigma, USA). Cells were then cultured at 37ºC, in a humidified atmosphere with 5 % 
CO2, in Dulbecco’s Modified Eagle Medium (DMEM, Sigma, USA) supplemented with 
10% of FBS (Invitrogen, USA) and 1% of antibiotics (A/B, Invitrogen, USA). After 
human bone marrow stromal cells (hBMSCs) reached confluence at passage 1, 30 000 
cells were plated in 24-well culture plates and cultured in 600 uL of osteogenic medium 
composed of DMEM plus 10% FBS and  1% of A/B, and supplemented with 10 mM 
beta-glycerophosphate (Sigma, USA), 50 µg/mL of ascorbic acid (Sigma, USA) and 10-
8M of dexamethasone (Sigma, USA) (29) for 24 hours before establishing the co-
culture with monocytes/macrophages.  
Human peripheral blood mononuclear cells (hPBMNCs) were isolated from buffy coats 
following the differential centrifugation procedure using Histopaque 1077 described 
above. Monocytes/macrophages were obtained by cell adhesion selection (30). Briefly, 
50 000 hPBMNCs were plated in 6.5mm Transwells® inserts, with 0.4µm pore 
polycarbonate membrane (Corning, USA), and left to adhere for 24 hours to select the 
monocytes/macrophage sub-population. After that time, non adherent cells were 
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discarded and the indirect contact co-cultures were set by placing the inserts in the 24-
well culture plates wells with the hBMSCs seeded 24 hours before. Both cell types 
were cultured in osteogenic medium, for 2, 5 and 7 days. Anti-BMP-2 antibody (Abcam, 
UK) was added to the medium of half of the hBMSCs in co-culture at a dilution of 1:100 
obtained after optimization (data not shown). Monocultures of hBMSCs in osteogenic 
medium were set as controls of the assay. 
 
3.2.2 Flow Cytometry 
After isolation, hPBMNCs were screened by flow cytometry for the following markers: 
CD14-PE, CD45-FITC and CD34-PE (all from BD Pharmingen, USA), and CD105-
FITC and CD90-APC (eBiosciences, USA). hBMSCs, at passage 1, were tested for the 
expression of CD45-FITC, CD73-PE and CD34-PE (all from BD Pharmingen, USA), 
CD31-APC(R&D Systems, USA), and CD105-FITC and CD90-APC (eBiosciences, 
USA) markers. Cells were ressuspended in cold PBS with 2% BSA and 100 uL of cell 
suspension with 2x105 cells, and incubated with the antibodies at the concentration 
advised by the manufacturer. After incubation for 20 minutes at room temperature in 
the dark, cells were washed with PBS/BSA and ressuspended in PBS with 1% of 
formaldehyde. Tubes were analyzed in a BD FACScalibur flow cytometer (BD 
Biosciences, USA). Cells of interest were gated in a forward versus side scatter dot plot 
with a linear scale. Isotype controls were made to discern non-specific from specific 
staining. A minimum of 10 000 gated events were acquired and displayed in dot plots 
created using the Cyflogic software (version 1.2.1, CyFlo Ltd, Finland). 
 
3.2.3 dsDNA quantification 
Proliferation of hBMSCs was assessed after total dsDNA quantification along the 
different culture time points. The test was performed using the PicoGreen 
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Quantification Kit (Invitrogen Corporation, California, USA), according to manufacturer 
instructions, in a lysed cell suspension obtained after osmotic and thermal shocks. 
Fluorescence was read in a microplate reader (Bio-Tek, USA) at 485 ex/ 525 em. 
 
3.2.4 Alkaline phosphatase (ALP) activity quantification 
The ALP activity quantification was performed in the same cell lysates used for the 
DNA quantification obtained by osmotic and thermal shocks and following an adapted 
p-nitrophenol assay (29). Briefly, 20 uL of lysate were incubated with 80 uL of p-
nitrophenol phosphate solution (0.2% w/w, in diethanolamine, Sigma, USA) at 37ºC, for 
45 minutes. The reaction was stopped using 80 uL of a 2M NaOH and 0.4 mM EDTA 
solution.  The optical density of the samples was read at 405 nm. A calibration curve 
was previously prepared using the p-nitrophenol standards (Sigma, USA) and used to 
extrapolate the ALP activity, which was then normalized against dsDNA results. 
 
3.2.5 Immunocytochemistry 
After 24 hours of hPBMNCs culture, the polycarbonate membranes were cut off from 
the inserts and the selected monocytes/macrophages were stained for CD14-FITC 
monocytic lineage marker using a mouse anti-human monoclonal antibody (BD 
Pharmingen, USA) in a concentration of 1:15. Non-specific binding was blocked by 
incubation with a 3% bovine serum albumin (BSA, Sigma, USA) solution in PBS for 30 
minutes. After 1 hour incubation at room temperature, Cells were washed in PBS and 
counterstained with DAPI (Invitrogen, USA) nuclear staining. 
The presence of the stromal progenitor marker STRO-1 in the hBMSCs cultured for 24 
hours was screened using a mouse anti-human monoclonal antibody (Invitrogen, 
USA), diluted 1:100. Briefly, after fixation with formalin, cells were incubated with a 3% 
BSA solution in PBS for 30 minutes to block non-specific binding. Cells were then 
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incubated with the primary antibody for 1 hour at room temperature and washed in 
PBS. Alexafluor 488 secondary antibody (Invitrogen, USA) was incubated with cells for 
one hour at room temperature. Cells were then washed in PBS and counter-stained 
with DAPI (Invitrogen, USA) nuclear staining. 
The expression of CD14 and STRO-1 in the monocytes/macrophages and hBMSCs 
was analysed using the Axioplan Imager Z1 fluorescence microscope (Zeiss, 
Germany). 
 
3.2.6 PCR analysis 
RNA extraction and cDNA production 
mRNA of hBMSCs was extracted, after each culture time-point,  using Tri-reagent 
(Sigma, USA) according to manufacturer instructions. Briefly, 800 µl of TriZol were 
added per 1X106 cells and samples were homogenized by vigorous pipetting.  
Following 5 minutes incubation, 160 µl of chloroform (Sigma, USA) were added to each 
sample; samples were then incubated for 15 min at 4°C and centrifuged at 13000rpm 
and 4°C for 15min. After the centrifugation the aqueous part of each sample was 
collected and an equal volume of isopropanol (Sigma, USA) was added. Following an 
overnight incubation at -20°C, samples were centrifuged at 9000 rpm and 4 ºC for 10 
minutes. Supernatants were discarded and pellets were washed in ethanol, centrifuged 
at 9000rpm and 4°C for 5min, and re-suspended in 12 µl of RNase/DNase free water 
(Gibco, UK). RNA quantity and purity were assessed with a NanoDrop ND-1000 
Spectrophotometer (NanoDrop Technologies, USA). Samples with a 260/280 ratio 
between 1.6 and 2.0 were used for cDNA synthesis. The cDNA synthesis was 
performed using iScript cDNA synthesis Kit (BioRad, USA) and the MiniOpticon Real-
Time PCR Detection System (BioRad, USA). An initial amount of 2 µg of mRNA was 
used in a total volume of 20 µl of RNase/DNase free water.  
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Quantitative Real Time PCR 
Osteocalcin and osteopontin transcripts were quantified in the cDNA samples using a 
quantitative Real Time PCR reaction. For each sample GAPDH was used as the 
housekeeping gene. The primers were designed using the Primer 3 software (v 0.4.0, 
Whitehead Institute, USA) and synthesized by MWG Biotech (Germany) as follows: 
osteocalcin forward 5’ GTG CAG AGT CCA GCA AAG GT 3’ and osteocalcin reverse 
5’ TCC CAG CCA TTG ATA CAG GT 3’; osteopontin forward 5’ CCC ACA GAC CCT 
TCC AAG TA5 3’ and osteopontin reverse 5’ GGG GAC AAC TGG AGT GAA AA 3’, 
GAPDH forward 5’ ACA GTC AGC CGC ATC TTC TT 3’ and GAPDH reverse 5’ GAC 
AAG CTT CCC GTT CTC AG 3’. A concentration of 200 nM of primer was used in a 
final volume of 25 µl of sample. The Real Time PCR reaction was done using the iQ 
Syber Green SuperMix (BioRad, USA), following manufacturer’s instructions, in a 
MiniOpticon Real-Time PCR Detection System (BioRad, USA). 
The relative quantification of osteocalcin and osteopontin expression was performed 
using the 2-∆∆CT method (Perkin Elmer User Bulletin No.2). All values were first 
normalized against GAPDH values and then the co-cultures values against 
monocultures values.  
 
3.2.7 Statistical analysis 
Data was obtained from 4 separate experiments with 3 replicates for each condition 
and averaged. Standard deviation is reported as a measure of sample deviation. 
Statistical analysis was performed using student t-test for n=4 and values were 
considered statistically significant for p≤0.05. In the case of the Quantitative Real Time 
RT-PCR results, the statistical analysis was performed in the ∆Ct values (31). 
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3.3 Results 
3.3.1 Cell characterization 
The isolated hPBMNCs were screened by flow cytometry for the expression of CD14, 
CD45, CD31, CD34, CD90 and CD105  markers (figure 3.1). Isolated cells were 
negative for CD90 and CD34 while a small population (approximately 3 %) was positive 
for CD105. Pan-leukocyte marker CD45 was present in more than 96 % of the cells. 
CD14-positive cells were found to be around 3% of the analyzed cells while CD31-
positive cells comprised 53% of the population.  
In what concerns to hBMSCs, the mononuclear fraction obtained from the bone marrow 
was analysed before the seeding to perform the co-cultures. Cells were negative for 
CD45, CD34 and CD31. On the other hand, more than 99% of cells expressed the 
mesenchymal stem cell markers CD73, CD90 and CD105 (figure 3.1). 
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Figure 3.1 – Flow cytometry analysis of hPBMNCs and hBMSCs prior to seeding. In the case of hPBMNCs, cells were 
gated to exclude dead cells, platelets and debris of erythrocytes.   
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The selected populations, monocytes/macrophages and hBMSCs were characterized 
24 hours after seeding, respectively for the expression of CD14 (Figure 3.2A) and 
STRO-1 (Figure 3.2B) markers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 – Characterization of Monocytes/macrophages (A) and hBMSCs (B,C) cultures after seeding. 
Monocytes/Macrophages cultures are positive for CD14 (green) (A). The hBMSCs express the stromal progenitor 
marker STRO-1 (green) (B) and present the typical fibroblast-like morphology (C). Cell nuclei were counterstained with 
DAPI (blue) (B). Bar = 100 um 
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The immunocytochemistry results showed that the cell population isolated from the 
bone marrow, albeit with different intensities between cells, was positive for STRO-1 
mesenchymal stem cell. In addition it also displayed a spindle shape morphology, as 
observed by optical microscopy (Figure 3.2C), that is typical of mesenchymal stem or 
progenitor stromal cells. The cells selected from the hPBMNCs were, as expected, 
positive for CD14.  
3.3.2 Proliferation of hBMSC 
The effect of monocyte/macrophages on the proliferation of hBMSCs was assessed by 
means of quantifying the dsDNA of the hBMSCs cultures at different time points 
(Figure 3.3). Results indicated that hBMSCs cultured in the presence of 
monocytes/macrophages proliferated more than cells in the control conditions from day 
2 onward (p<0.02) This effect was eliminated when the co-cultures were established in 
the presence of the anti-BMP-2 antibody. For this condition the proliferation rate of the 
hBMSCs was comparable to what was determined for the hBMSCs monocultures 
 
 
 
 
 
 
 
Figure 3.3 – Amount of dsDNA that correlates with cell number quantified along culture in hBMSCs (hBMSC) and in co-
culture with monocytes/macrophages with (Co-Cultures+Ab) and without (Co-Cultures) anti-BMP-2 antibody. *p<0.02 
relating to hBMSCs cultures for the same time point. 
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3.3.3 Osteogenic differentiation of hBMSC 
The influence of monocytes/macrophages over the osteogenic differentiation of 
hBMSCs was assessed following different approaches: (i)the quantification of the ALP 
activity, considered an early osteogenic marker and the relative quantification of the (ii) 
osteopontin and (iii) osteocalcin transcripts. 
The activity of the ALP enzyme at the second and seventh day of culture was 
significantly higher (p<0.02) in the hBMSCs co-cultured with monocytes/macrophages 
than in the hBMSC monocultures and in the co-culture with monocytes/macrophages in 
the presence of anti-BMP-2 antibody. At day 5, however, the opposite was observed; 
the ALP activity in both hBMSCs monocultures and co-cultures in the presence of anti-
BMP-2 antibody had significantly higher (p<0.02) values than in the co-cultures. 
Moreover, it is worth noting that the presence of anti-BMP-2 antibody in the culture at 
day 2 was not sufficient to reverse the increased ALP activity observed in the co-
culture of hBMSCs and monocytes/macrophages.  The ALP activity in the hBMSCs co-
cultured with monocytes/macrophages in the presence of anti- BMP-2 antibody was 
significantly higher (p<0.05) than in the hBMSCs in monoculture. (Figure 3.4) 
 
 
 
 
 
 
Figure 3.4 - Amount of hydrolysed p-nitrophenol phosphate that correlates with the ALP activity quantified along culture 
in hBMSCs (hBMSCs) and in co-culture with monocytes/macrophages with (Co-Cultures+Ab) and without (Co-Cultures) 
anti-BMP-2 antibody. Results were normalized against dsDNA values. § p<0.05 and * p<0.02 relating to hBMSCs for the 
same time point; # p<0.02 relating to Co-cultures for the same time point.  
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The osteogenic differentiation of the hBMSCs was screened at the molecular level by 
quantifying the osteopontin and osteocalcin expression relative to hBMSCs 
monocultures using real time RT-PCR (Figure 3.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 – Osteocalcin (A) and osteopontin (B) relative expressions calculated after quantitative real time RT-PCR. 
Results were first normalized against GAPDH and then against hBMSCs cultures and are presented as fold-change 
hBMSC monocultures. * p<0.02 and # p<0.05 statistically different ∆Ct values in comparison to hBMSCs cultures at the 
same time point. 
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The real time RT-PCR results showed that for day 2 and day 7 of culture, the 
expression of osteocalcin in hBMSCs in co-cultures have a fold change of 
approximately 4 (p<0.02) in comparison to the monocultures condition. A similar trend 
was observed at day 5 though the fold change was around 2. In opposition, the 
expression of osteocalcin in the hBMSCs co-cultured in the presence of anti-BMP-2 
antibody was not different from what was observed for the hBMSCs monoculture. 
(Figure 3.5A) On what concerns to the expression of osteopontin, an overexpression of 
this gene (fold change of 1.5) was observed in the hBMSCs in co-cultures in 
comparison to the hBMSCs in monoculture, for all the times of culture. Nonetheless, 
these observations were only statistically significant (p<0.05) at days 2 and 7. As for 
the osteopontin expression, the presence of anti-BMP-2 antibody in the cultures 
annulled the overexpression of the osteopontin gene as demonstrated by the fold 
change of 1 when comparing the co-cultures established in the presence of anti-BMP-2 
antibody with the hBMSCs monoculture. (Figure 3.5B) 
 
3.4 Discussion 
The study of cellular interactions after bone injury and during regeneration is of 
extreme importance for Tissue Engineering in the sense that it can help researchers to 
better design engineered constructs and to predict their outcome when applied in the 
clinics. While after bone injury, monocytes are recruited to the injury site and 
differentiate into inflammatory macrophages, in normal physiologic conditions, its 
recruitment to bone leads to their differentiation in bone-specific macrophages(18-19). 
Monocytes/macrophages are also known to produce several osteogenic factors (15-16, 
32-34) and several studies (16, 18) suggested its strong influence over the osteogenic 
function or the differentiation, of osteoblasts. Among those different osteogenic factors, 
is BMP-2(16, 18). 
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Based on this knowledge we hypothesized herein that peripheral blood 
monocytes/macrophages would also have a significant effect, , in particular through 
BMP-2, over the osteogenic differentiation of hBMSCs, the most studied cellular 
population that has been proposed for the construction of bone tissue engineering 
products(35). Furthermore, the magnitude of the monocytes/macrophages effect was 
further addressed by determining if the BMP-2 and the typical dexamethasone-
containing osteogenic medium would have a synergistic effect, over a short period of 
time, on hBMSCs osteogenic differentiation. 
In order to guarantee the validity of the proposed research strategy, our first concern 
was to use a progenitor cell population from the bone marrow, intimately linked with 
bone tissue. More than 95% of the isolated hBMSCs expressed CD73, CD90 and 
CD105 and were negative to CD14, CD34 and CD31 (<2%) conforming to the 
accepted mesenchymal stem cell markers pattern. After seeding cells in the cell culture 
plate wells, positivity for STRO-1 marker and spindle-shape morphology confirmed that 
cells maintained their mesenchymal phenotype (36). The marker profile of hPBMNCs, 
also confirmed the normal expression pattern of the peripheral blood leukocyte 
population (CD45+) with 3% of the population expressing the monocytic marker 
CD14(37). Furthermore the hPBMNCs were negative (<2%) for CD34, CD31 and 
CD90 and a low number (approximately 3%) was positive for CD105. The confirmation 
of the monocyte/macrophage lineage of the cells co-cultured with the hBMSCs was 
demonstrated by the expression of CD14 in the cells selected by adherence. The 
different intensities of expression observed after the immunocytochemistry reflect the 
different expression pattern of CD14 in monocytes and macrophages (38).  
Cell proliferation results showed that the presence of monocytes/macrophages had a 
positive effect on hBMSC proliferation and that this effect was inhibited by means of 
adding anti-BMP-2 antibody. By Real Time RT-PCR we detected the expression of 
BMP-2 by monocytes/macrophages (results not shown). This suggests that BMP-2 
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produced by monocytes/macrophages is involved in promoting hBMSCs proliferation. 
Reports in the literature concerning the effect of BMP-2 over bone marrow stromal cells 
proliferation are contradictory (39-41), which indicates that this effect may be highly 
dependent on the type of culture model used. Some works using hBMSCs showed a 
diminished proliferation when cells were cultured in the presence of BMP-2 (42-43). It 
is also well understood how cell proliferation and differentiation are inversely regulated 
(44). This seems to indicate that, in our model, BMP-2 acts synergistically with other 
soluble factor in the culture resulting in hBMSCs proliferation.  
ALP activity in the co-cultures was inhibited to the level of monocultures, at day 2 and 7 
of culture, after BMP-2 blocking, which reveal the direct effect of BMP-2 over ALP 
activity, as published by others (42). The fact that for day 5 the opposite result was 
verified, less ALP activity in the co-cultures, could be an artifact of the experiment 
related to the used culture model. This is further reinforced by the similar trend 
observed for the osteopontin expression. Nevertheless, the analysis of the expression 
of osteocalcin and osteopontin markers confirmed that the overexpression of those 
markers in the presence of monocytes/macrophages was eliminated by blocking BMP-
2. Once again, this is coherent to what is described as the effect of BMP-2 over the 
expression of osteogenic markers in hBMSCs (42). Osteocalcin and osteopontin are 
associated with the osteogenic differentiation and mineralization processes of hBMSCs 
(39, 41-42), thus an overexpression of these markers was expected.  
It is also known that hBMSCs produce BMP-2 during osteogenic differentiation (45). In 
the present work, the control condition, hBMSCs monocultures in osteogenic medium, 
clearly demonstrates how significant the presence of monocytes/macrophages is. In 
addition, the effect of monocyte/macrophage-produced BMP-2 was evaluated while 
cells were already being directed to osteogenic lineage by dexamethasone-containing 
osteogenic medium. Therefore, a synergistic effect to our knowledge unreported so far, 
of BMP-2 and the osteogenic factors in the culture medium cannot be discarded. Both 
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BMP-2 (46-47) and dexamethasone (48-49) ultimately upregulate a cascade of 
osteoblastic transcription factors among which is Runx2, although involving two 
different molecular pathways. In the case of dexamethasone, it has been proposed that 
its osteogenic effect is accomplished through a glucocorticoid-receptor mediated 
mechanism that modulates Runx2 phosphorylation via mitogen activated protein kinase 
phosphatase-1 (MKP-1) (48). On the other hand, it is well established that BMP-2 
upregulates Runx2 via the Smad pathway (50). Therefore, it is possible that the 
mechanisms triggered by both dexamethasone and BMP-2 have a cumulative effect on 
the osteogenic differentiation of hBMSC. The mechanisms orchestrating the osteogenic 
differentiation of hBMSC are as complex as important to be addressed even more if 
taking in account a possible synergistic effect of two known osteogenic factors. It is 
thus our consideration that the mechanisms proposed here should be the subject of a 
more pervasive study.  
The mechanisms orchestrating the osteogenic differentiation of hBMSC are as complex 
as important to be addressed, even more if taking in account a possible synergistic 
effect of two known osteogenic factors. Furthermore, this knowledge is potentially 
advantageous for the design of bone Tissue Engineering (TE) strategies. The 
prospective advantage of the presence of specific sub-populations of macrophages for 
the positive outcome of implanted scaffolds was previously hypothesized (51).  This 
concept was also the basis to demonstrate that peripheral blood-derived macrophages 
influence the degradation and remodelling of scaffolds made of extracellular matrix-
based natural materials (52).  Therefore, it is our belief that promoting the chemotaxis 
of such sub-population of cells to the implantation site, might be a valuable approach to 
promote the success of scaffold-based bone TE strategies. 
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3.5. Conclusions 
The present report confirms that peripheral blood monocytes/macrophages are capable 
of deeply influencing hBMSC metabolism. It is also strongly suggested that this 
mechanism is regulated by BMP-2 production by monocytes/macrophages. BMP-2 
effect over hBMSC differentiation was cumulative to the one exerted by 
dexamethasone-containing osteogenic medium and, additionally, promoted hBMSC 
proliferation. Synergistic effects between dexamethasone- and BMP-2-induced effects 
may explain this result but a more profound analysis, both in molecular terms and 
experimental time-spanning, is needed. 
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Chapter 4 
OSTEOBLASTS SUSTAIN THE FUNCTIONALITY OF ENDOTHELIAL PROGENITORS FROM THE 
MONONUCLEAR FRACTION OF UMBILICAL CORD BLOOD 
Abstract 
Vascularization is currently the most pressing issue in Tissue Engineering (TE) as to 
assure that engineered constructs are adequately perfused after in vivo transplantation 
is essential for the construct’s survival. The combination of endothelial cells with 
current TE strategies seems the most promising approach but doubts persist on which 
type of endothelial cells to use. Umbilical cord blood (UCB) cells have been suggested 
as a possible source of endothelial progenitors. 
Osteoblasts obtained from human adipose-derived stem cells (hASCs) were co-
cultured with the mononuclear fraction of human UCB for 7 and 21 days on 
carrageenan membranes. The expression of vWF and CD31, and the ability of 
uptaking DiI-AcLDL allowed detecting the presence of endothelial and monocytic 
lineages cells in the co-culture for all times of culture. In addition, the molecular 
expression of CD31 and VE-cadherin increased after 21 days of co-culture. The 
functionality of the system was assessed after transplantation in nude mice. Although 
an inflammatory response developed, blood vessels with cells positive for human CD31 
were detected in around the membranes. Furthermore, the number of blood vessels in 
the vicinity of the implants increased when cells from the mononuclear fraction of UCB 
composed the transplants in opposition to transplants only with osteoblasts.  
These results show how endothelial progenitors present in the mononuclear fraction of 
UCB can be sustained by osteoblasts co-culture and contribute to angiogenesis even 
in an in vivo setting of inflammatory response. 
 
Chapter based on Pirraco RP, Ferreira B, Santos TC, Frias AM, Marques AP, Reis 
RL, Osteoblasts sustain the functionality of Endothelial progenitors from the 
mononuclear fraction of Umbilical Cord Blood, (2011) submitted. 
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4.1 Introduction 
It is well established that vascularization is a critical issue when engineering a tissue 
(1-2). Improper inosculation and blood perfusion after transplantation will determine the 
failure of an implant especially if its thickness prevents, from oxygen and nutrient 
supplying, the transplanted cells. This is a present issue in bone Tissue Engineering 
(TE) where typically a 3-dimensional scaffold is seeded with osteogenic or 
osteoprogenitor cells, and transplanted in vivo for subsequent bone formation (1-2). 
The current limited clinical potential of this approach is directly related with deficient 
vascularization in vivo which results in necrosis at the bulk of the scaffold (1-5). 
Therefore, several strategies are being employed to try to circumvent this important 
challenge, one of which comprises the use of endothelial cells to accelerate 
inosculation and the implant’s vascularization after transplantation.  
Endothelial progenitor cells (EPCs) is one type of endothelial cells that has been 
recently in focus. These cells were first isolated from the mononuclear fraction of 
human peripheral blood by Asahara et al(6) but were, since then, also proven to exist 
in the bone marrow (7) and umbilical cord blood (UCB) (8). Studies have shown that 
EPCs transplantation can increase angiogenesis and vessel formation in different 
ischemia models (9-12).  UCB is considered the best source of EPCs since it contains 
10-times more CD34+ cells, one of the markers used to isolate EPCs, than peripheral 
blood (13). Furthermore, other blood mononuclear cells such as monocytes (14-15) 
and lymphocytes (16) were shown to have a positive and essential role in the in vitro 
formation of EPCs colonies pointing to a potential advantage of not specifically isolating 
CD34+ cells or other subpopulations to obtain EPCs.   
The intimate relationship between bone tissue and blood vessels is well studied. Bone 
formation is always accompanied by blood vessel development both in embryogenesis 
and post-natal growth (17). Bone multicellular units (BMU), responsible for bone 
remodeling, are always neighboring a blood vessel that grows as the BMU advances 
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(18-19). At cellular levels, endothelial cells have been proven to modulate the activity of 
osteoblasts and osteoblasts progenitors by direct and indirect interactions (20-27). On 
the other hand, osteoblasts are capable of controlling angiogenesis through the 
production of factors such as vascular endothelial growth factor (VEGF) (28-30) that is 
in turn upregulated when osteoblasts are in contact with endothelial cells (31).  More 
importantly, osteoblasts have been proven to support the maintenance of cells such as 
hematopoietic stem cells in several in vitro models (32-33) by direct contact (32).    
Carrageenans (CRGs) are a class of galactan polysaccharides that behave as 
extracellular matrix materials, like agars, in specific species of red seaweeds, including 
Gigartina, Chondrus, and Eucheuma (34-36). These galactan polysaccharides have 
been used in many industrial and some pharmaceutical applications (35, 37) and have 
been recently proposed for biomedical applications (38-40). The CRGs are grouped 
into several sub-types according to their sulphation patterns and distribution of 3,6-
anhydro-D-galactose residues (34-35). In the present work, a kappa-iota hybrid CRG 
derived from the seaweed Chondrus crispus was used. This hybrid CRG presents 
several processing advantages like a higher degree of flexibility, when compared to 
kappa CRG, and a higher robustness when compared to pure iota CRG (41-42). Being 
a natural occurring hybrid polymer, it behaves as a monocomponent system and not 
like a blend, concentrating in a single molecule, characteristics of both kappa and iota 
types.  
Therefore, the aim of this study was to define a co-culture system, using CRG 
membranes as carriers, composed by osteoblasts and cells from the mononuclear 
fraction of UCB by taking advantage of the osteoblast capacity to generate angiogenic 
conditions. The capacity of human osteoblasts cultured on CRG membranes to support 
the in vitro survival of human endothelial progenitors present in the mononuclear 
fraction of UCB was addressed. The developed systems were then transplanted into 
nude mice in order to infer about their in vivo functionality and therefore to allow us to 
conclude about the potential use of the mononuclear cells from the UCB, without 
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further selection, as a source of endothelial progenitors supported by co-culture with 
osteoblasts. 
 
4.2 Materials and Methods 
4.2.1 Carrageenan Membranes production 
Carrageenan type iota-kappa (hybrid) extracted from the red algae Chondrus crispus 
by CEAMSA company (Spain) was used to produce the membranes. Carrageenan 
(CRG) was dissolved in distilled water to a final concentration of 2% w/v. While hot, 25-
35 mL of the solutions were placed in square Petri plates and left to dry at room 
temperature for 48 hours. To preserve its structural features while cutting, the formed 
membranes were placed into a low-hydrating solution of 17% (v/v) ethanol plus 3% 
(w/v) potassium chloride (KCl) (Sigma, USA) and cut into small round samples of 1.1 
cm diameter and 1mm thickness. The CRG membranes were crosslinked in a water 
solution of 50% (v/v) 2-propanol (Fluka, Czech Republic), and 0.32M potassium 
hydroxide (KOH, Fluka, Czech Republic) and 4.63 mM of Epichlorohydrin (ECH, 
Aldrich, USA) for 24h, at 37ºC under 100 rpm agitation. The samples were then 
washed twice with a 17% ethanol (v/v) and 0.1M NaOH (Panreac, Spain) solution, 
aiming at blocking the partially reacted ECH and twice with water at 50Cº for 1h. Each 
group of CRG membranes used on each assay was then sterilized overnight with 70% 
ethanol. Before cellular assays, the membranes were maintained in sterile PBS 
(Sigma, USA) with 3% (w/v) KCl and washed twice in PBS immediately before cell 
seeding. 
 
4.2.2 Cell Isolation 
Umbilical cord blood and adipose tissue were obtained under cooperation agreements 
established with 3B’s Research Group and after approval of the respective Ethical 
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Committees. All samples were obtained after patient’s compliance and within total 
anonymity. 
 
Cord Blood Mononuclear cells (CBMNCs) 
Cord blood was collected during programmed caesareans in Hospital de São Marcos, 
Braga, Portugal. Cord was clamped in the proximity of the abdomen of the newborn 
and cut. Cord blood was collected from the vein, before placenta removal, directly to 
the collection bag containing CPDA I (Fenway Europe sprl, Belgium) as anticoagulant. 
Transport was carried out under controlled temperature conditions and samples were 
processed within 2 hours after collection. The blood was then diluted 2:1 in PBS 
(Sigma, USA) and placed over Histopaque 1077 (Sigma, USA) for density gradient 
centrifugation.  For this, 5 mL of Histopaque at room temperature were placed in a 15 
mL conical falcon tube and 3 mL of the cell suspension were carefully layered over it. 
The tubes were then centrifuged at 400 G for 30 minutes at room temperature. Cells in 
the interface between plasma and Histopaque were recovered using a pasteur pipette, 
washed three times in PBS (Sigma, USA), counted and used for establishing the co-
culture. 
 
Human Adipose Derived Stem Cells (hASCs) 
Discarded subcutaneous adipose tissue from liposuction procedures was collected to 
sterile containers with 100 mL of PBS with 10% antibiotics (Invitrogen, USA), at 
Hospital da Prelada, Porto, Portugal. Lipoaspirates were washed with PBS, in order to 
discard the majority of blood, and then digested with 0.05% collagenase II (Sigma, 
USA) at 37ºC for 45minutes. Following that, the digested tissue was passed through a 
strainer and centrifuged at 1000g for 10minutes, at 4ºC. The obtained pellet was 
ressuspended in PBS and centrifuged again at 800g for another 10minutes, at 4ºC. 
The resulting pellet was then ressuspended in Minimum Essential Medium alpha-
modification (alpha-MEM, Invitrogen, USA), supplemented with 10%FBS (Gibco, USA) 
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and 1% Antibiotic-antimycotic (Gibco, USA), filtered with a 100 µm pores size cell 
strainer (BD Biosciences, USA) and plated in tissue culture polystyrene flasks, using 
the referred culture medium. After 24 hours, colonies of spindle-shaped adhered cells 
started to appear 
 
4.2.3 Flow Cytometry 
After isolation, CBMNCs were screened by flow cytometry for the following markers: 
CD14-PE, CD45-FITC, CD34-PE and CD73-PE (all from BD Pharmingen, USA), and 
CD105-FITC and CD90-APC (eBiosciences, USA). Cells were ressuspended in cold 
PBS with 2% (w/v) BSA (Sigma, USA)) and 100 µL of cell suspension, with 2x105 cells, 
was incubated with the antibodies at the concentration advised by the manufacturer. 
After incubation for 20 minutes at room temperature in the dark, cells were washed with 
PBS/BSA, ressuspended in PBS with 1% of formaldehyde (Sigma, USA) and analyzed 
in a BD FACScalibur flow cytometer (BD Biosciences, USA). Cells of interest were 
gated in a forward versus side scatter dot plot with a linear scale. Isotype controls were 
made to discern non-specific from specific staining. A minimum of 10 000 gated events 
were acquired and displayed in dot plots created using the Cyflogic software (version 
1.2.1, CyFlo Ltd, Finland). 
 
4.2.4 Co-culture set-up 
The isolated hASCs at passage 3 were cultured in alpha-MEM supplemented with 
osteogenic factors, 10-8 M of dexamethasone (Sigma, USA), 10 mM beta-
glycerophosphate (Sigma, USA), and 50 µg/mL of ascorbic acid (Sigma, USA) for 3 
weeks in order to induce differentiation into the osteogenic lineage. After differentiation, 
cells were seeded on the membranes in a concentration of 82x103cells/cm2 and 
cultured for 5 days in M199 medium (Sigma, USA), commonly used to culture primary 
endothelial cells, supplemented with 10% FBS, 1% antibiotic/antimycotic, osteogenic 
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factors, 50 µg/mL of endothelial cell growth supplement (ECGS, BD Biosciences, USA) 
and 50 µg/mL of heparin (Sigma, USA). After this time, the mononuclear cells isolated 
from cord blood were seeded on the membranes at a concentration of 82x104 cells/cm2 
and cultured for further 7 and 21 days. Monocultures of ASCs-derived osteoblasts in 
the membranes were set as controls. 
 
4.2.5 DiI-AcLDL uptake assay 
After each time point, co-cultures were incubated with 10 µg/mL of the complex DiI-
AcLDL (Invitrogen, USA) for 4 hours, at 37ºC and 5% CO2. Cells were then washed 
with warm medium and fixed with 3.7% (v/v) buffered formalin (Sigma, USA) for 20 
minutes at room temperature. Cells were then counterstained with DAPI (Invitrogen, 
USA) and visualized using an Axioplan Imager Z1 fluorescence microscope (Zeiss, 
Germany). 
 
4.2.6 Immunocytochemistry 
After each culture time point, the samples were fixed in a 3.7% (v/v) buffered formalin 
solution for 30 minutes at room temperature. After fixation, cells were washed three 
times in PBS and used immediately for immunocytochemistry. Non-specific binding 
was blocked by incubating the membranes with a 3% (w/v) bovine serum albumin 
(BSA, Sigma, USA) solution in PBS (Sigma, USA) for 30 minutes. Cells were then 
incubated with the primary antibody diluted in 1% BSA/PBS for 1 hour at room 
temperature. Mouse anti-human CD31 (1:30, Dako, Denmark) and mouse anti-human 
vWF (1:100, Dako, Denmark) primary antibodies were used. Cells on the membranes 
were then washed three times with PBS (Sigma, USA) and incubated for 1 hour at 
room temperature with an appropriate AlexaFluor (Invitrogen, USA) secondary 
antibody diluted 1:500. After this time cells were washed in PBS, counterstained with 
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DAPI, and analyzed in an Axioplan Imager Z1 fluorescence microscope (Zeiss, 
Germany). 
 
4.2.7 Quantitative Real Time RT-PCR 
Messenger RNA (mRNA) of cells was extracted, after each in vitro time-point, using 
Tri-reagent (Sigma, USA) according to manufacturer instructions. 800 µl of the reagent 
were added per 1X106 cells and samples were homogenized by vigorous pipetting.  
Following 5 minutes incubation, 160 µl of chloroform (Sigma, USA) were added to each 
sample which were then incubated for 15 min at 4°C, and then centrifuged at 
13000rpm and 4°C for 15min. After centrifugation the aqueous part was collected and 
an equal volume of isopropanol (Sigma, USA) was added. Following an overnight 
incubation at -20°C, samples were centrifuged at 9000 rpm and 4 ºC for 10 minutes. 
Supernatants were discarded and pellets were washed in ethanol, centrifuged at 
9000rpm and 4°C for 5min and re-suspended in 12 µl of RNase/DNase free water 
(Gibco, UK). RNA quantity and purity were assessed with a NanoDrop ND-1000 
Spectrophotometer (NanoDrop Technologies, USA). Samples with a 260/280 ratio 
between 1.6 and 2.0 were used for cDNA synthesis. The cDNA synthesis was 
performed using iScript cDNA synthesis Kit (BioRad, USA) and the thermoblock of the 
MiniOpticon Real-Time PCR Detection System (BioRad, USA). An initial amount of 2 
µg of mRNA was used in a total volume of 20 µl of RNase/DNase free water.  
Osteocalcin and osteopontin transcripts were quantified in the cDNA samples using a 
quantitative Real Time PCR reaction. For each sample GAPDH was used as the 
housekeeping gene. The primers were designed using the Primer 3 software (v 0.4.0) 
and synthesized by MWG Biotech (Germany) as follows: Human GAPDH forward 5’ 
ACA GTC AGC CGC ATC TTC TT3’ and reverse 5’ GAC AAG CTT CCC GTT CTC AG 
3’; human osteocalcin forward 5’ GTG CAG AGT CCA GCA AAG GT 3’ and reverse 
5’TCC CAG CCA TTG ATA CAG GT 3’: human osteopontin forward 5’CCC ACA GAC 
Chapter 4 - Osteoblasts sustain the functionality of endothelial progenitors from the MN fraction of UCB 
119 
 
CCT TCC AAG TA 3’ and reverse 5’ GGG GAC AAC TGG AGT GAA AA 3’; human 
collagen I forward 5’ AGC CAG CAG ATC GAG AAC AT 3’ and reverse 5’ ACA CAG 
GTC TCA CCG GTT TC 3’; human VE-cadherin forward 5’ CAC AGT GCT GGC CAT 
GGA 3’ and reverse 5’ GTC CTG CGG ATG GAG TAT CC 3’;  human CD31 forward 5’ 
AAG GCC AGA TGC ACA TCC 3’ and reverse 5’ TTC TAC CCA ACA TTA ACT TAG 
CAG G 3’; human vWF forward 5’  CCC TGG GTT ACA AGG AAG AAA AT 3’ and 
reverse 5’ AGT GTC ATG ATC TGT CCT CCT CTT AG 3’. A concentration of 200 nM 
of primer was used in a final volume of 25 µl of sample. The Real Time PCR reaction 
was done using the iQ Syber Green SuperMix (BioRad, USA), following manufacturer’s 
instructions, in a MiniOpticon Real-Time PCR Detection System (BioRad, USA). 
The relative quantification of gene expression was performed using the 2-∆∆CT method 
(Perkin Elmer User Bulletin No.2). All values were first normalized against GAPDH 
values and then against the respective monoculture. 
 
4.2.8 In vivo assay 
Four-weeks-old female Balb/C nude mice with an average weight of 20 g (Charles 
River Laboratories Inc. USA) were anaesthetized with a mixture of ketamine (1.2 
mg/mouse s.c., Imalgene® 1000, Merial, Lyon, France) and medetomidine (20 
µg/mouse s.c., Domitor®, Orion Corp., Finland) prepared in physiological serum. After 
the confirmation of analgesia/anaesthesia one incision was performed, reaching a 
maximum of 1.5 cm each, in the intrascapular region. Two craniolateral oriented 
pockets were created by blunt dissection and the implants were subcutaneously 
inserted. Two CRG membranes were implanted in each animal and 3 animals were 
used per condition.  The incisions were sutured and the mice transferred to heated 
recovery compartments. When the recovery from analgesia/anaesthesia was confirmed 
they were returned to their respective cages and kept under food and drink ad libitum. 
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After 7 and 21 days post implantation, animals were euthanized with an intracardiac 
overdose of anaesthesia for implants retrieval and processed for characterization. 
 
4.2.9 Histology 
Standard hematoxylin and eosin (H&E) stainings were used to make a general 
morphological assessment of the sectioned tissues. Briefly, sections were 
deparaffinized in xylene (Thermo Scientific, USA) and hydrated by incubation with 
increasingly diluted ethanol solutions. Sections were then washed in water and 
incubated with Hematoxylin (Sigma, USA) for 5 minutes. After this, sections were 
washed under running tap water for 10 minutes and finally ddH2O. After the incubation 
with eosin (Sigma, USA) for 1 minute, sections were dehydrated with ethanol, washed 
with xylene and mounted with Histofluid (Marienfeld, Germany). 
 
4.2.10 Immunohistochemistry 
After deparaffinization, sections were incubated with antigen retrieval solution (10mM 
Sodium Citrate, 0.05% Tween 20, pH 6.0) and heated in the microwave for 2 minutes 
at maximum power. After cooling, sections were incubated with 3% H2O2 for five 
minutes to inhibit non-specific peroxidase activity and washed with PBS. The next step 
was to block non-specific protein interactions by incubating with a 3% (w/v) BSA 
solution for 30 minutes. Sections were then washed in PBS-tween 20 (PBS-T, Sigma, 
USA) and incubated with the mouse anti-human CD31 (1:30, Dako, Denmark) primary 
antibody overnight at 4ºC. Sections were then washed in PBS-T and incubated for 45 
minutes at room temperature with a biotinylated secondary antibody (Vector Labs, UK). 
After washing, cells were incubated first with Streptavidin-HRP (Vector Labs, UK) and 
then with 3,3’-diaminobenzidine (DAB) chromogenic substrate (Vector Labs, UK). Cells 
were then observed in an in an Axioplan Imager Z1 microscope (Zeiss, Germany). 
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4.2.11 Blood vessel quantification 
After H&E staining, sections were observed in an Axioplan Imager Z1 microscope and 
analyzed for blood vessels using Axiovision software (Zeiss, Germany). The number of 
perfused blood vessels was counted in the periphery of the implants within a 200 µm 
distance.  Three different sections with two cuts per sample (n=6) were used in this 
procedure.  
 
4.2.12 Statistical Analysis 
In vitro data was obtained from 4 independent experiments with 3 replicates for each 
condition and averaged. Standard deviation is reported as a measure of sample 
deviation. Statistical analysis of blood vessel quantification was performed using one 
way ANOVA test with Tukey-Kramer method as a post-hoc pairwise comparison test. 
The statistical analysis of the Quantitative Real Time RT-PCR results was performed 
using the t student-test for n=4. Values were considered statistically significant for 
p<0.05. 
 
4.3 Results 
4.3.1 CBMNCs Phenotype 
The expression profile of CD14, CD45, CD34, CD90, CD105 and CD73 markers in the 
isolated human CBMNCs was determined by flow cytometry (figure 4.1). The isolated 
cells expressed the hematopoietic marker CD34 (1.8%), the monocytic marker CD14 
(4.94%), the CD90 (6.27%) and the CD105 (7.8%) surface proteins. In addition, 13.8% 
of the population was positive for the expression of CD73 while 4.9% expressed the 
endothelial marker CD31. 
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Figure 4.1 - Flow cytometry analysis of CBMNCs immediately after isolation and prior to seeding. Cells were gated to 
exclude dead cells, platelets and debris of erythrocytes. The black lines represent stained cells; grey lines are the 
controls. The percentage of positive cells for each marker is indicated in the graph 
 
 
 
4.3.2 Co-cultures Characterization 
The uptake of the DiI-AcLDL was assessed after 7 and 21 days of in vitro co-culture. 
Cells with internalized DiI-AcLDL were observed throughout the surface of the 
membranes and without any specific organization (figure 4.2). The morphology and 
distribution of cells did not change throughout the time of co-culture. A similar cellular 
distribution was observed when cells in the co-culture were stained for CD31 and vWF 
markers (figure 4. 2). As for the DiI-AcLDL, the patter of expression of CD31 and vWF 
was similar for all the tested co-culture times.   
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Figure 4.2 – Co-cultures of osteoblasts and CBMNCs on the carrageenan membranes after 7 and 21 days. (A) 
Endothelial cell markers, CD31 (red) and vWF (green), were detected by immunocytochemistry. (B) DiI-AcLDL (red) 
staining identifies cells from the phagocytic and endothelial lineages. Nuclei were stained with DAPI (blue) 
 
 
The quantification of the transcripts for the genes of interest was also performed after 7 
and 21 days of co-culture (figure 4.3). The expression level of osteogenic genes 
osteopontin, osteocalcin and collagen I, did not change in relation with monocultures 
for the same time period. On the contrary, the expression of vWF, VE-cadherin and 
CD31 genes significantly increased when compared to monocultures for the same time 
period. The variation of the expression of vWF for 7 days of co-culture was of  2.8 fold 
while for 21 days of co-culture the fold change was of 2.7. In the case of the VE-
cadherin gene, for 7 days of co-culture the expression varied 3.0 fold while for 21 days 
of co-cultures there was a change of 13.5 fold. Regarding the CD31 gene expression a 
positive variation of 3.3 fold was detected after 7 days of co-culture, while for 21 days 
of co-culture, the variation was of 9.3 fold. 
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Figure 4.3 – Quantitative Real Time RT-PCR of osteopontin (OP), osteocalcin (OC), collagen I (COL I), vWF, VE-
cadherin (VE-Cd), and CD31 transcripts in co-cultures of osteoblasts and CBMNCs on carrageenan membranes after 7 
and 21 days.  
 
4.3.3 In vivo performance 
The nature of the host reaction was analyzed based on the histological and 
immunohistological characterization of the tissues surrounding the different implants 
recovered (figure 4.4). The histological evaluation of the obtained sections showed no 
particular differences between the co-cultured (Figures 4.4A-H) and monocultured 
(Figure 4.4I-L) carrageenan membranes for 7 and for 21 days in vitro, for each 
implantation period. A significant inflammatory infiltrate surrounded the membranes at 
day 7 of implantation of both systems co-cultured in vitro for 7 (figure 4.4A) and 21 
(figure 4.4C) days.   
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Figure 4.4 – Histological characterization of carrageenan membranes with co-cultured hASCs-derived osteoblasts and 
CBMNCs (A-H) and monocultures of hASCs-derived osteoblasts (I-L)   in vitro for 7 (A, B, E, F, I, J) and 21 (C, D, G, H, 
K, L) days, and after 7 (A, C, E, G, I, K) and 21 (B, D, F, H, J, L) days of implantation. Implants sections were stained 
with hematoxylin-eosin (A-L) 
 
This infiltrate was characterized by the presence of some polymorphonuclear 
neutrophils, of a significant number of macrophages, either resident or recruited from 
circulation, and some foreign body giant cells (FBGCs) and lymphocytes (figure 4. 4E, 
G). The inflammatory infiltrate around the membranes co-cultured in vitro for 21 days 
was surrounded by vascularized adipose tissue (figure 4.4C, G). 
After 21 days of implantation of the membranes, the extension of the inflammatory 
infiltrate clearly increased (figure 4.4B, D, J, L) as compared with the early implantation 
time period. The presence of many mononuclear cells  similarly to the early time period 
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(Figure 4.4F, H) was observed. Moreover, macrophages fused together forming 
FBGCs, lymphocytes maintained their apparent activation status some plasma cells 
were identified. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 – Immunohistological characterization of carrageenan membranes with co-cultured hASCs-derived 
osteoblasts and CBMNCs (A-D) and monocultures of hASCs-derived osteoblasts (E-H)   in vitro for 7 (A, B, E, F) and 21 
(C, D, G, H) days, and after 7 (A, C, E, G) and 21 (B, D, F, H) days of implantation. Immunostaining was performed to 
localize human CD31 marker. Sections were counterstained with hematoxylin. 
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Perfused blood vessels around the implants with the co-cultures were found to possess 
cells positive for human CD31 marker (Figure 4. 5A-D) while this was not the case of 
the implants with the monocultures of osteoblasts (Figure 4.5 E-H). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 – Quantification of blood vessels within the 200 µm around the surface of the implanted membranes. 
Implanted carrageenan membranes with the co-cultures (Co-Culture) and with osteoblast monocultures (Ctrl) were 
compared. *statistical significance for p≤0.05  
 
Blood vessels were quantified in the periphery of the implants within a 200 µm distance 
for all the conditions, with and without UCB MNC (figure 4.6). The number of vessels 
did not significantly vary with the in vitro culture and implantation times. However, the 
number of blood vessels was always greater when MNCs from cord blood were 
present. This difference was statistically significant when comparing the co-culture 
conditions and their respective monoculture control. 
 
4.4. Discussion 
The need to address the vascularization problem in TE is widely recognized as 
essential for a successful strategy. More so when engineering bone tissue, which 
normally involves the use of complex 3D structures prone to necrosis if not correctly 
perfused (1-5). The use of endothelial cells in bone tissue engineered constructs has 
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been proven to be promising in promoting in vivo vascularization and construct survival 
(31, 43-46). The cell source is however still an issue due to the limited number of 
autologous cells obtained. UCB has been shown to contain endothelial progenitors that 
can be used to promote the vascularization of bone tissue engineered constructs (45).  
Furthermore, current cord blood cryopreservation techniques allow the preservation of 
the potential of endothelial progenitors to be isolated from this source (47-48). Reports 
showing the positive influence of diverse populations of the UCB mononuclear fraction 
in the behavior of endothelial progenitor cells (EPCs) have also reinforced the potential 
of this cells source (16, 49).  Mononuclear fractions of peripheral blood depleted from 
CD14+ monocytes lose the ability to form colony forming unit-endothelial cells (CFU-
EC) (49). In fact, CD14 positive cells have been suggested to be pro-angiogenic (16) 
and capable of differentiating into endothelial cells (15). Furthermore, CD4+ T cells 
were proven to be essential to the CFU-EC formation by CD14+ cells (16). Using 
MNCs from cord blood for vascularization purposes could then be an advantageous 
alternative to the typically used isolation of its specific sub-populations (6).  
Several co-culture constructs of EPCs with MSCs/osteoblasts have been described for 
bone tissue engineering (43, 45-46). Although most of them successfully lead to 
increased vascularization of their constructs because of EPCs, the isolation and culture 
of these cells is a long and complex process. This work therefore proposes the use of 
the complete mononuclear fraction of UCB in order to be able to define a co-culture 
system carrying functional endothelial progenitors. 
The present work allowed verifying that osteoblasts obtained from adipose-derived 
stem cells support the survival of endothelial progenitors present in the mononuclear 
fraction of UCB. Taichman and colleagues (33) previously demonstrated how 
osteoblasts can support the maintenance of hematopoietic progenitors in vitro. Later 
Jung et al(32) proved that this supportive effect of osteoblasts required direct cell-cell 
contact. We hypothesized that osteoblasts can have a similar action on the endothelial 
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progenitors present in the mononuclear fraction of the UCB. Throughout the culture 
times, the monolayers of osteoblasts supported the culture of CD31 and vWF positive 
cells and of cells capable of uptaking DiI-AcLDL. These properties are commonly used 
to define EPCs, however, blood monocytes have been shown to present these markers 
under angiogenic conditions (49-50). In addition, over expression of the endothelial 
genes vWF, CD31 and VE-cadherin was detected in comparison with monocultures of 
MNCs under the same culture conditions and more significant in the case of CD31 and 
VE-cadherin genes after 21 days of co-culture. This result for VE-cadherin is 
particularly remarkable as its expression is strongly linked to the maintenance of new 
blood vessels integrity (51). Although striking, this promotion of the expression of 
endothelial genes is not unexpected. In fact osteoblasts produce factors, such as 
vascular endothelial growth factor (VEGF) (30),  that are capable of inducing the 
endothelial phenotype from progenitors (6).  Furthermore, the ECM deposited by 
osteoblasts is composed by fibronectin which may support the adherence of 
endothelial progenitors from the CBMNCs (52). Fuchs and colleagues (46) have in fact 
demonstrated that outgrowth endothelial cells, a type of EPCs, have increased 
endothelial activity when co-cultured with osteoblasts.  
Contrarily to the endothelial lineage related genes, the expression of osteogenic genes 
osteopontin, osteocalcin and collagen I, did not change throughout the time, which is 
not unexpected as the osteoblastic supporting cells were fully differentiated at the time 
of the co-culture set-up. Co-culture systems established with mesenchymal stem cells 
or other osteoblast progenitors instead of osteoblasts are probably more prone to be 
influenced by the other cell types. This was demonstrated by Fedorovich and 
colleagues (53) in a co-culture model where EPCs promote the osteogenic 
differentiation of MSCs, while these promote the proliferation of the EPCs. In our 
strategy, totally differentiated cells were the ones we wanted to test. 
Carrageenans are natural sulphated polyssacharides that have a widespread use in 
the food industry (54). Recently,  kappa-carrageenans have been proposed for 
Chapter 4 - Osteoblasts sustain the functionality of endothelial progenitors from the MN fraction of UCB 
 
130 
 
regenerative medicine purposes (38-40) presumably due to their favorable mechanical 
properties and an anticoagulant effect (55). We hypothesized that membranes 
produced using a kappa-iota hybrid type of this natural polymers could act as carriers 
to test the functionality of the developed co-cultures in vivo. To our surprise, a very 
strong and progressive inflammatory reaction was detected after implantation of the 
CRG membranes. Furthermore, the amount and nature of the inflammatory infiltrate did 
no vary with the implant type,  CRG membranes only with osteoblasts and co-cultured 
with CBMNCs, which seems to indicate that the cellular component did not significantly 
influence the inflammatory reaction. Solutions of carrageenan from kappa, iota and 
lambda types have been used to induce acute inflammation in animal models (56-58). 
Moreover, as Tobacman thoroughly reviewed (54), the ingestion of carrageenan, used 
in the food industry,  is associated with the onset of several lesions in the gastro-
intestinal tract in several animal models. Its use as a food additive is in fact very 
controversial due to health concerns (54, 59-60).  Additionally, an acute inflammatory 
response, characterized by an abundant neutrophilic exudate and high levels of c-
reactive protein, was reported after implanting gelatin/kappa-carrageenan (55%/45% 
w/w) sponges. The intensity of the reaction was nevertheless milder when the weight 
percentage of carrageenan was lowered to 9% suggesting a dose-dependent 
inflammatory effect of this polyssacharide. A similar acute inflammatory response that 
progressed to chronic inflammation was observed after implanting our membranes 
made of hybrid carrageenan. Although these results impair their potential use for tissue 
engineering or regenerative medicine purposes, the functionality of the defined co-
culture system was nevertheless demonstrated. 
A link between chronic inflammation and angiogenesis is well described in the literature 
(61-63) as there are many factors secreted by inflammatory cells that can act on EPCs 
(64-65). Furthermore, differentiation of EPCs and their contribution to angiogenesis in 
pathological situations is also been observed experimentally (7, 66). In our model, 
human CD31-positive cells were found forming the wall of perfused blood vessels in 
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the vicinity of the implant for all the times of culture. This suggests that an endothelial 
progenitor population present in the co-cultures was able to respond to the stimuli 
present at the implantation site and to differentiate and to contribute to angiogenesis in 
the inflammatory setting. These results also demonstrate the usefulness of the 
mononuclear fraction of UCB as a source of endothelial cells or endothelial progenitors 
without previous selection.  In addition to the proved active participation of transplanted 
CBMNCs in new blood vessels formed, their impact over the number of vessels formed 
around the implants was also demonstrated.  A significantly higher number of vessels 
formed around the implants containing the CBMNCs than around the implants only with 
osteoblasts. 
Overall, this work suggests that osteoblasts can support the maintenance of endothelial 
progenitors present in CBMNCs. Furthermore, the latter can be used to increase 
vascularization in vivo in an inflammatory setting. This can potentially be very 
interesting for future bone Tissue Engineering approaches although more studies have 
to be made especially using biomaterial carriers/supports capable of eliciting host 
reactions with different degrees of severity. 
 
4.5. Conclusions 
The current work showed that osteoblasts sustain in vitro the survival of endothelial 
progenitors present in the mononuclear fraction of UCB in a direct co-culture system 
established using carrageenan membranes as supports. The functionality of the cells 
from UCB co-cultured with osteoblasts was demonstrated in an in vivo inflammatory 
setting. The presence of human CD31-positive cells in blood vessels around the 
implant as well as the increased number of blood vessels when the mononuclear 
fraction of UCB was used, confirms the existence of a sub-population of that fraction 
that can contribute to angiogenesis. This is an indication of the potential use of the 
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mononuclear cells from the UCB, without further selection, as a source of endothelial 
progenitors supported by co-culture with osteoblasts. 
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Chapter 5 
FIBROBLASTS REGULATE OSTEOBLASTS THROUGH GAP JUNCTIONAL COMMUNICATION 
ABSTRACT 
Fibroblasts are present in most tissues of the body playing an active role in the 
regulation of the homeostasis of such tissues. While the fibroblasts heterotypic 
interactions are fairly acknowledged in the regeneration of tissues such as skin and 
periodontal ligament, their role in bone regeneration is far from being understood. We 
hypothesized that fibroblasts could influence bone cells, and since connexin 43 is the 
predominant connexin in both fibroblasts and osteoblasts, we speculated that those 
heterotypic interactions would occur through gap junctional communication (GjC). IN 
order to test that, direct co-cultures of human mesenchymal stem cell (hMSCs)-derived 
osteoblasts and human dermal fibroblasts (hDFb) were established in the presence 
and absence of the GjC inhibitor α-glycyrrhetinic acid. The existence of the 
communication between hMSCs-derived osteoblasts and hDFb via this pathway was 
demonstrated by the transference of the gap junction (Gj) permeable dye calcein-AM 
from the donor cells to the recipient cells, independently of their type. The amount of 
transferred dye was decreased when gap junctional communication inhibitor was used. 
While the proliferation of the hMSCs-derived osteoblasts was not affected by the 
presence of the hDFb, the level of osteogenic markers such as alkaline phosphatase 
activity and osteocalcin transcripts in hMSCs-derived osteoblasts was severely 
diminished. This effect was partially reversed by adding the inhibitor of GjC to the co-
cultures, which strongly suggests that fibroblasts regulate osteoblasts behaviour 
partially through GjC. This information can be critical to predict the outcome of 
strategies aiming to promote bone regeneration as for example in bone Tissue 
Engineering approaches. 
 
Chapter based on Pirraco RP, Cerqueira MT, Reis RL, Marques AP, Fibroblasts 
regulate osteoblasts through Gap Junctional Communication, (2010) submitted. 
Chapter 5 - Fibroblasts regulate osteoblasts through Gap Junctional Communication 
 
144 
 
5.1 Introduction 
Cell-cell interactions are fundamental for the normal function of every system of the 
human body. Tissue function and repair depends on a complex network of cellular 
communication that occurs at different levels and is based on the production of soluble 
factors and on the direct cell-cell contact (1-4). In fact, the detailed knowledge of these 
interactions and respective communication mechanisms is of extreme importance in 
Tissue Engineering and therapeutic approaches as it contributes to a more precise 
prediction of the outcome of an implanted Tissue Engineered construct. In this sense, 
co-culture systems established with different types of cells are useful tools to study 
such interactions. Some co-culture models were also defined and have been used to 
predict and to modulate the outcome of osteochondral tissue engineered constructs (5-
6). These works and others (1, 3, 7-9) have shown that direct cell-cell communication 
between different types of cells present on the bone microenvironment, such as 
chondrocytes and endothelial cells, is essential for both bone development and bone 
remodelling.  
Fibroblasts are key players in regenerative processes in different types of tissues. In 
the case of ligaments, such as the periodontal ligament (10) or anterior cruciate 
ligament (11), fibroblasts interactions with osteoblasts are essential for tissue 
development, function and regeneration. Another example is the case of skin wound 
healing where fibroblastic interaction with keratinocytes is essential to restore epithelial 
functions thus promoting wound closure and tissue repair (12). In the case of tissue 
engineering constructs, where biomaterials are combined with cells, proteins and/or 
other biological agents, all the system will be subjected to an environment specific of a 
foreign body reaction after implantation (13). How the immune system interacts with 
these cells and how biomaterials influence these interactions is still far from being 
understood. Nonetheless it is known that fibroblast stimulatory potential correlates to 
the in vivo fibrotic response after biomaterials implantation (14). Thus, interactions 
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between fibroblasts and osteoblasts, transplanted or native, can be of great importance 
to determine the outcome of an implanted bone tissue construct. Some studies have 
been made concerning the effect of fibroblast-secreted soluble factors, namely 
prostaglandins (PG), in osteogenic cells (15-16). In these works, the authors proved 
that the conditioned medium from cultures of fibroblasts from rat skin or from human 
periodontal ligament inhibited the mineralization of rat bone marrow stromal cells in 
osteogenic medium. This effect was reverted when indomethacin or anti-PG 
antibodies, were added to the fibroblast cultures.  To our knowledge direct interactions 
between osteoblasts and fibroblasts through gap junctions have not been described in 
the literature. The majority of the works regarding heterotypic cellular interactions in 
bone focus on the communication between osteoblasts and osteocytes (1, 7, 17) and 
between osteoblasts and endothelial cells (3, 18-20). Gap junctional communication 
(GjC) is known to be involved in bone cellular differentiation (1, 8, 20), in cellular 
communication between endothelial cells and osteoblasts(3), in mechanical signal 
transduction between bone cells (8) and in immune response and tissue inflammation 
and repair (2). The most important gap junctional protein present in osteoblasts (21) is 
connexin 43 (Cx43) and GjC through this protein modulates osteoblast gene 
expression (22). This protein is also widely expressed in fibroblasts (23) and is 
involved, for instance, in skin wound healing(24-25). In the latter case, modulation of 
connexin 43-mediated GjC has increased tissue repair rate (24-25).  
The aim of this work was primarily to verify the existence and the nature of direct 
interactions between human mesenchymal stem cell (MSC)-derived osteoblasts and 
human dermal fibroblasts (hDFb). By hypothesising that these two cell types 
communicate through GjC, the importance of these mechanisms was analysed by 
assessing the effects of hDFb over the osteogenic phenotype of the hMSC-derived 
cells.  
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5.2 Materials and Methods 
5.2.1 Co-culture of osteoblasts and fibroblasts 
Human bone marrow mesenchymal stem cells (hMSCs) were purchased from Lonza 
(Lonza, Switzerland). Cells were cultured in osteogenic medium composed of DMEM 
plus 10% FBS (Invitrogen, USA) and  1% of antibiotics  (Invitrogen, USA), and 
supplemented with 10 mM beta-glycerophosphate (Sigma, USA), 50 µg/mL of ascorbic 
acid (Sigma, USA) and 10-8M of dexamethasone (Sigma, USA) for three weeks.  
Human dermal fibroblasts (hDFb) were isolated from fresh skin specimens (discarded 
tissue) from informed healthy patients undergoing plastic surgery at Hospital da 
Prelada, Porto, Portugal and under a protocol previously approved by the Ethical 
Committee. After being washed with sterile phosphate-buffered saline (PBS; Sigma, 
USA), the skin was cut into small pieces (2mm2) and digested with 2.4u/mL Dispase II 
(Sigma, USA) solution at 4ºC overnight. The epidermis was removed, and the 
remaining dermal parts were further incubated with 0.1% collagenase type IA (Sigma, 
USA) for 3hours at 37ºC under gently agitation. The digested dermis was then passed 
through a 100µm cell strainer (BD Biosciences, USA), centrifuged and the cell 
suspension ressuspended in low-glucose DMEM medium (Sigma, USA) supplemented 
with 10% FBS and 1% Antibiotic/Antimycotic (both Invitrogen, USA).  
A hMSC-derived osteoblast cell suspension, with a cell density of 5 x 103 cells/mL, was 
prepared, transferred to 24-well culture plates (1mL per well) and incubated for 24 
hours. After this time of culture, hDFb were prepared and added to the wells previously 
seeded with osteoblasts at a cell density of 2.5 x 103 cells/mL (1 ml per well) thus 
establishing the direct contact co-culture model. Monocultures of osteoblasts were kept 
as controls in parallel with the co-culture for 2, 7 and 12 days. All cells were used in 
passage 3. 
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5.2.2 Alizarin Red Staining and Immunocytochemistry  
Before establishing the co-culture model, the hMSCs-derived osteoblasts and the 
isolated hDFb were characterized as follows. After culture of hMSC in osteogenic 
medium for three weeks, cells were fixed and mineralization was assessed using 
alizarin red staining. Briefly, a solution of 0.1 % of alizarin red (Sigma-Aldrich, USA) 
was prepared in ddH20 and the pH was adjusted to 4.6 by using a 10% ammonium 
hydroxide solution.  
After isolation from dermis, hDFb were screened for the presence of the Fibroblast 
Surface Protein (FSP) marker using a monoclonal mouse anti-FSP antibody (Sigma, 
USA) at a concentration of 1:500. Briefly, after fixation with formalin, cells were 
incubated with 3% BSA in PBS for 30 minutes to block non-specific binding. Cells were 
then incubated with the primary antibody for 1 hour at room temperature and washed in 
PBS. Alexafluor 488 (Invitrogen, USA) secondary antibody in a concentration of 1:500 
was incubated with cells for one hour at room temperature. Cells were then washed in 
PBS and counter-stained with DAPI nuclear staining. 
Both types of cells were screened for connexin 43 before setting up the co-cultures, 
following a similar immunocytochemistry protocol as described above. A rabbit anti-
human connexin 43 antibody (ABM, Canada) was used as primary antibody (1:100 
dilution) and a Alexafluor 488 (Invitrogen, USA) goat anti-rabbit antibody was used as 
secondary antibody (1:500 dilution). 
 
5.2.3 Gap junctional communication (GjC) assessment 
The visualization of GjC was achieved using the parachute technique (26). Briefly, 
either hDFb or hMSCs-derived osteoblasts were prepared by seeding 7 x104 cells per 
24 well coverslip, 24 hours before the assay. At the time of the assay, hMSCs-derived 
osteoblasts or hDFb were labelled with 2 µM of calcein-AM for 15 minutes at 37ºC. 
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Cells were then thoroughly washed with PBS, seeded over the previous culture of the 
other cell type (7 x103 cells/well) and cultured for 15 minutes at 37ºC. Cultures were 
observed with the Axioplan Imager Z1 fluorescence microscope (Zeiss, Germany) to 
assess if the Gj-permeable calcein was transferred from the “parachuted” cells to the 
cells in the monolayer.   
The assessment of the involvement of GjC between the osteoblasts and fibroblasts in 
co-culture was targeted by using a chemical inhibitor of Gj communication, 18-alpha-
Glycyrrhetinic acid (AGA, Sigma, USA). AGA was dissolved in fresh DMSO and diluted 
to working solution of 25 mM with PBS. The co-cultures were prepared as previously 
described but 18-alpha-glycyrrhetinic acid was added to the medium attaining a final 
concentration of 100 µM. The used concentration was determined after previous 
toxicity testing (results not shown). 18-AGA was added to the cultures 24 hours before 
the establishment of the co-cultures and of the parachute assay. In the case of the co-
cultures, 18-AGA was added to the culture medium every renewal, i.e., every other 
day. Controls were made by adding either DMSO or AGA to osteoblasts monocultures 
in the same concentrations.  
 
5.2.4 Cell number quantification 
Cell proliferation was assessed through total dsDNA quantification in hMSCs-derived 
osteoblasts monocultures and in co-cultures along the culture time. The test was 
performed using the PicoGreen Quantification Kit (Invitrogen Corporation, California, 
USA), according to the manufacturer instructions in a lysed cell suspension obtained 
after osmotic and thermal shocks. Fluorescence was read in a microplate reader (Bio-
Tek, USA) at 485 ex/ 525 em. 
In parallel, the number of hMSCs-derived osteoblasts in monoculture and in co-culture 
with hDFb was followed in time using a cell tracking fluorescent marker. In the 
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beginning of each experiment an osteoblast cell suspension was prepared and 
incubated with a 2 µM solution of 1,1′-Dioctadecyl-3,3,3′,3′-
tetramethylindocarbocyanine perchlorate (DiI, Sigma, USA) in culture medium for 15 
minutes at 37 ºC. After, cells were washed 3 times in warm medium and seeded for the 
experiments as described above. After each time point, three samples of each 
condition were fixed with formalin and stained with DAPI (Sigma, USA), a nuclei 
marker. Fluorescent micrographs of three independent fields of each one of the 
analyzed samples were taken and analysed using the image-processing software 
ImageJ (Wayne Rasband, NIH, USA). The fraction of osteoblasts in the co-cultures 
was determined by dividing the number DiI positive cells by the total number of cells 
given by DAPI staining. The direct correlation between the dsDNA values and the cell 
number (27) allowed to extrapolate the dsDNA values corresponding to the fraction of 
osteoblasts in culture.  
 
5.2.5 Alkaline phosphatase (ALP) activity quantification 
The ALP activity quantification was performed in the cell lysates obtained by osmotic 
and thermal shocks and following an adapted p-nitrophenol assay.(28) Briefly, 20 uL of 
sample were incubated with 80 uL p-nitrophenol phosphate solution (0.2% w/w, in 
diethanolamine, Sigma, USA) at 37ºC, for 45 minutes. The reaction was stopped using 
80 uL of a 2M of NaOH and 0.4 mM of EDTA solution.  The optical density of the 
samples was read at 405 nm. A calibration curve was previously prepared using the p-
nitrophenol standards (Sigma, USA) and used to extrapolate the ALP activity. Results 
were normalized against dsDNA results as described above. 
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5.2.6 PCR analysis 
RNA extraction and cDNA production 
mRNA was extracted using TriZol (Invitrogen, USA) reagent according to manufacturer 
instructions. Briefly 800 µl of TriZol were added per 1X106 cells and samples were 
homogenized by vigorous pipetting.  Following 5 minutes incubation, 160 µl of 
chloroform (Sigma, USA) were added to each sample; samples were then incubated 
for 15 min at 4°C and centrifuged at 13000rpm and 4°C for 15min. After the 
centrifugation the aqueous part of each sample was collected and an equal volume of 
isopropanol (Sigma, USA) was added. Following an overnight incubation at -20°C, 
samples were centrifuged at 9000 rpm and 4 ºC for 10 minutes. Supernatants were 
discarded and pellets were washed in ethanol, centrifuged at 9000rpm and 4°C for 
5min, and ressuspended in 12 µl of RNase/DNase free water (Gibco, UK). RNA 
quantity and purity were assessed with a NanoDrop ND-1000 Spectrophotometer 
(NanoDrop Technologies, USA). Samples with a 260/280 ratio between 1.6 and 2.0 
were used for cDNA synthesis. The cDNA synthesis was performed using iScript cDNA 
synthesis Kit (BioRad, USA) and the MiniOpticon Real-Time PCR Detection System 
(BioRad, USA). An initial amount of 2 µg of mRNA was used in a total volume of 20 µl 
of RNase/DNase free water.  
 
Quantitative Real Time PCR 
Osteocalcin and osteopontin transcripts were quantified in the cDNA samples using a 
quantitative Real Time PCR reaction. For each sample GAPDH was used as the 
housekeeping gene. The primers were designed using the Primer 3 software (v 0.4.0) 
and synthesized by MWG Biotech (Germany) as follows: osteocalcin forward 5’ 
GTGCAGAGTCCAGCAAAGGT 3’ and osteocalcin reverse 5’ 
TCCCAGCCATTGATACAGGT 3’; osteopontin forward 5’ CCC ACA GAC CCT TCC 
AAG TA5 3’ and osteopontin reverse 5’ GGG GAC AAC TGG AGT GAA AA 3’; 
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GAPDH forward 5’ ACAGTCAGCCGCATCTTCTT 3’ and GAPDH reverse 5’ 
GACAAGCTTCCCGTTCTCAG 3’. A concentration of 200 nM was used for all the 
primers in a final volume of 25 µl of sample. The Real Time PCR reaction was done 
using the iQ Syber Green SuperMix (BioRad, USA) following manufacturer instructions 
in a MiniOpticon Real-Time PCR Detection System (BioRad, USA). 
The relative quantification of osteocalcin and osteopontin expression was performed 
using the 2-∆∆CT method (Perkin Elmer User Bulletin No.2). All values were first 
normalized against GAPDH values and then co-culture values against osteoblasts 
monocultures without inhibitor values at each time point of culture.  
 
5.2.7 Statistical analysis 
Data was obtained from 4 separate experiments with 3 replicates for each condition 
and averaged. Standard deviation is reported as a measure of sample deviation. 
Statistical analysis was performed for dsDNA and ALP quantification using one way 
ANOVA test with Tukey-Kramer method as a post-hoc pairwise comparison test. In the 
case of the Quantitative Real Time RT-PCR results, the statistical analysis was 
performed in the ∆Ct values (29) using the t student-test for n=4. Values were 
considered statistically significant for p≤0.05. 
 
5.3 Results 
5.3.1 Human bone marrow MSCs-derived osteoblasts and hDFb characterization 
Isolated cells from human dermis were screened for Fibroblast Surface Protein. 
Results showed that this marker was uniformly distributed throughout the culture 
showing that isolated cells were a homogeneous fibroblast population Furthermore, 
looking at light microscopy, one could see that cells presented a typical fusiform 
morphology (Figure 5.1A). 
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hMSCs-derived osteoblasts showed an expected compact polygonal morphology after 
3 weeks of culture in osteogenic medium. Furthermore, their ability to mineralize the 
deposited matrix was assessed after Alizarin Red staining. The intense red colour 
shows that the matrix was heavily mineralized after 3 weeks of culture in standard 
osteogenic medium (Figure 5.1B). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 - Characterization of hMSCs-derived osteoblasts (A) and hDFb (B, C, D) before co-culture set-up. 
Mineralized matrix (red) after Alizarin Red staining in cultures of MSC-derived osteoblasts cultured for 3 weeks in 
standard osteogenic medium (A). hDFb are stained with mouse anti-human Fibroblast Surface Protein (C) and 
counterstained with DAPI (B). A merged picture is presented in D. Representative phase contrast micrographs of 
each cell type are presented as inserts. 
 
5.3.2 Assessment of Cx43 presence and GjC between osteoblasts and fibroblasts 
The presence of Cx43 protein in both fibroblasts and osteoblasts cultures was 
assessed by immunocytochemistry (figure 5.2). Micrographs show that this gap 
junctional protein was ubiquitously expressed throughout the culture of both types of 
cells. The fluorescence microscopy results showed no significant differences in terms 
of the presence of this surface protein in both types of cells.  
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Figure 5.2 - Immunocytochemistry against gap junction protein Connexin 43 (Cx43, green) in both hMSCs-derived 
osteoblasts (Ost) and human dermal fibroblasts (hDFb) cultures. Cell nuclei were counterstained with DAPI (blue) 
 
 
Furthermore, Cx43 presence was also assessed during the co-cultures. Like for the 
hMSCs-derived osteoblasts and hDFb monocultures, the gap junctional protein was 
present in a uniform manner in the co-cultures of hMSCs-derived osteoblasts and 
hDFb (figure 5.3).  
 
 
 
 
 
 
 
 
 
 
Figure 5.3 - Micrographs depicting co-cultures of hMSCs-derived osteoblasts and human dermal fibroblasts. Previously 
labeled hMSCs-derived osteoblasts are positive for Dil (red, A) and Connexin 43 (green, B) while hDFb only present 
signal for connexin 43 (green, B). Cell nuclei were counterstained with DAPI (blue, C). A merge picture of A, B and C is 
presented (D). 
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Heterotypic gap junctional communication between hMSCs-derived osteoblasts and 
hDFb was assessed by using the gap junctional permeable fluorescent dye calcein-
AM. Looking at the fluorescence images it was clearly seen that after a short amount of 
time, 15 minutes, both hMSCs-derived osteoblasts and hDFb were capable of 
establishing heterotypic gap junctional communication, allowing calcein-AM to be 
transferred from the just seeded cells, round and brighter cells, to the adhered 
monolayer (figure 5.4 A and B). This observation was true both when fibroblasts or 
osteoblasts were the “parachuted” cells. When AGA was added to the culture medium, 
the transference of calcein-AM between cultured and parachuted cells was inhibited 
(figure 5.4 C and D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 - Micrographs of the parachute technique to prove gap junctional communication between hMSCs-derived 
osteoblasts and hDFb. Either hMSCs-derived osteoblasts or hDFb were stained with calcein-AM and seeded over hDFb 
or hMSCs-derived osteoblasts, respectively. The transference of the gap junctional permeable dye was observed after 
15 minutes of incubation at 37ºC from the just seeded and labeled hDFb (A, C) or hMSCs-derived osteoblasts (B, D) to 
the adhered monolayer. The addition of AGA to the cultures inhibited the transfer of the fluorescent dye (C, D). 
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5.3.3 Cell proliferation  
hMSCs-derived osteoblast proliferation was measured by extrapolating the amount of 
dsDNA corresponding to the fraction of hMSCs-derived osteoblasts in co-culture from 
the total dsDNA quantified. The fraction of hMSCs-derived osteoblasts in co-culture 
resulting from the DiI-positive cells in the co-cultures was calculated by analysing the 
fluorescence images as described above. The extrapolated dsDNA results that directly 
correlate with the number of cells were plotted against culture time (Figure 5.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 - Amount of dsDNA that correlates with the cell number quantified along culture of A) hMSCS-derived 
osteoblasts in monoculture (Ost) and in co-cultures (Coc),and B) hDFb in monoculture (Fib) and in co-cultures (Fib in 
Coc) both with and without gap junctional inhibitor (+Inhi). *p<0.05 in one way ANOVA test.  
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The dsDNA values at days 2, 7 and 12 for the hMSCs-derived osteoblasts 
monocultures in the presence and absence of GjC inhibitor were statistically different 
(p<0.05) from the ones in the co-cultures, also with and without inhibitor. Additionally, 
dsDNA values for both co-culture groups were constant throughout the time of culture 
meaning that no proliferation of hMSCs-derived osteoblasts in those conditions 
occurred. No differences were detected for the dsDNA amounts when comparing the 
co-cultures in the presence and absence of inhibitor (p>0.05) suggesting that the 
observed effect over hMSCs-derived osteoblasts did not involve GjC. Some inhibition, 
at days 7 and 12, was found when 18-AGA was added to the osteoblast monocultures 
(p<0.05), as expected. (Figure 5.5A) 
Regarding dsDNA quantification for hDFb (figure 5.5B) no statistical significant 
difference was found between any of the tested conditions along the time of culture 
(p>0.05) indicating a normal proliferation rate for hDFb.  
 
5.3.4 Osteoblastic activity 
The analysis of the osteoblastic activity as assessed by the quantification of the ALP 
activity in co-cultures in comparison to the monocultures showed that the activity of this 
enzyme was significantly inhibited (p<0.05) in the presence of fibroblasts. When the co-
cultures were performed in the presence of the GjC inhibitor, the values of ALP activity 
increased significantly (p<0.05) in comparison to what was observed in the co-cultures 
in the absence of AGA. Moreover, for day 7 of culture the ALP activity was similar in 
the co-cultures with AGA and in the monocultures of hMSCs-derived osteoblasts in the 
presence of the GjC inhibitor (p>0.05). The addition of GjC inhibitor to the 
monocultures (p<0.05) of hMSCs-derived osteoblasts induced a statistical significant 
decrease in the ALP activity at all times of culture (figure 5.6). 
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Figure 5.6. Amount of hydrolysed p-nitrophenol phosphate that correlates with the ALP activity quantified along culture 
in osteoblasts monocultures (Ost) and in co-cultures with hDFb (Coc), both with (+Inhi) and without gap junctional 
inhibitor. *p<0.05 after one way ANOVA test.  
 
The expression of the osteogenic markers osteopontin and osteocalcin was quantified 
using quantitative real time RT-PCR (figure 5.7). The expression of the osteopontin 
gene in the co-culture with and without GjC inhibitor, in comparison to hMSCs-derived 
osteoblasts monocultures, was not changed. Osteopontin expression was detected for 
hDFb cultures for all the times of culture although at much lower levels than in the 
hMSCs-derived osteoblasts monocultures (figure 5.7B). As for osteocalcin, 
underexpression (p<0.05) of this gene was observed when hMSCs-derived osteoblasts 
were cultured in the presence of hDFb which was reversed (p<0.05), when co-cultures 
were established in the presence of GjC inhibitor.  
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Figure 5.7. Osteocalcin (A) and osteopontin (B) relative expression in co-cultures (Coc), co-cultures with gap junctional 
inhibitor (Coc+Inhi) and fibroblasts (hDFb) calculated after quantitative real time RT-PCR. Results were first normalized 
against GAPDH and then against hMSCs-derived osteoblast monocultures at each day of culture. *p<0.05 against the 
∆Ct of the monocultures after t-test. 
 
5.4 Discussion 
Fibroblasts are found in most tissues of the body. They play key roles in regulating 
extracellular matrices and, depending on the tissue they belong to, in their regeneration 
(10-12, 30). In the particular case of bone tissue, fibroblasts have been linked to the 
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release of osteoclastogenic factors such as RANKL(31-33), osteoprotegerin(31-32) and 
cathepsin K(32), thus rendering them a significant role in periprosthetic loosening of hip 
arthroplasty by controlling osteoclastogenesis. As described before, fibroblasts are also 
linked to the production of prostaglandins that inhibit the mineralizing activity of BMSC 
during osteogenic differentiation. (15-16). In this work we hypothesized that such 
regulatory functions by fibroblasts might not be restricted to osteoclastogenesis nor to 
the production of soluble factors. We therefore considered GjC as a way fibroblasts 
could influence osteoblasts. To test this hypothesis we established a co-culture system 
of hMSCs-derived osteoblasts and hDFb in the presence and absence of AGA, a 
chemical GjC inhibitor. The effect of hDFb over hMSCs-derived osteoblasts was 
assessed in terms of cell proliferation and maintenance of the osteoblastic phenotype. 
In a first phase, gap junctional communication between those types of cells was 
proven. Co-cultures were then set up in normal and GjC-inhibiting conditions and cell 
proliferation, as well as the production of ALP and expression of osteopontin and 
osteocalcin, was analyzed along the culture.  
Gap junctions (Gjs) are channels formed between the cell plasma membrane by the 
assembly of connexins (1, 8, 34-35). These channels allow the intercellular exchange 
of ions and metabolites known to have significant effects on the metabolism of the cells 
(1-2, 8, 34-35). Various studies of GjC in osteoblasts (3, 21, 36-37) and fibroblasts (23, 
38) showed that the predominant connexin involved in homotypic GjC in both types of 
cells is the same, Cx43. Besides the homotypic GjC existing in osteoblasts and 
fibroblasts, there are examples of heterotypic GjC communication between osteoblastic 
cells and osteocytes(1, 17) and endothelial cells(3, 39). In the present work, heterotypic 
communication between hMSCs-derived osteoblasts and hDFb through Gjs was 
proven to occur. The use of the parachute technique, first employed by Ziambaras et al 
(26) to assess the effect  of cyclic stretch on GjC between osteoblasts,  but widely used 
thereafter to identify GjC,(40) permitted to verify the transference of the calcein-AM dye 
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from donor cells to recipient cells, independently of their type. The heterotypic GjC 
between hMSCs-derived osteoblasts and hDFb was further analysed in a co-culture 
system using a GjC inhibitor, AGA (41). The dsDNA results clearly demonstrated that 
hMSCs-derived osteoblasts in the co-cultures have their proliferation impaired in the 
presence of fibroblasts. This result is mainly due to the higher hDFb proliferation rate. 
Even when one tries to adjust the initial proportion of the two types of cells, hMSCs-
derived osteoblasts were limited in terms of physical space and nutrient supply thus 
having their proliferation inhibited. This effect masked a possible inhibition of 
osteoblasts’ proliferation derived from the presence of AGA in the co-cultures and 
consequential GjC disruption(42) since no significant difference (p>0.05) is found in 
dsDNA values for co-cultures with and without the GjC inhibitor. On the other hand, this 
inhibitory effect by AGA is evident when comparing the results of the monocultures of 
hMSC-derived osteoblasts cultured with and without AGA (p<0.05).  Since no statistical 
difference (p>0.05) was found between the dsDNA values of hDFb for all the conditions 
and time points we can conclude that these were not affected by the presence of 
osteoblasts or by the presence of 18-AGA. 
The regulation of bone cell differentiation as well as the modulation of gene expression 
in bone cells has been also connected to Gap junctional communication (36, 43-44).  
This issue was addressed in our work by quantifying the activity of ALP and by 
assessing, at the molecular level, eventual changes over the expression of osteocalcin 
and osteopontin in the hMSCs-derived osteoblasts. ALP activity of the hMSCs-derived 
osteoblasts was greatly affected by the presence of fibroblasts in the cultures. This 
effect was partially reversed by adding AGA to the co-cultures; in the presence of AGA 
the ALP activity values were always significantly higher (p<0.05) than those determined 
for the co-cultures in the absence of AGA  indicating that GjC is implicated on the 
hDFb’s inhibitory effect. Nevertheless, for the second and twelfth day of culture the 
ALP activity in the co-cultures with AGA was significantly lower (p<0.05) than that of 
monocultures in the presence of AGA, which can be explained by the negative effect of 
Chapter 5 - Fibroblasts regulate osteoblasts through Gap Junctional Communication 
 
161 
 
fibroblasts on osteoblast mineralizing ability through the production of soluble factors 
(11, 15-16). In other hand, ALP values for monocultures in the presence of AGA were 
always significantly inferior (p<0.05) to the ones for control monocultures. This is an 
expected outcome from the inhibition of homotypic GjC in osteoblasts cultures.  
As stated before, the modulation of GjC in osteoblasts results in the alteration of the 
expression of genes important for their osteogenic behaviour (36, 43-44). The relative 
expression of osteogenic-related genes osteocalcin and osteopontin was also 
addressed. In the presence of fibroblasts the expression of osteocalcin was 
downregulated between 1.5 fold for day 7 and 2 fold for day 2 (p<0.05). Although it is 
rather difficult to define these values as down regulation, the fold-change values for co-
cultures without the GjC inhibitor were always significantly lower  (p<0.05) than for 
cultures in the presence of inhibitor. Since this effect of fibroblasts was reverted when 
AGA was added to the co-cultures a correlation was thus established between GjC and 
the expression of this important osteogenic gene. Surprisingly, no difference (p>0.05) 
in fold change was observed in co-cultures with or without AGA for osteopontin 
expression. Although osteopontin is an osteoblast related gene it is also expressed by 
other cells (45) and it is involved in several processes such as inflammation, cancer 
progression and others(46-48). Among the osteopontin-producing cells are the 
fibroblasts (49-50). In our experiments, osteopontin expression was detected in the 
fibroblasts monocultures although at lower levels (p>0,05) than in the hMSCs-derived 
osteoblasts. Therefore, in the case of the co-cultures, both hMSCs-derived and hDFb 
osteopontin mRNA transcripts were quantified and the results cannot be specifically 
attributed to the hMSCs-derived osteoblasts. 
To our knowledge this is the first work showing fibroblasts-osteoblasts interactions 
through GjC. As mentioned above, heterotypic GjC involving osteoblasts have a great 
phenotypic impact in the latter. Taylor et al (51) reported that osteocytes under fluid 
shear were capable of controlling osteoblasts’ ALP activity through GjC. Villars and 
colleagues (39) demonstrated that GjC are required for human vascular endothelial 
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cells (HUVECS) to promote the differentiation of osteoprogenitor cells. More recently, 
Ciovacco et al (52) observed that the positive effect of megakaryocytes over osteoblast 
proliferation is further enhanced when GjC between these two cell types is inhibited. 
Therefore, it is well established that heterotypic GjC involving osteoblasts and other cell 
types can modulate the behaviour of the latter. We were able to demonstrate that in a 
direct co-culture system, hMSCs-derived osteoblasts and hDFb communication 
involves GjC. Moreover, hDFb were shown to exert a negative effect over the hMSCs-
derived osteoblasts traduced in diminished ALP activity and downregulation of 
osteocalcin expression. Though, the detailed molecular mechanisms of the fibroblastic 
effect over osteoblasts through GjC can only be the subject of speculation. The 
involvement of secondary messengers such as Ca2+, IP3 or cAMP that can permeate 
through Gjs and act on the recipient cell (53-55) or the modulation by Gjs of the 
propagation of kinase signalling triggered by extracellular cues among adjacent cells, 
are all possible pathways to explore in order to obtain a complete picture of the 
heterotypic action of fibroblasts over osteoblasts through GjC. 
 
5.5 Conclusions 
In this work it was originally demonstrated not only the existence of Gap Junctional 
Communication between hMSCs-derived osteoblasts and hDFb but also the negative 
effects of fibroblasts over the osteoblasts using that pathway. These conclusions can 
be very relevant for a bone Tissue Engineering strategy when a construct with ex-vivo 
cultured osteoblast is implanted, as immediately afterwards it is expected an 
inflammatory reaction with the involvement of fibroblasts. The present work represents 
therefore an advance in predicting the outcome of such devices and constitutes a first 
step for exploring the communication mechanisms existing between fibroblasts and 
osteoblastic cells.  
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Chapter 6 
DEVELOPMENT OF OSTEOGENIC CELL SHEETS FOR BONE TISSUE 
ENGINEERING APPLICATIONS  
 
Abstract 
The use of scaffolds in combination with osteogenic cells has been the gold standard in 
Bone Tissue Engineering strategies. These strategies have, however, in many cases 
failed to produce the desired results due to issues such as the immunogenicity of the 
biomaterials used and cell necrosis at the bulk of the scaffold related to deficient 
oxygen and nutrients diffusion. Here, we originally propose the use of cell sheet (CS) 
engineering as a possible way to overcome some of these obstacles. Osteogenic CSs 
were fabricated by culturing rat bone marrow cells in thermo-responsive culture dishes. 
The CSs were recovered from the dishes using a low temperature treatment and then 
were implanted subcutaneously in nude mice. New bone formation was verified from 
day 7 post transplantation using x-ray, µ-CT and histology. It was also verified the 
presence of a vascularized marrow in the new formed bone after 6 weeks of 
transplantation.  Osteoid deposition in the interior of the new bone suggests bone 
remodelling. Furthermore, osteocytes could be found in the new formed bone, 
supporting the conclusion that healthy bone tissue was formed after ectopically 
transplanting of osteogenic CSs.  These results therefore confirm the great potentiality 
of CS engineering to be used in bone tissue engineering applications. 
 
Chapter based on Pirraco RP, Obokata H, Iwata T, Marques AP, Tsuneda S, Yamato 
M, Reis RL, Okano T, Development of Osteogenic Cell Sheets for Bone Tissue 
Engineering Applications  (2011) Tissue Engineering Part A 17:1507-1515 
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6.1 Introduction 
The number of people that require medical intervention in order to solve bone related 
illnesses such as non-union fractures or loss of bone tissue due to cancer tends to 
grow due to the constant aging of population (1-3). Currently, the gold-standard 
strategies to address issues like critical bone defects are the use of autologous bone 
graft, allografts and materials like ceramics and metals (1, 3-4). All of these strategies 
have significant problems; examples are availability of tissues, donor site morbidity 
issues, immunogenic and integration in the host tissue, that limit their application range 
and their overall performance(1, 5). It has been accepted for a few years that new 
strategies are needed in order to address the challenges posed in this field. Tissue 
Engineering (TE)-based strategies have been trying to solve many of the above 
referred to problems. These approaches typically involve the use of different cell types 
suitable for bone TE, growth factors and 3D biodegradable scaffolds (4, 6). Such 
approaches, however, face in many cases serious problems such as the immune 
response to the implanted construct, inadequate biodegradability rate and the lack of 
vascularization which leads to cell necrosis in the bulk of the construct (2, 7-10).  
Cell sheet engineering technique using thermo-responsive dishes might constitute a 
useful alternative to solve some of the mentioned issues. This technique, as proposed 
by Professor Okano’s group allows for the recovery of the cells within its own matrix to 
be used as intact single or multilayered cell sheets to engineer transplantable tissues 
(11-13).So far this technology was proposed for the treatment of several tissues such 
as cornea(14), myocardium(15), periodontal ligament(16) and bladder(17) but never for 
bone. The peculiar mechanical and biological properties of bone tissue make the 
translation of the obtained outcomes from the regeneration of the above mentioned 
tissues into bone rather complicated. Others have previously attempted to produce cell 
sheets for the regeneration of bone tissue (18-20). Zhou and colleagues (20) combined 
osteogenic cell sheets made form porcine bone marrow stromal cells wrapping them 
around polycaprolactone–calcium phosphate scaffolds. Analysis post-subcutaneous 
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implantation of the construct showed some degree of new bone formation but mainly at 
the periphery of the scaffolds. The same pattern of new calcified tissue, around the 
scaffold, was achieved by Gao et al (19), using a coral scaffold, and Akahane et al. 
(18), using a hydroxyapatite ceramic scaffold. In the latter case, the cell sheets were 
also ectopically implanted without any scaffold (18) and new bone formation, albeit 
disorganized, was verified. In the three cases, new bone tissue was fairly disorganized, 
poorly vascularised and limited to the surface of the scaffolds on where the cell sheets 
were wrapped. In contrast with the above referred works, where cells were detached 
using a cell scraper, the use of thermo-responsive dishes allows for the use of an intact 
cell-cell and cell-matrix architecture, due to the well developed culture dish recovery 
methods (12-13). 
In this work, we aimed at studying the in vivo bone formation potential of osteogenic 
cell sheets recovered non-invasively by temperature decrease. Osteogenic cell sheets 
were developed from rat bone marrow stromal cells, cultured in thermo-responsive 
dishes, and then characterized. The developed sheets were subsequently transplanted 
subcutaneously to the dorsal flap of nude mice. Implants were recovered at different 
time points post-transplantation and characterized. New bone formation was apparent 
from 7 days post-implantation. Six weeks after implantation thick, vascularised new 
bone with what appears to be bone marrow was clearly observed. 
 
6.2 Materials and Methods 
6.2.1 Temperature-responsive culture surfaces 
Thermo-responsive dishes (CellSeed, Tokyo, Japan) were prepared as previously 
described (21). Briefly, N-isopropylacrylamide monomer in 2-propanol solution was 
spread onto 35 mm diameter culture dishes (BD Biosciences, Franklin Lakes, NJ). 
Dishes were then irradiated by electron beam, resulting in both polymerization and 
covalent grafting of the poly(N-isopropylacrylamide) (PIPAAm) onto the cell culture 
surfaces. PIPAAm-grafted dishes were rinsed with cold-distilled water to remove 
Chapter 6 - Development of Osteogenic Cell Sheets for Bone Tissue Engineering Applications  
 
174 
 
ungrafted monomer, and dried in nitrogen gas. Dishes were finally sterilized with 
ethylene oxide gas prior to experimental use. 
 
6.2.2 Cell sheets fabrication 
Bone marrow was flushed from the femurs of 4 weeks old male Wistar rats (Charles 
River, Yokohama, Japan). After vigorous pipetting to disaggregate any clumps, the 
suspension was placed over Histopaque 1083 (Sigma-Aldrich, Tokyo, Japan) and 
centrifuged at 2500RPM for 25 minutes. The mononuclear cell fraction was recovered 
after centrifugation and washed in phosphate buffered saline (PBS, (Sigma-Aldrich, 
Tokyo, Japan)) to remove any remaining Histopaque. Cells were then seeded in 100 
mm of diameter dishes and cultured in basal medium (DMEM (low glucose; Wako Pure 
Chemical Industries, Tokyo, Japan), supplemented with 10% fetal bovine serum (Japan 
Bioserum Co.Ltd, Hiroshima, Japan) and 100 units/ mL of penicillin–streptomycin 
(Sigma-Aldrich Japan, Tokyo, Japan)) at 37 ºC and in a 5% of CO2 humidified 
atmosphere. After 24 hours of culture, non-adherent cells were removed from the 
culture and the adherent cells were then cultured until semi-confluence was achieved. 
Cells were detached using a 0.25% trypsin-EDTA solution (Gibco BRL 
LifeTechnologies, Carlsbad, USA) and seeded in 35 mm of diameter thermo-
responsive dishes at a concentration of 2.5 x 105 cells per dish. Cultures were 
maintained for three weeks in osteogenic medium (basal medium supplemented with 
10-8 M dexamethasone (Sigma-Aldrich, Tokyo, Japan), 50 µg/mL ascorbic acid (Sigma-
Aldrich, Tokyo, Japan) and 10 mM beta-glycerophosphate (Sigma-Aldrich, Tokyo, 
Japan). 
 
6.2.3 Recovery of cells from thermoresponsive dishes 
In order to recover the cells from the thermoresponsive dishes, culture medium was 
removed from the culture dishes and replaced with 1 mL of PBS. A poly(vinylidene 
difluoride) (PVDF) (Immobilon-P, DURAPORE®, Millipore Corporation, Billerica, USA) 
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membrane with 20 cm of diameter was placed over the cells in the thermoresponsive 
dishes and incubated at 20 ºC for 10 minutes. After this time, cell sheets spontaneously 
detached from thermoresponsive dishes. Some of the recovered cell sheets were fixed 
in 10% formalin (Wako Pure Chemicals, Osaka, Japan) for posterior histological 
characterization. 
 
6.2.4 In vivo transplantation 
The transplantation of the cells sheets was carried out as reported previously (22). 
Briefly, 6 weeks old male nude mice (Charles River Japan, Yokohama, Japan) (6 
animals per transplantation time) were anesthetized with a constant flux of 4% of 
isofluorane.  Dorsal skin was cut opened using 3x3cm cutting sides. Recovered cell 
sheets were placed on mouse subcutaneous dorsal flap and left to adhere to the 
connective tissue of dorsal skin for 5 minutes. After that time, the PVDF membranes 
were removed and silicone membranes were placed over the cell sheets to prevent the 
contact between the cell sheets and the muscular tissue. Control mice (3 animals per 
transplantation time) were also prepared by implanting only silicone membranes. Skin 
incisions were closed using 5-0 nylon sutures. Animals were kept with food and water 
ad libitum. After 7 days, 3 weeks and 6 weeks of transplantation, animals were 
euthanized with CO2 and implants were recovered for histological characterization. 
 
6.2.5 Histological characterization 
After fixation, both in vitro recovered cell sheet and implanted samples were embedded 
in paraffin, without demineralization, and 5 µm thick sections were made. Hematoxylin 
and eosin staining was performed following standard protocols.  
To assess mineral deposition Alizarin Red staining was performed. Briefly, a solution of 
0.1 % of alizarin red (Sigma-Aldrich, Tokyo, Japan) was made in ddH2O and the pH 
was adjusted to 4.6. Sections were deparaffinized and 1 mL of alizarin red solution was 
added to each slide. Sections were observed in the microscope until correct amount of 
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colour developed. Pink/purple colour was considered positive for mineral deposition. 
Sections were then washed in ethanol and xylene. Micrographs of the sections were 
taken after both stainings. 
Immunostaining for osteocalcin was performed by incubating both cell sheet and 
implant sections with a 1/200 anti–osteocalcin antibody (Millipore Corporation, Billerica, 
USA) overnight, at 4 ºC,  and then for one hour, room temperature, with a biotinylated 
secondary antibody (DakoCytomation, Glostrup, Denmark). Sections were incubated 
with Streptavidin-HRP (DakoCytomation, Glostrup, Denmark) solution for 20 minutes 
and then treated with DAB chromogenic substrate solution (DakoCytomation, Glostrup, 
Denmark) for 3 minutes. 
Stained sections were analysed with an Eclipse E800 microscope (Nikon, Tokyo, 
Japan). 
 
6.2.6 Micro-computed Tomography 
To investigate the 3D structure of the mineralized tissue formed after transplantation, 
non-destructive techniques, X-Ray and Micro-Computed Tomography (SkyScan, 
Kontich, Belgium) were used. Recovered implants, after paraffin embedding, were cut 
in half and scanned in a high-resolution mode of 11,32 µm x/y/z and an exposure time 
of 1900ms. The energy of the scanner used was 50 keV with 171 mA current. The 
Micro-CT scans were followed by a 3D reconstruction of serial images. 
 
6.3 Results and discussion 
6.3.1 Osteogenic Cell Sheets 
The herein used cell sheet engineering methodology allowed fabricating and 
recovering intact rat bone marrow-derived cell sheets composed by a dense 
collagenous matrix where cells are embedded (figure 6.1A). By micrograph 
observations, the estimated thickness of the cell sheets after recovery was of about 30 
µm (figure 6.1). Although this value does not reflect the real thickness of the sheet in 
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vitro due to the phenomena of contraction of the sheet that happens after the release 
from the dish, it corresponds to the thickness of the implanted cell sheets. 
The presence of what appeared to be mineral deposits was clearly macroscopically 
identified in the sheets before its recovery from the thermoresponsive dishes. In fact, 
after the recovery of the cell sheets from the dishes several mineral nodules were 
attached to the dish, which was expected to happen considering the osteogenic 
differentiation culture protocol used. 
Alizarin Red staining was used to confirm the presence of mineral deposition in the 
cultured cell sheets (figure 6.1B). Significant mineral deposition in the cultured cell 
sheets was observed as evidenced by the intensity of the staining. 
Immunohistochemistry against osteocalcin was used to validate the osteogenic nature 
of the cultured cell sheets. Osteocalcin is a non-collagenous matrix protein whose 
secretion correlates with matrix mineralization and therefore it is a marker for the 
osteogenic phenotype (23-25). The results showed that the cultured cell sheets were 
highly expressing this protein, once again demonstrating the osteogenic nature of the 
developed cell sheets (figure 6.1C). 
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Figure 6.1 – In vitro cultured cell sheets after low-temperature recovery from thermoresponsive dishes characterized 
using (A) H&E staining, (B) alizarin red staining (mineral deposition in purple) and  (C) immunocytochemistry for 
osteocalcin (expression in brown).  Asterisks mark the basal side of the cell sheets. 
 
6.3.2 In Vivo Bone Formation 
Evidences of in vivo new bone formation after transplantation of the osteogenic cell 
sheets were confirmed by X-ray and µ-CT analysis (figure 6.2). After 7 days of 
transplantation the amount of dense tissue is already significant and a notorious 
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increase in the density of the neo-bone was observed as the transplantation time 
increases. 
 
Figure 6.2 – Representative x-ray (A, D and G) and µ-CT images (side [C, F and I] and front view [B, E and H]) of the 
transplants (each divided in half after recovery) after (A-C) 7 days, (D-F) 3 weeks and (G-I) 6 weeks of implantation. 
Bars in the x-ray images represent 2 mm and are valid for all the images. 
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These results were further confirmed by Alizarin Red/H&E staining (figure 6.3). 
Mineralized tissue was observed at the implant site just seven days post-
transplantation. The amount of new- mineralized bone increased through-out the time 
of transplantation until it reached a maximum 6 weeks post-transplantation.  
The new bone developed in what appears to be separated patches along the width of 
the subcutaneous dorsal flap. Six weeks after transplantation numerous contiguous 
bone patches, with a maximum thickness of 250 µm and a maximum width of 1 mm 
(figure 6.3) were clearly observed. In fact, crossing these results with the µ-CT 3D 
reconstruction (figure 6.2C), the patches observed in the histology were ramifications of 
the same bone mass. These bone masses had a flat form that may result either from 
the original form of the cell sheets, or from the local mechanical environment present in 
the mouse’s subcutaneous site of transplantation, which determined the form of the 
new tissue (26-27), or from both.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3 – Amount of Calcium, quantified by the o-cresolphtaleine-complexone method (bars),  and volume of 
mineralised tissue measured by µ-CT (line), of the retrieved samples at different times post-implantation. *p<0.05 
relating to “7 days” values and § p<0.05 relating to “3 weeks” values for both Ca2+ quantification and mineralized tissue 
volume. 
 
Osteocalcin immunohistochemistry results showed that this protein was expressed at 
different locations even after only 7 days of transplantation (figure 6.4A). These positive 
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sites seem to correlate to sites where new bone was being formed. With the increase 
of new bone formed with the transplantation time, it was clear that the majority of the 
cells that were positive for this protein were concentrated around the new tissue 
(figures 6.4B and 6.4C). This is an expectable outcome because this protein is directly 
related to matrix mineralization and, consequently to new bone formation (23-25).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4 - Alizarin red and Haematoxylin staining of the transplants sections recovered after (A) 7 days, (B) 3 weeks 
and (C, D, E and F) 6 weeks of implantation. D and E are sequential close-ups of image C. Yellow arrowheads in E 
mark osteocytes and red arrowheads in F mark osteoid deposition. Mineral deposition is in purple.  
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The most striking feature observed in the new-bone at 6 weeks post-transplantation 
was the void largest patches (figures 6.3D and 6.3E). This fact may indicate that bone 
remodelling was occurring, following the normal bone tissue metabolism where bone is 
constantly resorbed and formed (28-30). In fact figure 6.3F clearly shows osteoid 
deposition. Moreover, numerous cells could be found in those void marrow spaces, 
among which red blood cells that seems to indicate vascularisation of the new formed 
bone. This fact reinforces the hypothesis that the new formed bone is being 
remodelled, since it is proven the existence of a direct connection between vasculature 
and bone remodelling (31-35). Also very important to notice was the presence of 
osteocytes, as it is visible in figure 6.3E since, besides being the most common cells in 
bone tissue, these cells are believed to be regulators of bone homeostasis (36-38). 
Previous works that used osteogenic cell sheets in in vivo settings(18-20), either with 
or without scaffolds, have successfully produced new bone tissue. However, the new 
formed tissue was in most cases either disorganized (18) or incapable of growing in the 
interior of the scaffold (19-20). In the latter situations, the limitations imposed by the 
use of scaffolds, namely cell migration to the interior of the scaffold and oxygen and 
nutrient diffusion limitations (7-10), impaired those strategies to achieve more 
successful outcomes. However, in the work of Akahane et al (18),  cell sheets are also 
implanted without any scaffold and new bone tissue was formed. In this work, cell 
sheets were recovered using a cell scraper. Although cell-to-cell junctions are 
preserved using this method, the use of thermo-responsive dishes guarantees that 
both cell-matrix junctions and the ECM itself are preserved (12-13). The ECM can then 
serve as a natural glue that enable these sheets to be applied virtually in any anatomic 
site when implanted. Maeda and colleagues (39) recently developed a device that 
allows a minimally invasive endoscopic transplantation of cell sheets fabricated in 
thermo-responsive dishes. Further developments of this method can bring the way to, 
using a minimally invasive surgery, deliver cell sheets as de facto sheets for many 
applications, in opposition to the hypothesis of just injecting them, as suggested by 
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Akahane and colleagues (18). The herein proposed methodology might be applied in 
flat bones defects, which, due to the nature of the cell sheets, is the most obvious 
choice. However, methods such as the overlay of several cell sheets combined with 
polysurgery (40) can be the answer to create thicker and bigger bone tissue. This will 
be addressed in future studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5 – Immunocytochemistry for osteocalcin in the transplants sections recovered after (A) 7 days, (B) 3 weeks 
and (C) 6 weeks of implantation. (D) corresponds to the negative control  section obtained from the nude mice where 
only the silicon membranes were implanted for 6 weeks.  
 
6.4 Conclusions 
As already demonstrated for other tissues, cell sheet engineering is also a very 
promising technique for bone tissue engineering applications. This work demonstrated 
that new bone tissue, with very interesting characteristics, namely the presence of 
osteocytes, vascularisation and bone marrow formation, was formed from a single 
osteogenic cell sheet. 3D neo-bone tissue was obtained in vivo without the use of any 
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biodegradable scaffold and a new window of opportunity with great potential is open in 
the bone tissue engineering field. 
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Chapter 7 
ENDOTHELIAL CELLS ENHANCE THE IN VIVO BONE FORMING ABILITY OF 
OSTEOGENIC CELL SHEETS 
 
Abstract 
Addressing the vascularization problem is of vital importance when engineering three-
dimensional tissues. The application of endothelial cells in tissue engineered constructs 
is being increasingly used in order to obtain pre-vascularized constructs and to 
enhance in vivo neo-vascularization.  
In this work, rat bone marrow stromal cells were cultured in thermo-responsive dishes 
under osteogenic conditions to obtain homotypic or heterotypic, with human umbilical 
vein endothelial cells, cell sheets. Cells were retrieved as sheets from the dishes after 
incubation at 20°C. Monoculture osteogenic CS were stacked on top of homotypic or 
heterotypic CS, and subcutaneously implanted in the dorsal flap of nude mice for 7 
days. The implants characterization clearly showed mineralized tissue formation for 
both conditions. Transplanted osteogenic cells were found at the new tissue site 
demonstrating the CS bone-inductive effect. Perfused vessels, positive for human 
CD31, confirmed the contribution of human umbilical vein endothelial cells (HUVECs) 
for the neo-vascularization of co-culture CS constructs. Furthermore, calcium 
quantification and expression of osteocalcin and osterix genes were higher for the CS 
constructs with HUVECs demonstrating a more robust osteogenic potential of these 
constructs.  
This work originally demonstrates the potential of using ECs, combined with osteogenic 
CS, to increase the in vivo vascularization of CS-based 3D constructs for bone tissue 
engineering purposes. . 
Chapter based on Pirraco RP, Iwata T, Yoshida T, Marques AP, Yamato M, Reis RL, 
Okano T, Endothelial cells enhance the in vivo bone forming ability of Osteogenic Cell 
Sheets, (2011) submitted 
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7.1 Introduction 
The use of scaffolds in combination with osteogenic cells has been the gold standard in 
Bone Tissue Engineering strategies (1-4). These imply that the engineered constructs 
would then be transplanted to patients in order to restore or improve the function of 
bone tissue. Bone engineered constructs have however often failed to produce the 
desired results due to issues such as the immunogenicity of the biomaterials used, and 
cell necrosis at the bulk of the scaffold related to deficient oxygen and nutrients 
diffusion (5-9). Oxygen and nutrient supply is in fact a critical issue when aiming at 
artificially creating thick tissues such as bone (1-2). The consequence of this is that 
successful production of tissue engineered products has been quite limited to thin 
tissues such as skin (9). This scenario illustrates how vascularization is a major hurdle 
of bone tissue engineering. An approach that has been increasingly studied to 
overcome this issue is the in vitro pre-vascularization of the constructs (6, 9-11). This 
strategy relies on combining, with the engineered construct, endothelial cells that will 
self-organize in pre-vascular structures, which will anastomose with the host 
vasculature after implantation. Nonetheless, the success of this approach to solve the 
vascularization issue of tissue engineered constructs strongly depends on a fast and 
functional anastomosis of the pre-vascular network with the host’s vasculature (9).  
Cell sheet (CS) engineering as proposed by Okano et al (12-14) is based on the use of 
thermo-responsive poly-N-isopropylacrylamide (PIPPAam)-grafted culture surfaces that 
allow the recovery of confluent cells in the form of sheets. The principle of the method 
is based on the hydrophilic/hydrophobic nature of PIPPAam, below/above its low 
critical solution temperature (LCST), respectively forming cell adhesive and cell 
repellent (12-14) surfaces. Cell adhesion is therefore controllable by means of 
modulating the temperature. Using this strategy, Okano’s group has been proposing 
solutions for the regeneration of cornea(15), myocardium(16), periodontal ligament(17) 
and bladder(18), among others. Recently, we have proposed the use of osteogenic CS 
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produced using thermo-responsive dishes for bone tissue engineering applications 
(19). In that work, using a single CS we successfully obtained, ectopically, vascularised 
bone with marrow. Osteogenic CS obtained by mechanical retrieval with cells scrapers, 
alone or combined with scaffolds, were also tested for bone tissue engineering 
purposes but the general outcome was a poor amount of new bone tissue formed (20-
22). Nakamura et al (23)  previously demonstrated, however, the full regeneration of a 
rat critical size defect by using CS recovered by cell scraper. These works further show 
how scaffold–free, CS-based constructs can be applied for bone regeneration.  
The recovery of CS using thermo-responsive methods presents several advantages 
over the use of enzymatic and mechanical dissociation methods (24). It was 
demonstrated that mechanical recovery of cells by scraping depletes ECM proteins 
from the resulting sheets (24). On the contrary, recovery of cells from 
thermoresponsive dishes preserves ECM proteins (13-14), which act as a natural glue 
thus avoiding the use of sutures after transplantation (13-14). This advantage has been 
also explored to construct 3D CS-based tissues, as the adhesion of the successive CS 
occurs naturally. The vascularization of the 3D CS-based tissues is an essential issue 
since necrosis affects non-vascularized transplanted tissues thicker than 100 µm (25). 
This was previously addressed by Shimizu and colleagues (25) by multi-transplanting 
rat cardiomyocytes CS. Using this strategy, the authors were able to create 1 mm-thick 
myocardium with an organized vascular network. The pre-vascularization of CS-based 
3D constructs has nevertheless been the focus recent works (26-27).  The combination 
of several myoblasts sheets (recovered from PIPPAam dishes) and human umbilical 
vein endothelial cells (HUVECs) using a CS stacking methodology resulted in the 
generation of a pre-vascularized cell dense tissue (27). This work is a first proof-of-
concept on how CS engineering has the potential to produce 3D pre-vascularized 
tissues.  
Considering the need to promote the formation of vascularized neo-bone tissue the aim 
of the present work was to further develop our previously (19) proposed CS-based 
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strategy for bone tissue engineering. With this purpose the potential of combining 
osteogenic CS with endothelial cells to increase the vascularization of cell constructs 
was assessed, and the influence of endothelial cells over the amount of bone tissue 
formed was demonstrated. Rat osteogenic CS were obtained using thermo-responsive 
dishes and stacked with HUVECs in between. The constructs were then implanted 
subcutaneously in the dorsal flap of nude mice and characterized in terms of 
involvement of the transplanted cells on both bone tissue formation and 
vascularization.   
 
7.2. Materials and Methods 
7.2.1 Temperature-responsive culture surfaces 
Thermo-responsive dishes (CellSeed, Tokyo, Japan) were prepared as previously 
described (28). Briefly, N-isopropylacrylamide monomer in 2-propanol solution was 
spread onto 35 mm diameter culture dishes (BD Biosciences, Franklin Lakes, NJ). 
Dishes were then irradiated by electron beam, resulting in both polymerization and 
covalent grafting of PIPAAm onto the cell culture surfaces. PIPAAm-grafted dishes 
were rinsed with cold-distilled water to remove ungrafted monomer, and dried in 
nitrogen gas. Dishes were finally sterilized with ethylene oxide gas prior to 
experimental use. 
 
7.2.2 Cell sheets fabrication 
Bone marrow was flushed from the femurs of 4 weeks old male Wistar rats (Charles 
River, Yokohama, Japan). After careful pipetting to disaggregate any clumps, the 
suspension was seeded in 75 cm2 Primaria culture flasks (BD Biosciences, USA) and 
cultured in basal medium (α-MEM with Glutamax I, low glucose (Gibco, USA), 
supplemented with 10% fetal bovine serum (Japan Bioserum Co.Ltd, Japan) and 100 
units/mL of penicillin–streptomycin (Sigma-Aldrich Japan, Japan) at 37 ºC and in a 5% 
of CO2 humidified atmosphere. After 24 hours of culture, non-adherent cells were 
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removed and the adherent cells were then maintained in culture until semi-confluence 
was achieved. Rat bone marrow stromal cells (rBMSCs) were detached using a 0.25% 
trypsin-EDTA solution (Gibco BRL LifeTechnologies, USA) and seeded in 35 mm of 
diameter thermo-responsive dishes at a concentration of 2.5 x 105 cells per dish. 
Cultures were maintained for 21 days in osteogenic medium (basal medium 
supplemented with 10-8 M dexamethasone (Dexart, Fuji Pharma, Japan), 50 µg/mL 
ascorbic acid (Sigma-Aldrich, Japan) and 10 mM beta-glycerophosphate (Sigma-
Aldrich, Japan). HUVECs were purchased from Lonza (Lonza, Japan), seeded in 75 
cm2 Primaria culture flasks and cultured in Endothelial Cell Growth Medium MV2 
(ECGM, Promocell, Germany).  
 
7.2.3 Establishment of co-cultures 
HUVECs at passage 3 were seeded on the thermoresponsive-dishes with the rBMSCs, 
at a density of 1 x 105 cells per dish, 3 days before those completed the 21 days of 
osteogenic differentiation. Co-cultures were maintained in ECGM supplemented with 
10-8 M dexamethasone, 50 µg/mL ascorbic acid (Sigma-Aldrich, Tokyo, Japan) and 10 
mM beta-glycerophosphate (Sigma-Aldrich, Japan) for 3 days until transplantation. 
 
7.2.4 Recovery of cells from thermoresponsive dishes 
In order to recover the cells from the thermoresponsive dishes, culture medium was 
removed from the culture dishes and replaced by 1 mL of PBS ( Sigma-Aldrich, Japan). 
A poly(vinylidene difluoride) (PVDF) (Immobilon-P, Millipore Corporation, USA) 
membrane with 2 cm of diameter was placed over the rBMSCs monocultures and 
incubated at 20ºC for 10 minutes. After this time, CS spontaneously detached from 
thermoresponsive dishes. CS-membrane constructs were stacked over the 
rBMSCs/HUVECs co-cultures and the procedure to detach the adhered CS repeated. 
Controls consisted of two stacked monocultured osteogenic CS. 
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7.2.5 In vivo transplantation 
The transplantation of the stacked cells sheets was carried out as reported previously 
(27). Briefly, 6 weeks old female nude mice (Charles River, Japan) were anesthetized 
with a constant flux of 4% of isofluorane.  Dorsal skin was cut opened using 3x3cm 
cutting sides. Recovered CS constructs were placed on mouse subcutaneous dorsal 
flap and left to adhere to the connective tissue of dorsal skin for 5 minutes. After that 
time, the PVDF membranes were removed and silicone membranes were placed over 
the CS to prevent the contact between the CS and the muscular tissue. Control mice 
were prepared by implanting constructs composed of two stacked osteogenic 
monocultured sheets. Skin incisions were closed using 5-0 nylon sutures. Animals 
were kept with food and water ad libitum for all the experiment duration. After 7 days of 
transplantation, animals were euthanized with CO2 and implants were recovered for 
histological characterization. Since the implanted cells were from male rats and the 
hosts were female, we were able to track by immunohistochemistry the implanted cells 
by screening for the sex-determining region Y protein, exclusively present in the male 
cells. 
 
7.2.6 Histological characterization 
Both in vitro recovered CS constructs and implanted samples were fixed in 4% 
paraformaldehyde (Wako Pure Chemicals, Japan) and embedded in paraffin, without 
demineralization to obtain 5 µm thick sections. Hematoxylin and eosin staining was 
performed following standard protocols.  
Immunostaining was performed in both in vitro recovered CS constructs and implanted 
samples using the following antibodies: goat anti-mouse/-rat SRY (Santa Cruz 
Biotechnology, USA), rabbit anti-human/-mouse/-rat collagen I (Abcam, USA), rabbit 
anti-human/-rat/-mouse osteopontin (Abcam, USA), rabbit anti-human/-mouse/-rat 
osterix (Santa Cruz Biotechnology, USA) and mouse anti-human CD31 
(DakoCytomation, Danmark). Briefly, sections were incubated with the primary 
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antibody overnight, at 4 ºC, and then for one hour, at room temperature, with the 
biotinylated secondary antibody (DakoCytomation, Denmark). Sections were incubated 
with Streptavidin-HRP (DakoCytomation, Denmark) solution for 20 minutes and then 
treated with DAB chromogenic substrate solution (DakoCytomation, Denmark). Stained 
sections were analysed with an Eclipse E800 microscope (Nikon, Japan). 
To assess mineral deposition, Alizarin Red staining was performed both on the dishes 
with the differentiated rBMSCs and on the deparaffinized histological sections. 
Samples were incubated with alizarin red S solution (Sigma-Aldrich, Tokyo, Japan) and 
observed in the microscope until correct amount of colour developed. Cells were then 
counterstained with haematoxylin and washed in ethanol and xylene.  
 
7.2.7 PCR analysis 
RNA extraction and cDNA production 
mRNA was extracted from tissues using TriZol (Invitrogen, USA) reagent according to 
manufacturer instructions. Briefly 800 µl of TriZol were added per 50 mg of tissue and 
samples were homogeneized by vigorous pipetting and maceration.  Following 5 
minutes incubation, 160 µl of chloroform (Sigma, USA) were added to each sample; 
samples were then incubated for 15 min at 4°C and centrifuged at 13000rpm and 4°C 
for 15min. After the centrifugation the aqueous part of each sample was collected and 
an equal volume of isopropanol (Sigma, USA) was added. Following an overnight 
incubation at -20°C, samples were centrifuged at 9000 rpm and 4 ºC for 10 minutes. 
Supernatants were discarded and pellets were washed in ethanol, centrifuged at 
9000rpm and 4°C for 5min, and ressuspended in 12 µl of RNase/DNase free water 
(Gibco, UK). RNA quantity and purity were assessed with a NanoDrop ND-1000 
Spectrophotometer (NanoDrop Technologies, USA). Samples with a 260/280 ratio 
between 1.6 and 2.0 were used for cDNA synthesis. The cDNA synthesis was 
performed using iScript cDNA synthesis Kit (BioRad, USA) and the MiniOpticon Real-
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Time PCR Detection System (BioRad, USA). An initial amount of 2 µg of mRNA was 
used in a total volume of 20 µl of RNase/DNase free water.  
 
Quantitative Real Time PCR 
Mouse osteocalcin, collagen I and osterix transcripts were quantified in the cDNA 
samples using a quantitative Real Time PCR reaction.  For each sample GAPDH was 
used as the housekeeping gene. The primers were designed using the Primer 3 
software (v 0.4.0) and synthesized by MWG Biotech (Germany) as follows: osteocalcin 
forward 5’ CTGAGTCTGACAAAGCCTTC 3’ and osteocalcin reverse 5’ 
GCTGTGACATCCATACTTGC 3’; collagen I forward 5’ 
GAGCGGAGAGTACTGGATCG 3’ and collagen I reverse 5’ 
GCTTCTTTTCCTTGGGGTTC 3’; osterix forward 5’ GCTCCTCGGTTCTCTCCATCTG 
3’ and osterix reverse 5’ TGTGTTGCCTGGACCTGGTG; Mouse GAPDH forward 5’ 
ACGGCCGCATCTTCTTGTGCA 3’ and  mouse GAPDH reverse 5’ 
AATGGCAGCCCTGGTGACCA 3’;  
 A concentration of 200 nM was used for all the primers in a final volume of 25 µl of 
sample. The Real Time PCR reaction was done using the EvaGreen SuperMix 
(BioRad, USA) following manufacturer instructions in a MiniOpticon Real-Time PCR 
Detection System (BioRad, USA). 
The relative quantification of the referred gene transcripts expression was performed 
using the 2-∆∆CT method (Perkin Elmer User Bulletin No.2). All values were first 
normalized against GAPDH values and then the CS with HUVECs values against the 
CS alone values at each time point of culture.  
 
7.2.8 Calcium Quantification 
Halves of the recovered implants were weighted in and incubated in HCl 0,5M to 
remove and dissolve the calcium. Calcium quantification in the obtained solutions was 
performed with the o-cresolphtalein-complexon method using the Roche Cobas kit 
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of the samples was read at 570 nm in a microplate reader Synergy
Germany). The calcium concentrations were extrapolated from the calibration curve 
obtained using serial dilutions of a calcium chloride solution and then nor
the initial tissue mass. 
 
7.3 Results 
7.3.1 In vitro Cell Sheets characterization
Osteogenic differentiation of rBMSCs 
by the intense and uniform
culture in osteogenic medium (figure 
detected in basal medium culture
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1 – Alizarin Red staining (A) and CD31 immunostaining (C and D) of osteogenic cell sheets co
HUVECs just before retrieval from thermo
side dish) and cultured in basal medium (A, right side dish). The nuclei of all cells are stained blue with DAPI nuclear 
staining (B) and HUVECS (CD31 positive) distribution is depicted in green. A merge micrograph of B and C is presented 
(C). 
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rBMSCs cultured under osteogenic conditions, after 3 days, were organized in round or 
elongated colonies on top of the rBMSC.  
 
After recovery from the thermoresponsive dishes following low temperature treatment
the organization of the HUVECs remained in
human CD31 in a transversal section of the co
After recovery from dishes following low temperature treatment,
heterotypic CS were histologically 
were composed by a thick collagenous matrix
sheets was confirmed by Alizarin Red staining (figure 
of the CSs was further corroborated
protein osteopontin (figure 
The male origin of the cells 
SRY marker (figure 7.2F).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2 - Histological characterization  of osteogenic cell sheets after retrieval from thermo
sheets were stained with H&E (B) and alizarin red (C) and immunostained for CD31 (A) osteopontin (D), osterix (E) and 
SRY (F). Asterisks (*) indicate basal side of the cell sheets.
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Red staining (figure 7.3E and 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3 - Histological characterization of retrieved implants 7 days after transplantation of the co
monoculture (B, D, F) constructs.  Retrieved constructs were stained with H&E (A, B) and alizarin red (E, F) and 
immunostained for osteopontin (C,D).
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Comparing the SRY and the osterix stainings
cells (figure 7.4A and 7.4B)
possible to conclude that osteogenic cells
present and contributing to the formation of mineralized tissue. 
transcripts of bone-related genes were quantified for the retrieved implants
7.4E). Osteocalcin and osterix were significan
times after the implantation of the co
without HUVECs. No statistical significant difference was detected for the collagen I 
transcripts quantity between co
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.4 - Immunohistological characterization 
cell sheet (B, D) constructs implantation.  Retrieved constructs were immunostained for SRY (A, B) and osterix (C, D). 
Quantitative RT-PCR analysis (E) and calcium quantification (F) was performed in retrieved constructs one w
implantation.  In E, osteocalcin, osterix and collagen I transcripts were quantified in both co
and control cell sheet constructs (* p<0.05 relating to control values). Calcium was quantified using the o
complexon method and values were normaliz
 that respectively identify only 
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The amount of calcified tissue produced after the transplantation of the co
control constructs was determined through calcium quantification (figure 4
calcium values per amount of retrieved tissue detected for the co
were significantly higher than for the controls.
The presence of human endothelial cells in the retrieved 
confirmed by immunostaining for human CD31 (figure 
endothelial cells positive for human CD31 were
 
 
 
 
 
 
 
Figure 7.5 – Immunohistological characterization
implantation. Implants were immunostained for human CD31 (E, F) and counterstained with DAPI (F). White arrows 
indicate perfused blood vessel. 
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Monocultured and co-cultured with HUVECs, rat osteogenic CS were produced using 
thermoresponsive surfaces and the CS technology. As previously reported (19),  
mineralized CS, positive for matrix protein osteopontin and for bone related 
transcription factor osterix, all strong indicators of its osteogenic nature, and composed 
by a thick collagenous matrix were obtained by culturing rBMSCs in osteogenic 
conditions for 21 days.  
The perfusion of tissue engineered constructs after transplantation is one of the most 
critical aspects to a successful regenerative approach (6, 9-11).  Strategies for 
improving the vascularization of tissue engineered constructs consist on the use of 
growth factors or on the constructs in vitro or in vivo pre-vascularization (9, 30). The 
use of angiogenic growth factors is proven to increase the vascularization of implanted 
constructs (9, 30) but the difficulty in controlling their delivery often results in 
disorganized and leaky vessels (9, 30). In the case of in vivo prevascularization, the 
need to perform multiple surgeries is seen as a serious drawback of the approach (9). 
For these reasons, most of the current research is focusing on ways to in vitro pre-
vascularize constructs using endothelial cells in order to accelerate its perfusion after 
transplantation (6, 9-11). Similar efforts have been intense in the CS engineering field 
(26-27, 31). Sasagawa et al (27) seeded HUVECs between myoblast CS, building 5-
layers constructs, to obtain in vitro a capillary-like network that anastomosed when 
implanted in nude rats allowing the survival of the construct.  Another work (26) 
showed that the positioning of endothelial cells within two fibroblast CS constructs was 
determinant for tubular formation and influences its lumen area in vitro. Thus, it is 
increasingly clear that stacking several CS results in a suitable 3D environment for 
endothelial cells to form a pre-vascular network in vitro. In the herein presented work it 
was shown that HUVECs, seeded over rBMSCs 3 days before the end of the 
osteogenic differentiation period, self-organized either in small round colonies or in 
elongated aggregates resembling a network. Since these co-cultured CS were not 
cultured in vitro after stacking with a second osteogenic CS, which could provide a 3D 
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matrix for HUVECs re-organization, the formation of capillary-like structures, as seen in 
other works (26-27, 31), was not expected.  
The transplantation of the stacked CS constructs to nude mice clearly resulted in 
mineralized tissue formation after 7 days, both in the presence and absence of 
HUVECs. The new tissue was strongly positive for alizarin red and for bone matrix 
protein osteopontin, which confirms its mineralization and osteogenic nature. Moreover, 
it was organized in patches throughout the flap, in accordance to what was observed at 
later time points of implantation of a single CS. (19).  
The capacity of an implanted construct to induce host to produce new tissue is critical 
in a tissue engineering strategy. The contribution to neo-tissue formation of the 
transplanted cells was discriminated from the contribution of host’s cells by 
immunostaining for SRY.  The SRY protein is encoded by a gene located in the short 
arm of the Y chromosome (32) and therefore can be used to identify cells from male 
origin and, in this case, to distinguish transplanted cells from cells from the host female 
mice. Therefore, the comparison of the SRY and osterix stainings, the latter identifying 
both mouse and rat cells, permitted to verify the presence of host’s osteogenic cells in 
addition to the transplanted ones, within the new formed tissue. This proveswithout any 
doubt that the implanted CS constructs are inducing new bone formation through the 
recruitment of host’s bone forming cells.  
Although in vitro pre-vascularization ensures a faster perfusion of the construct after 
implantation, one of its pitfalls comprehends the complexity and slow determination of 
the ideal in vitro culture conditions and construct 3D design for allowing endothelial 
cells to form networks while maintaining at the same time the function of tissue-specific 
cells (6, 9). CS engineering, as CS are easy to obtain and to manipulate for assembling 
3D constructs therefore allowing a fast optimization of protocols for pre-vascularization, 
presents advantages. Nonetheless, in this work besides producing a pre-vasculature, 
we intended to take advantage of the mutual beneficial effects of the crosstalk between 
endothelial cells and osteoblasts (6), and of the intimate relation between blood vessels 
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and bone formation (6, 33) to prove that the mere presence of HUVECs within the CS-
based construct would be advantageous for new tissue formation. For this reason, the 
CS were only stacked right before implantation in determent of the pre in vitro culture of 
the 3D constructs. To achieve this, two assumptions had to be verified: the presence of 
HUVECs in new vessels, and more mineralized tissue formed after implantation of 
HUVEC-containing CS-based constructs.  
In fact, the transplanted human endothelial cells were distributed in the new tissue, 
forming vessels which were perfused with erythrocytes thus showing HUVECs 
contribution to new tissue vascularization. This is reinforced by the fact that human VE-
Cadherin transcripts were detected by qRT-PCR in the samples with HUVECs (results 
not shown).  Furthermore, calcium quantification allowed to conclude that a higher 
amount of mineralized tissue was formed in the co-culture constructs. Based on these 
results we are able to confirm the postulated hypothesis and to state clearly that 
HUVECs positively contributed to the osteogenic potential of the developed 3D CS-
based constructs. This conclusion was further reinforced by quantitative RT-PCR 
analysis of the transcripts of bone related proteins osteocalcin, osterix and collagen I. 
The expression of osteocalcin and osterix was significantly increased for co-cultured 
CS implants, which is also consistent with the higher amount of mineralized tissue 
formed. The similarity regarding the collagen I transcripts quantification between 
conditions can be explained by the fact that this protein is also present in tissues other 
than bone, such as the connective tissue found in the analyzed dorsal flaps (34-35). 
Although it was demonstrated that the transplanted HUVECs participate in the 
neovascularization of the construct we might speculate that in addition to a faster 
perfusion of the implant, the osteogenesis promoting effect of the endothelial cells (6, 
33) also led to a higher amount of bone tissue formed. Future studies will clarify on the 
exact role of endothelial cells on the formation of the new mineralized tissue. 
One aspect aspect that was not addressed in this work is the possibility of further 
culturing in vitro the stacked cell sheet constructs to build a de facto prevascular 
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network. A 3D vessel network was previously achieved in vitro in vitro by culturing five 
stacked myoblast cell sheets interspersed with HUVECs. Moreover, HUVECs were 
cultured between two myoblast cell sheets were capable of forming a network after 3 
days of co-culture (27).  Although a similar approach was not followed in the present 
work, given those previous results using similar number of cell sheets, it can be 
speculated that the in vitro formation of a capillary-like network would promote the 
vascularization of the construct and, consequently, the rate of new bone formation. 
This might also be of interest when stacking increasing number of osteogenic cell 
sheets combined with endothelial cells ultimately to obtain the thickest viable construct 
possible to consider the application of one or several scaffold-free osteogenic cell 
sheet constructs in a large bone defect. 
 
7.5 Conclusions 
Herein we have demonstrated that when combined with osteogenic CS, endothelial 
cells participate in the neo-vascularization of the new tissue formed in an ectopic 
implantation model. More importantly, double osteogenic CS constructs, with 
endothelial cells in between, led to a faster, and in increased amounts, formation of 
bone tissue as compared with control constructs without HUVECs. This, together with 
the presence of HUVECs in new vessels, confirmed its positive contribution to the 
osteogenic potential of the developed 3D CS-based constructs. It was also 
demonstrated that the transplanted CS-based constructs induce bone formation 
through the recruitment of host’s bone forming cells. 
This work highlights the versatility of CS engineering for tissue engineering 
applications, in particular for vascularized bone tissue engineering. 
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Chapter 8 
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The limitations of current strategies of Bone Tissue Engineering require a more 
thorough characterization of the mechanisms of cellular interaction between osteogenic 
cells and other cells of interest. This type of studies must mimic the in vivo setting in a 
closer way than has been achieved so far. Co-culture systems give researchers the 
chance to reproduce more accurately in vitro highly complex situations found in a living 
organism. This allows for obtaining more accurate results and consequently a faster 
advance of the knowledge which ultimately and optimally will translate better therapies 
to address the regeneration of bone defects. 
Monocytes/macrophages are immune cells present during host response, always 
developed after the implantation of a biomaterial/construct. These cells were shown to 
produce BMP-2 that can accelerate the osteogenic differentiation of osteoprogenitor 
cells. Although only a part of the whole host response scenario, it strongly suggests 
that this characteristic of monocytes/macrophages can be used to potentiate bone 
constructs outcome. The contrary happens with fibroblasts which are deeply involved in 
the formation of the fibrotic capsule that is often a mark of host response. The 
demonstration of the way fibroblasts inhibit the osteogenic activity of osteoblasts will 
allow for bone tissue engineers to consider this fact and to potentially address it by 
controlling this inhibitory effect.  
In addition to the host reaction issue another serious concern in current bone Tissue 
Engineering approaches, the vascularization hurdle, was also addressed in this thesys. 
The source of endothelial cells to assemble bone tissue engineered constructs is 
critical. Endothelial progenitor cells have been proposed as a possible source for 
creating vascularised complex 3D tissue-like structures. However, the steps for their 
isolation are time consuming and a significant controversy regarding their specific 
markers impair their future use. Moreover, the beneficial interactions between 
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osteoblasts and endothelial cells have been demonstrated as being a valuable tool for 
successfully engineer bone tissue. An in vitro co-culture system established on 
carrageenan membranes permitted to sustain the endothelial potential of the cells of 
mononuclear fraction of umbilical cord blood for subsequent implantation. More 
importantly, those mononuclear cells were capable of contributing to angiogenesis in 
vivo in an inflammatory setting which is common after implanting tissue engineered 
devices. Once again, this can potentially be very interesting for future bone Tissue 
Engineering approaches, although more detailed studies have to be made especially 
using biomaterial carriers/supports capable of eliciting host reactions with different 
degrees of severity.  
 A strategy to potentially avoid the use of biomaterials is the use of cell sheets. The 
potential of cell sheet engineering for bone Tissue Engineering applications was 
successfully demonstrated in different studies presented herein. Single osteogenic cell 
sheets were capable of promoting new bone formation that significantly increased 
along the implantation time. The new formed bone was vascularised, had a cellularized 
marrow and osteocytes which suggests that it is mature bone. Despite this result, in 
order to pursue an increased amount of newly formed bone and promote its 
vascularization, stacked osteogenic cell sheets co-cultured with endothelial cells were 
created. The verification of this hypothesis was originally achieved in vivo. A significant 
amount of bone tissue was formed and was greater when endothelial cells were 
present. More importantly, the endothelial cells were present in perfused vessels which 
suggest their contribution to the vascularization of the new bone tissue. In sum, the 
potential of using scaffold-free cell sheets for bone tissue engineering purposes and 
the advantage of co-culturing endothelial cells with the cell sheets for increased in vivo 
vascularization was confirmed. 
The results obtained in this thesis demonstrate not only the usefulness of using co-
culture models to characterize heterotypic cell interactions but also the establishment 
of cell sheet engineering as a valid technology for bone tissue engineering purposes. 
  
 
 
 
